document_id	relation	head_text	head_span	head_type	tail_text	tail_span	tail_type
25591652_en	ABBREVIATION	idiopathic generalized epilepsies	510-543	DISO	IGE	545-548	DISO
25591652_en	ALTERNATIVE_NAME	topiramate	352-362	CHEM	TPM	364-367	CHEM
25591652_en	ALTERNATIVE_NAME	valproates	389-399	CHEM	VPA	401-404	CHEM
25591652_en	ALTERNATIVE_NAME	carbamazepine	413-426	CHEM	CBZ	428-431	CHEM
25591652_en	ALTERNATIVE_NAME	lamotrigine	440-451	CHEM	LTG	453-456	CHEM
25591652_en	ALTERNATIVE_NAME	levetiracetam	468-481	CHEM	LEV	483-486	CHEM
25591652_en	ABBREVIATION	juvenile absence epilepsy	686-711	DISO	JAE	713-716	DISO
25591652_en	ABBREVIATION	childhood absence epilepsy	760-786	DISO	CAE	788-791	DISO
25591652_en	ABBREVIATION	juvenile myoclonic epilepsy	846-873	DISO	JME	875-878	DISO
25591652_en	SUBCLASS_OF	idiopathic generalized epilepsies	510-543	DISO	epilepsies	533-543	DISO
25591652_en	SUBCLASS_OF	juvenile absence epilepsy	686-711	DISO	epilepsy	703-711	DISO
25591652_en	ALTERNATIVE_NAME	epilepsies	533-543	DISO	epilepsy	703-711	DISO
25591652_en	SUBCLASS_OF	childhood absence epilepsy	760-786	DISO	epilepsy	778-786	DISO
25591652_en	SUBCLASS_OF	juvenile myoclonic epilepsy	846-873	DISO	epilepsy	865-873	DISO
25591652_en	HAS_CAUSE	eyelid myoclonus	916-932	DISO	Jeavons syndrome	934-950	DISO
25591652_en	SUBCLASS_OF	Jeavons syndrome	934-950	DISO	epilepsy	865-873	DISO
25591652_en	HAS_CAUSE	Seizure aggravations	976-996	FINDING	AEDs	1012-1016	CHEM
25591652_en	SUBCLASS_OF	resistant epilepsy	1096-1114	DISO	epilepsy	1106-1114	DISO
25591652_en	SUBCLASS_OF	resistant epilepsy	1234-1252	DISO	epilepsy	1244-1252	DISO
25591652_en	HAS_CAUSE	seizure aggravation	1448-1467	FINDING	CBZ	1488-1491	CHEM
25591652_en	SUBCLASS_OF	epileptic syndromes	1565-1584	DISO	non IGE	1586-1593	DISO
25591652_en	HAS_CAUSE	seizure aggravation	1448-1467	FINDING	LTG	1525-1528	CHEM
25591652_en	HAS_CAUSE	seizure aggravation	1448-1467	FINDING	TPM	1530-1533	CHEM
25591652_en	HAS_CAUSE	seizure aggravation	1448-1467	FINDING	CBZ	1538-1541	CHEM
25591652_en	HAS_CAUSE	seizure aggravation	1903-1922	FINDING	LTG	1953-1956	CHEM
25591652_en	HAS_CAUSE	seizure aggravation	1903-1922	FINDING	CBZ	1965-1968	CHEM
25591652_en	HAS_CAUSE	seizure aggravation	1903-1922	FINDING	TPM	1980-1983	CHEM
25591652_en	AFFECTS	eyelid myoclonus	916-932	DISO	eyelid	916-922	ANATOMY
25591652_en	HAS_CAUSE	epileptic seizure aggravation	22-51	FINDING	antiepileptic drugs	68-87	CHEM
25591652_en	ABBREVIATION	antiepileptic drugs	68-87	CHEM	AED	89-92	CHEM
25591652_en	ALTERNATIVE_NAME	poor prognosis	1119-1133	FINDING	poor outcome	1257-1269	FINDING
25591652_en	HAS_CAUSE	aggravation	559-570	FINDING	CBZ	576-579	CHEM
25591652_en	HAS_CAUSE	aggravation	559-570	FINDING	VPA	593-596	CHEM
25591652_en	HAS_CAUSE	aggravation	559-570	FINDING	TPM	605-608	CHEM
25591652_en	HAS_CAUSE	aggravation	559-570	FINDING	LEV	632-635	CHEM
25591652_en	HAS_CAUSE	aggravation	559-570	FINDING	LTG	617-620	CHEM
25591652_en	HAS_CAUSE	aggravated absences	649-668	FINDING	CBZ	645-648	CHEM
25591652_en	HAS_CAUSE	"True" aggravation	1272-1290	FINDING	CBZ	1311-1314	CHEM
25591652_en	HAS_CAUSE	"True" aggravation	1272-1290	FINDING	TPM	1363-1366	CHEM
25591652_en	HAS_CAUSE	"True" aggravation	1272-1290	FINDING	VPA	1376-1379	CHEM
25591652_en	HAS_CAUSE	"True" aggravation	1272-1290	FINDING	LTG	1385-1388	CHEM
25591652_en	HAS_CAUSE	"True" aggravation	1272-1290	FINDING	LEV	1394-1397	CHEM
25591652_en	HAS_CAUSE	"True" aggravation	1272-1290	FINDING	clonazepam	1411-1421	CHEM
25591652_en	HAS_CAUSE	absences	814-822	DISO	CBZ	645-648	CHEM
25591652_en	HAS_CAUSE	myoclonic jerks	827-842	DISO	CBZ	645-648	CHEM
25591652_en	HAS_CAUSE	absences	902-910	DISO	CBZ	645-648	CHEM
25591652_en	HAS_CAUSE	eyelid myoclonus	916-932	DISO	CBZ	645-648	CHEM
25591652_en	HAS_CAUSE	absences	902-910	DISO	Jeavons syndrome	934-950	DISO
25591652_en	HAS_CAUSE	myoclonic jerks	827-842	DISO	juvenile myoclonic epilepsy	846-873	DISO
25591652_en	HAS_CAUSE	absences	814-822	DISO	juvenile myoclonic epilepsy	846-873	DISO
25591652_en	ALTERNATIVE_NAME	Aggravated seizures	265-284	FINDING	seizure aggravation	202-221	FINDING
25591652_en	HAS_CAUSE	Seizure	1137-1144	DISO	resistant epilepsy	1234-1252	DISO
25591652_en	HAS_CAUSE	Seizures aggravation	1683-1703	FINDING	TPM	1753-1756	CHEM
25591652_en	HAS_CAUSE	Seizure aggravation	1775-1794	FINDING	AEDs	1810-1814	CHEM
25591652_en	ASSOCIATED_WITH	idiopathic generalized epilepsies	510-543	DISO	aggravation	559-570	FINDING
25591652_en	ASSOCIATED_WITH	juvenile absence epilepsy	686-711	DISO	aggravated absences	649-668	FINDING
25591652_en	ASSOCIATED_WITH	childhood absence epilepsy	760-786	DISO	aggravated absences	649-668	FINDING
25591652_en	ASSOCIATED_WITH	absences	660-668	DISO	aggravated absences	649-668	FINDING
25591652_en	ASSOCIATED_WITH	seizure	202-209	DISO	seizure aggravation	202-221	FINDING
25591652_en	ASSOCIATED_WITH	epileptic seizure	22-39	DISO	epileptic seizure aggravation	22-51	FINDING
25591652_en	ASSOCIATED_WITH	seizures	276-284	DISO	Aggravated seizures	265-284	FINDING
25591652_en	ASSOCIATED_WITH	Seizure	976-983	DISO	Seizure aggravations	976-996	FINDING
25591652_en	ASSOCIATED_WITH	Seizure	1137-1144	DISO	Seizure aggravation	1137-1156	FINDING
25591652_en	ASSOCIATED_WITH	seizure	1448-1455	DISO	seizure aggravation	1448-1467	FINDING
25591652_en	ASSOCIATED_WITH	Seizures	1683-1691	DISO	Seizures aggravation	1683-1703	FINDING
25591652_en	ASSOCIATED_WITH	Seizure	1775-1782	DISO	Seizure aggravation	1775-1794	FINDING
25591652_en	ASSOCIATED_WITH	seizure	1903-1910	DISO	seizure aggravation	1903-1922	FINDING
25591652_en	HAS_CAUSE	epileptic seizure	22-39	DISO	epileptic	22-31	DISO
25591652_en	ALTERNATIVE_NAME	epileptic seizure aggravation	22-51	FINDING	seizure aggravation	202-221	FINDING
25591652_en	ALTERNATIVE_NAME	seizure aggravation	202-221	FINDING	aggravation	559-570	FINDING
25591652_en	ASSOCIATED_WITH	childhood	760-769	PHYS	childhood absence epilepsy	760-786	DISO
25591652_en	HAS_CAUSE	pattern of aggravation	1053-1075	FINDING	aggravation	1064-1075	FINDING
25591652_en	HAS_CAUSE	aggravation	1669-1680	FINDING	AEDs	1654-1658	CHEM
25591652_en	HAS_CAUSE	risk of aggravation	2007-2026	FINDING	aggravation	2015-2026	FINDING
25591652_en	ALTERNATIVE_NAME	myoclonic jerks	827-842	DISO	myoclonic	855-864	DISO
25591652_en	HAS_CAUSE	myoclonic	855-864	DISO	myoclonic epilepsy	855-873	DISO
25591652_en	ALTERNATIVE_NAME	myoclonic	855-864	DISO	myoclonus	923-932	DISO
25591652_en	ASSOCIATED_WITH	resistant epilepsy	1096-1114	DISO	pattern of aggravation	1053-1075	FINDING
25591652_en	SUBCLASS_OF	LTG	1953-1956	CHEM	AEDs	1810-1814	CHEM
25591652_en	SUBCLASS_OF	CBZ	1965-1968	CHEM	AEDs	1810-1814	CHEM
25591652_en	SUBCLASS_OF	TPM	1980-1983	CHEM	AEDs	1810-1814	CHEM
25591652_en	SUBCLASS_OF	TPM	1753-1756	CHEM	AEDs	1654-1658	CHEM
25591652_en	SUBCLASS_OF	CBZ	1488-1491	CHEM	AEDs	1654-1658	CHEM
25591652_en	SUBCLASS_OF	LTG	1525-1528	CHEM	AEDs	1654-1658	CHEM
25591652_en	SUBCLASS_OF	CBZ	1538-1541	CHEM	AEDs	1654-1658	CHEM
25726786_en	ABBREVIATION	mild cognitive impairment	176-201	DISO	MCI	203-206	DISO
25726786_en	ABBREVIATION	coronary artery disease	301-324	DISO	CAD	326-329	DISO
25726786_en	ABBREVIATION	electroencephalogram	242-262	LABPROC	EEG	264-267	LABPROC
25726786_en	HAS_CAUSE	Mild cognitive impairment	1-26	DISO	coronary artery disease	44-67	DISO
25726786_en	HAS_CAUSE	MCI	931-934	DISO	CAD	913-916	DISO
25726786_en	HAS_CAUSE	cognitive disorders	1404-1423	DISO	CAD	1427-1430	DISO
25726786_en	AFFECTS	coronary artery disease	44-67	DISO	coronary artery	44-59	ANATOMY
25726786_en	AFFECTS	coronary artery disease	301-324	DISO	coronary artery	301-316	ANATOMY
25726786_en	AFFECTS	coronary artery lesions	1165-1188	DISO	coronary artery	1165-1180	ANATOMY
25726786_en	AFFECTS	cerebral ischemia	1240-1257	DISO	cerebral	1240-1248	ANATOMY
25726786_en	SUBCLASS_OF	Mild cognitive impairment	1-26	DISO	cognitive impairment	6-26	DISO
25726786_en	SUBCLASS_OF	mild cognitive impairment	176-201	DISO	cognitive impairment	181-201	DISO
25726786_en	AFFECTS	more severe coronary lesions	753-781	FINDING	coronary	765-773	ANATOMY
25726786_en	TO_DETECT_OR_STUDY	electroencephalogram	242-262	LABPROC	mild cognitive impairment	176-201	DISO
25726786_en	TO_DETECT_OR_STUDY	EEG	94-97	LABPROC	Mild cognitive impairment	1-26	DISO
25726786_en	TO_DETECT_OR_STUDY	EEG	1304-1307	LABPROC	neuronal dysfunction	1262-1282	DISO
25726786_en	TO_DETECT_OR_STUDY	EEG	1304-1307	LABPROC	cerebral ischemia	1240-1257	DISO
25726786_en	TO_DETECT_OR_STUDY	EEG	1345-1348	LABPROC	cognitive disorders	1404-1423	DISO
25726786_en	PHYSIOLOGY_OF	cardiac contractility	1197-1218	PHYS	cardiac	1197-1204	ANATOMY
25726786_en	PHYSIOLOGY_OF	cardiac contractility	792-813	PHYS	cardiac	792-799	ANATOMY
25726786_en	PART_OF	coronary artery	44-59	ANATOMY	coronary	44-52	ANATOMY
25726786_en	PART_OF	coronary artery	301-316	ANATOMY	coronary	301-309	ANATOMY
25726786_en	PART_OF	coronary artery	1165-1180	ANATOMY	coronary	1165-1173	ANATOMY
25726786_en	AFFECTS	neuronal dysfunction	1262-1282	DISO	neuronal	1262-1270	ANATOMY
25726786_en	PHYSIOLOGY_OF	parietooccipital theta activity	862-893	PHYS	parietooccipital	862-878	ANATOMY
25726786_en	HAS_CAUSE	higher spectral power	826-847	FINDING	CAD	913-916	DISO
25726786_en	HAS_CAUSE	lower cardiac contractility	786-813	FINDING	CAD	913-916	DISO
25726786_en	HAS_CAUSE	more severe coronary lesions	753-781	FINDING	CAD	913-916	DISO
25726786_en	HAS_CAUSE	lower cardiac contractility	786-813	FINDING	MCI	931-934	DISO
25726786_en	HAS_CAUSE	more severe coronary lesions	753-781	FINDING	MCI	931-934	DISO
25726786_en	ORIGINS_FROM	topographical features	216-238	FINDING	electroencephalogram	242-262	LABPROC
25726786_en	FINDING_OF	higher spectral power	826-847	FINDING	parietooccipital theta activity	862-893	PHYS
25726786_en	ASSOCIATED_WITH	mild cognitive impairment	176-201	DISO	demographic factors	140-159	FINDING
25726786_en	ASSOCIATED_WITH	mild cognitive impairment	176-201	DISO	clinical factors	127-159	FINDING
25726786_en	HAS_CAUSE	MCI	931-934	DISO	lower level of education	727-751	FINDING
25726786_en	SUBCLASS_OF	coronary artery	44-59	ANATOMY	artery	53-59	ANATOMY
25726786_en	PHYSIOLOGY_OF	Θ-rhythm	849-857	PHYS	parietooccipital	862-878	ANATOMY
25726786_en	ASSOCIATED_WITH	coronary lesions	765-781	DISO	more severe coronary lesions	753-781	FINDING
25726786_en	ASSOCIATED_WITH	coronary artery lesions	1165-1188	DISO	severity of coronary artery lesions	1153-1188	FINDING
25726786_en	ORIGINS_FROM	EEG power	1304-1313	FINDING	EEG	1304-1307	LABPROC
25726786_en	TO_DETECT_OR_STUDY	EEG	1304-1307	LABPROC	neuronal	1262-1270	ANATOMY
25726786_en	TO_DETECT_OR_STUDY	EEG	1304-1307	LABPROC	cerebral	1240-1248	ANATOMY
25726786_en	ALTERNATIVE_NAME	cognitive impairment	181-201	DISO	cognitive disorders	1404-1423	DISO
25823269_en	ALTERNATIVE_NAME	systemic sclerosis	391-409	DISO	SDS	411-414	DISO
25823269_en	ABBREVIATION	pulmonary hypertension	443-465	DISO	PH	467-469	DISO
25823269_en	ABBREVIATION	right atrial pressure	646-667	PHYS	RAP	669-672	PHYS
25823269_en	ABBREVIATION	cardiac output	754-768	PHYS	CO	770-772	PHYS
25823269_en	ABBREVIATION	pulmonary arterial hypertension	903-934	DISO	PAH	936-939	DISO
25823269_en	ABBREVIATION	pulmonary vascular resistance	1631-1660	PHYS	PVR	1662-1665	PHYS
25823269_en	ABBREVIATION	stress-induced pulmonary hypertension	286-323	DISO	SIPH	325-329	DISO
25823269_en	ABBREVIATION	mean pulmonary artery pressure	183-213	PHYS	MPAP	215-219	PHYS
25823269_en	AFFECTS	pulmonary hypertension	443-465	DISO	pulmonary	443-452	ANATOMY
25823269_en	AFFECTS	left heart injuries	481-500	DISO	left heart	481-491	ANATOMY
25823269_en	PART_OF	left heart	481-491	ANATOMY	heart	486-491	ANATOMY
25823269_en	TO_DETECT_OR_STUDY	thermodilution technique	779-803	LABPROC	cardiac output	754-768	PHYS
25823269_en	TO_DETECT_OR_STUDY	thermodilution technique	779-803	LABPROC	pulmonary artery wedge pressure	714-745	PHYS
25823269_en	TO_DETECT_OR_STUDY	thermodilution technique	779-803	LABPROC	hemodynamic	633-644	PHYS
25823269_en	AFFECTS	pulmonary arterial hypertension	903-934	DISO	pulmonary arterial	903-921	ANATOMY
25823269_en	APPLIED_TO	lung test	1926-1935	LABPROC	lung	1926-1930	ANATOMY
25823269_en	HAS_CAUSE	PAH	2421-2424	DISO	SDS	2406-2409	DISO
25823269_en	TO_DETECT_OR_STUDY	thermodilution technique	779-803	LABPROC	systolic pressure	675-706	PHYS
25823269_en	TO_DETECT_OR_STUDY	thermodilution technique	779-803	LABPROC	right atrial pressure	646-667	PHYS
25823269_en	TO_DETECT_OR_STUDY	thermodilution technique	779-803	LABPROC	MPAP	708-712	PHYS
25823269_en	ABBREVIATION	pulmonary artery wedge pressure	714-745	PHYS	PAWP	747-751	PHYS
25823269_en	AFFECTS	stress-induced pulmonary hypertension	286-323	DISO	pulmonary	301-310	ANATOMY
25823269_en	AFFECTS	pulmonary hypertension	46-68	DISO	pulmonary	46-55	ANATOMY
25823269_en	AFFECTS	lung injuries	472-500	DISO	lung	472-476	ANATOMY
25823269_en	PART_OF	right atrial	646-658	ANATOMY	atrial	652-658	ANATOMY
25823269_en	PHYSIOLOGY_OF	right atrial pressure	646-667	PHYS	right atrial	646-658	ANATOMY
25823269_en	PHYSIOLOGY_OF	pulmonary artery wedge pressure	714-745	PHYS	pulmonary artery	714-730	ANATOMY
25823269_en	PART_OF	pulmonary artery	188-204	ANATOMY	pulmonary	188-197	ANATOMY
25823269_en	PART_OF	pulmonary artery	714-730	ANATOMY	pulmonary	714-723	ANATOMY
25823269_en	PART_OF	pulmonary	443-452	ANATOMY	lung	472-476	ANATOMY
25823269_en	PHYSIOLOGY_OF	cardiac output	754-768	PHYS	cardiac	754-761	ANATOMY
25823269_en	PART_OF	pulmonary arterial	903-921	ANATOMY	pulmonary	903-912	ANATOMY
25823269_en	PART_OF	pulmonary vascular	1631-1649	ANATOMY	pulmonary	1631-1640	ANATOMY
25823269_en	PHYSIOLOGY_OF	pulmonary vascular resistance	1631-1660	PHYS	pulmonary vascular	1631-1649	ANATOMY
25823269_en	AFFECTS	pulmonary vasculopathy	2190-2212	DISO	pulmonary	2190-2199	ANATOMY
25823269_en	TREATED_USING	PAH	2280-2283	DISO	PAH-specific drugs	2280-2298	CHEM
25823269_en	SUBCLASS_OF	SIPH	2167-2171	DISO	pulmonary vasculopathy	2190-2212	DISO
25823269_en	HAS_CAUSE	higher levels	1588-1601	FINDING	SIPH	1565-1569	DISO
25823269_en	HAS_CAUSE	level of uric acid was also higher	1754-1788	FINDING	SIPH	1796-1800	DISO
25823269_en	HAS_CAUSE	calculated DETECT risk was significantly higher	1682-1729	FINDING	SIPH	1737-1741	DISO
25823269_en	HAS_CAUSE	improve lifetime prognosis	2362-2388	FINDING	PAH-specific drugs	2280-2298	CHEM
25823269_en	FINDING_OF	correlations	1485-1497	FINDING	MPAP	1506-1510	PHYS
25823269_en	TO_DETECT_OR_STUDY	thermodilution technique	779-803	LABPROC	diastolic pressure	688-706	PHYS
25823269_en	FINDING_OF	higher levels	1588-1601	FINDING	MPAP	1613-1617	PHYS
25823269_en	FINDING_OF	higher levels	1588-1601	FINDING	pulmonary vascular resistance	1631-1660	PHYS
25823269_en	FINDING_OF	higher levels	1588-1601	FINDING	PAWP	1671-1675	PHYS
25823269_en	FINDING_OF	no changes	1831-1841	FINDING	NT-proBNP levels	1845-1861	PHYS
25823269_en	FINDING_OF	no changes	1831-1841	FINDING	telangiectasias	1863-1878	PHYS
25823269_en	ORIGINS_FROM	no changes	1831-1841	FINDING	EchoCG	1915-1921	LABPROC
25823269_en	ORIGINS_FROM	no changes	1831-1841	FINDING	lung test	1926-1935	LABPROC
25823269_en	FINDING_OF	decrease	2003-2011	FINDING	MPAP	2015-2019	PHYS
25823269_en	FINDING_OF	decrease	2003-2011	FINDING	transpulmonary gradient	2024-2047	PHYS
25823269_en	FINDING_OF	tended to decrease	2109-2127	FINDING	NT-proBNP levels	2092-2108	PHYS
25823269_en	FINDING_OF	tended to decrease	2109-2127	FINDING	MPAP/CO ratio	2074-2087	PHYS
25823269_en	FINDING_OF	tended to decrease	2109-2127	FINDING	PVR	2069-2072	PHYS
25823269_en	ASSOCIATED_WITH	PAH	2255-2258	DISO	precedes the development of clinical PAH	2218-2258	FINDING
25823269_en	SUBCLASS_OF	stress-induced pulmonary hypertension	286-323	DISO	pulmonary hypertension	301-323	DISO
25823269_en	SUBCLASS_OF	pulmonary hypertension	301-323	DISO	hypertension	311-323	DISO
25823269_en	SUBCLASS_OF	systemic sclerosis	86-104	DISO	sclerosis	95-104	DISO
25823269_en	SUBCLASS_OF	pulmonary hypertension	46-68	DISO	hypertension	56-68	DISO
25823269_en	SUBCLASS_OF	stress-induced pulmonary hypertension	31-68	DISO	pulmonary hypertension	46-68	DISO
25823269_en	TREATED_USING	stress-induced pulmonary hypertension	31-68	DISO	bosentan	11-19	CHEM
25823269_en	FINDING_OF	elevated mean pulmonary artery pressure	174-213	FINDING	mean pulmonary artery pressure	183-213	PHYS
25823269_en	TREATED_USING	stress-induced pulmonary hypertension	286-323	DISO	bosentan	266-274	CHEM
25823269_en	PHYSIOLOGY_OF	mean pulmonary artery pressure	183-213	PHYS	pulmonary artery	188-204	ANATOMY
25823269_en	ALTERNATIVE_NAME	pulmonary	443-452	ANATOMY	lung	472-476	ANATOMY
25823269_en	SUBCLASS_OF	right atrial pressure	646-667	PHYS	pressure	659-667	PHYS
25823269_en	SUBCLASS_OF	pulmonary artery wedge pressure	714-745	PHYS	pressure	737-745	PHYS
25823269_en	ALTERNATIVE_NAME	heart	486-491	ANATOMY	cardiac	754-761	ANATOMY
25823269_en	SUBCLASS_OF	pulmonary arterial hypertension	903-934	DISO	hypertension	922-934	DISO
25823269_en	TREATED_USING	SIPH	978-982	DISO	bosentan	1000-1008	CHEM
25823269_en	ASSOCIATED_WITH	pulmonary arterial hypertension	903-934	DISO	risk of pulmonary arterial hypertension	895-934	FINDING
25823269_en	SUBCLASS_OF	uric acid	1763-1772	CHEM	acid	1768-1772	CHEM
25823269_en	FINDING_OF	level of uric acid was also higher	1754-1788	FINDING	level of uric acid	1754-1772	PHYS
25823269_en	ASSOCIATED_WITH	level of uric acid	1754-1772	PHYS	uric acid	1763-1772	CHEM
25823269_en	HAS_CAUSE	decrease	2003-2011	FINDING	bosentan	1961-1969	CHEM
25823269_en	HAS_CAUSE	tended to decrease	2109-2127	FINDING	bosentan	1961-1969	CHEM
25823269_en	ASSOCIATED_WITH	NT-proBNP levels	2092-2108	PHYS	NT-proBNP	2092-2101	CHEM
25823269_en	ASSOCIATED_WITH	pulmonary vasculopathy	2190-2212	DISO	precedes the development of clinical PAH	2218-2258	FINDING
25823269_en	SUBCLASS_OF	SDS-associated PAH	2406-2424	DISO	SDS	2406-2409	DISO
25823269_en	SUBCLASS_OF	SDS-associated PAH	2406-2424	DISO	PAH	2421-2424	DISO
25823273_en	ABBREVIATION	coronary heart disease	993-1015	DISO	CHD	1017-1020	DISO
25823273_en	AFFECTS	Cardiovascular diseases	1-24	DISO	Cardiovascular	1-15	ANATOMY
25823273_en	AFFECTS	cardiovascular diseases	173-196	DISO	cardiovascular	173-187	ANATOMY
25823273_en	TO_DETECT_OR_STUDY	blood biochemical test	728-750	LABPROC	blood	728-733	ANATOMY
25823273_en	AFFECTS	coronary heart disease	993-1015	DISO	heart	1002-1007	ANATOMY
25823273_en	PART_OF	coronary	993-1001	ANATOMY	heart	1002-1007	ANATOMY
25823273_en	HAS_CAUSE	development of hypertension	830-857	FINDING	high concentration of sulfur dioxide	881-917	FINDING
25823273_en	HAS_CAUSE	coronary heart disease	993-1015	DISO	high levels of nitrogen dioxide	1040-1071	FINDING
25823273_en	ASSOCIATED_WITH	hypertension	845-857	DISO	development of hypertension	830-857	FINDING
25823273_en	TO_DETECT_OR_STUDY	blood general tests	580-617	LABPROC	blood	580-585	ANATOMY
25823273_en	TO_DETECT_OR_STUDY	immunological tests	598-617	LABPROC	blood	580-585	ANATOMY
25823273_en	HAS_CAUSE	high concentration of sulfur dioxide	881-917	FINDING	sulfur dioxide	903-917	CHEM
25823273_en	HAS_CAUSE	high levels of nitrogen dioxide	1040-1071	FINDING	nitrogen dioxide	1055-1071	CHEM
25823273_en	HAS_CAUSE	CHD	1236-1239	DISO	may result from the influence of EFs	1277-1313	FINDING
25823273_en	HAS_CAUSE	hypertension	1219-1231	DISO	may result from the influence of EFs	1277-1313	FINDING
25823273_en	USED_IN	sulfur	903-909	CHEM	sulfur dioxide	903-917	CHEM
25823273_en	SUBCLASS_OF	sulfur dioxide	903-917	CHEM	dioxide	910-917	CHEM
25823273_en	SUBCLASS_OF	nitrogen dioxide	1055-1071	CHEM	dioxide	1064-1071	CHEM
25823273_en	USED_IN	nitrogen	1055-1063	CHEM	nitrogen dioxide	1055-1071	CHEM
25823273_en	HAS_CAUSE	development of hypertension	830-857	FINDING	copper	938-944	CHEM
25823273_en	HAS_CAUSE	development of hypertension	830-857	FINDING	zinc	968-972	CHEM
25823273_en	HAS_CAUSE	coronary heart disease	993-1015	DISO	zinc	1095-1099	CHEM
25823273_en	ASSOCIATED_WITH	cardiovascular diseases	173-196	DISO	development of cardiovascular diseases	158-196	FINDING
25823273_en	HAS_CAUSE	development of cardiovascular diseases	158-196	FINDING	influence of environmental factors (EFs)	110-150	FINDING
25823275_en	ALTERNATIVE_NAME	arbidol	22-29	CHEM	umifenovir	31-41	CHEM
25823275_en	ALTERNATIVE_NAME	Arbidol	223-230	CHEM	umifenovir	232-242	CHEM
25823275_en	TREATED_USING	influenza	1949-1958	DISO	umifenovir	1918-1928	CHEM
25823275_en	TREATED_USING	influenza	61-70	DISO	arbidol	22-29	CHEM
25823275_en	AFFECTS	acute respiratory tract infection	507-540	DISO	respiratory tract	513-530	ANATOMY
25823275_en	TREATED_USING	influenza	267-276	DISO	Arbidol	223-230	CHEM
25823275_en	AFFECTS	respiratory tract infection	513-540	DISO	respiratory tract	513-530	ANATOMY
25823275_en	TREATED_USING	influenza	970-979	DISO	umifenovir	903-913	CHEM
25823275_en	TREATED_USING	influenza	1019-1028	DISO	umifenovir	903-913	CHEM
25823275_en	TREATED_USING	influenza	1063-1072	DISO	umifenovir	903-913	CHEM
25823275_en	TREATED_USING	influenza	1318-1327	DISO	umifenovir	1335-1345	CHEM
25823275_en	TREATED_USING	influenza	1742-1751	DISO	umifenovir	1800-1810	CHEM
25823275_en	TREATED_USING	influenza	1742-1751	DISO	placebo	1829-1836	CHEM
25823275_en	HAS_CAUSE	reduced with umifenovir compared to placebo	1488-1531	FINDING	umifenovir	1501-1511	CHEM
25823275_en	HAS_CAUSE	reduction of time to resolution of all symptoms of the disease	2041-2103	FINDING	umifenovir	1918-1928	CHEM
25823275_en	HAS_CAUSE	reducing the severity of symptoms of the disease and durations of virus shedding	2105-2185	FINDING	umifenovir	1918-1928	CHEM
25823275_en	TREATED_USING	influenza	1318-1327	DISO	placebo	1393-1400	CHEM
25823275_en	HAS_CAUSE	reduced with umifenovir compared to placebo	1488-1531	FINDING	Severity of illness	1427-1446	FINDING
25823275_en	SUBCLASS_OF	respiratory tract infection	513-540	DISO	infection	531-540	DISO
25823275_en	PHYSIOLOGY_OF	respiratory	513-524	PHYS	respiratory tract	513-530	ANATOMY
25823275_en	HAS_CAUSE	efficacy	755-763	FINDING	time to resolution of all symptoms	779-813	FINDING
25823275_en	HAS_CAUSE	efficacy	755-763	FINDING	severity of symptoms and illness	815-847	FINDING
25823275_en	HAS_CAUSE	efficacy	755-763	FINDING	durations of virus shedding	849-876	FINDING
25823275_en	ALTERNATIVE_NAME	efficacy	755-763	FINDING	efficacy of umifenovir	891-913	FINDING
25823275_en	ASSOCIATED_WITH	influenza	1063-1072	DISO	clinical and epidemiological data	1091-1124	FINDING
25823275_en	HAS_CAUSE	time to resolution of all symptoms	1159-1193	FINDING	Umifenovir	1127-1137	CHEM
25823275_en	ASSOCIATED_WITH	influenza	1318-1327	DISO	laboratory-confirmed influenza	1297-1327	FINDING
25823275_en	HAS_CAUSE	All symptoms were resolved	1196-1222	FINDING	umifenovir	1335-1345	CHEM
25823275_en	ASSOCIATED_WITH	influenza	1318-1327	DISO	All symptoms were resolved	1196-1222	FINDING
25823275_en	ASSOCIATED_WITH	intoxication	1471-1483	DISO	reduced with umifenovir compared to placebo	1488-1531	FINDING
25823275_en	ASSOCIATED_WITH	catarrhal symptoms	1448-1466	DISO	reduced with umifenovir compared to placebo	1488-1531	FINDING
25823275_en	TREATED_USING	catarrhal symptoms	1448-1466	DISO	umifenovir	1501-1511	CHEM
25823275_en	TREATED_USING	intoxication	1471-1483	DISO	umifenovir	1501-1511	CHEM
25823275_en	HAS_CAUSE	viral shedding	1682-1696	FINDING	Umifenovir	1643-1653	CHEM
25823275_en	ASSOCIATED_WITH	influenza	1742-1751	DISO	shedding influenza virus	1733-1757	FINDING
25823275_en	HAS_CAUSE	ignificantly reduced in the umifenovir group compared to placebo	1772-1836	FINDING	shedding influenza virus	1733-1757	FINDING
25823275_en	HAS_CAUSE	reducing the severity of symptoms of the disease and durations of virus shedding	2105-2185	FINDING	the severity of symptoms of the disease	2114-2153	FINDING
25823275_en	HAS_CAUSE	reducing the severity of symptoms of the disease and durations of virus shedding	2105-2185	FINDING	durations of virus shedding	2158-2185	FINDING
25823275_en	ASSOCIATED_WITH	influenza	1949-1958	DISO	most pronounced in the acute stage of the disease	1972-2021	FINDING
25823275_en	ASSOCIATED_WITH	influenza	1949-1958	DISO	reduction of time to resolution of all symptoms of the disease	2041-2103	FINDING
25823275_en	ASSOCIATED_WITH	influenza	1949-1958	DISO	reducing the severity of symptoms of the disease and durations of virus shedding	2105-2185	FINDING
25842921_en	ABBREVIATION	ischemic cardiomyopathy	75-98	DISO	ICM	100-103	DISO
25842921_en	ABBREVIATION	chronic heart disease	151-172	DISO	CHD	174-177	DISO
25842921_en	AFFECTS	CHD	985-988	DISO	endothelial	1001-1012	ANATOMY
25842921_en	AFFECTS	hypoxia	1130-1137	DISO	fascicules	1201-1211	ANATOMY
25842921_en	AFFECTS	coronary insufficiency	536-558	DISO	coronary	536-544	ANATOMY
25842921_en	AFFECTS	coronary atherosclerosis	1836-1860	DISO	coronary	1836-1844	ANATOMY
25842921_en	AFFECTS	damaged myocardium	1885-1903	DISO	myocardium	1893-1903	ANATOMY
25842921_en	AFFECTS	chronic heart disease	151-172	DISO	heart	159-164	ANATOMY
25842921_en	SUBCLASS_OF	ischemic cardiomyopathy	75-98	DISO	chronic heart disease	151-172	DISO
25842921_en	APPLIED_TO	cardiac biopsies	315-331	LABPROC	cardiac	315-322	ANATOMY
25842921_en	AFFECTS	damage to the vascular bed	1454-1480	DISO	vascular bed	1468-1480	ANATOMY
25842921_en	TO_DETECT_OR_STUDY	biochemical monitoring	804-826	LABPROC	blood	830-835	ANATOMY
25842921_en	TO_DETECT_OR_STUDY	biochemical monitoring	804-826	LABPROC	triglyceride levels	852-871	PHYS
25842921_en	PHYSIOLOGY_OF	microhemocirculatory	1053-1073	PHYS	microhemocirculatory bed	1053-1077	ANATOMY
25842921_en	TO_DETECT_OR_STUDY	biochemical monitoring	804-826	LABPROC	levels	865-871	PHYS
25842921_en	PHYSIOLOGY_OF	morphological changes	1927-1948	PHYS	myocardium	1893-1903	ANATOMY
25842921_en	AFFECTS	chronic heart failure	198-219	DISO	heart	206-211	ANATOMY
25842921_en	HAS_CAUSE	impaired blood flow	1103-1122	DISO	endothelial changes	1001-1020	FINDING
25842921_en	HAS_CAUSE	hypoxia	1130-1137	DISO	endothelial changes	1001-1020	FINDING
25842921_en	AFFECTS	damage to microvessels	1275-1297	DISO	microvessels	1285-1297	ANATOMY
25842921_en	AFFECTS	damage to nerve endings	1275-1359	DISO	nerve endings	1346-1359	ANATOMY
25842921_en	AFFECTS	damage to lymph capillaries	1275-1340	DISO	lymph capillaries	1323-1340	ANATOMY
25842921_en	AFFECTS	damage to stroma	1275-1321	DISO	stroma	1315-1321	ANATOMY
25842921_en	AFFECTS	damage to cardiomyocytes	1275-1313	DISO	cardiomyocytes	1299-1313	ANATOMY
25842921_en	AFFECTS	damage to the myocardial tissue	1454-1502	DISO	myocardial tissue	1485-1502	ANATOMY
25842921_en	PART_OF	myocardial tissue	1485-1502	ANATOMY	myocardial	1485-1495	ANATOMY
25842921_en	HAS_CAUSE	micro disturbances	1597-1667	DISO	occurring lesions	1534-1551	DISO
25842921_en	HAS_CAUSE	lymphocirculatory disturbances	1608-1667	DISO	occurring lesions	1534-1551	DISO
25842921_en	HAS_CAUSE	innervation disturbances	1627-1667	DISO	occurring lesions	1534-1551	DISO
25842921_en	HAS_CAUSE	conduction disturbances	1644-1667	DISO	occurring lesions	1534-1551	DISO
25842921_en	HAS_CAUSE	ICM	1783-1786	DISO	myocardial changes	1738-1756	FINDING
25842921_en	HAS_CAUSE	cardiomyocyte damage	1683-1703	DISO	occurring lesions	1534-1551	DISO
25842921_en	AFFECTS	chronic heart failure	2175-2196	DISO	heart	2183-2188	ANATOMY
25842921_en	SUBCLASS_OF	chronic heart failure	2175-2196	DISO	ICM	2145-2148	DISO
25842921_en	HAS_CAUSE	irregular diffuse cardiosclerosis	1562-1595	DISO	occurring lesions	1534-1551	DISO
25842921_en	SUBCLASS_OF	ischemic cardiomyopathy	75-98	DISO	chronic heart failure	198-219	DISO
25842921_en	APPLIED_TO	cardiac biopsies	315-331	LABPROC	myocardia	403-412	ANATOMY
25842921_en	ORIGINS_FROM	triglyceride	852-864	CHEM	blood	830-835	ANATOMY
25842921_en	ASSOCIATED_WITH	Compensatory responses	1387-1422	PHYS	damage to the vascular bed	1454-1480	DISO
25842921_en	ASSOCIATED_WITH	adaptive responses	1404-1422	PHYS	damage to the myocardial tissue	1454-1502	DISO
25842921_en	ASSOCIATED_WITH	Compensatory responses	1387-1422	PHYS	damage to the myocardial tissue	1454-1502	DISO
25842921_en	ORIGINS_FROM	trophic component	1028-1045	CHEM	microhemocirculatory bed	1053-1077	ANATOMY
25842921_en	AFFECTS	endothelial changes	1001-1020	FINDING	endothelial	1001-1012	ANATOMY
25842921_en	HAS_CAUSE	endothelial changes	1001-1020	FINDING	CHD	985-988	DISO
25842921_en	ORIGINS_FROM	trophic component	1028-1045	CHEM	endothelial	1001-1012	ANATOMY
25842921_en	PART_OF	endothelial	1001-1012	ANATOMY	microhemocirculatory bed	1053-1077	ANATOMY
25842921_en	SUBCLASS_OF	chronic heart disease	151-172	DISO	heart disease	159-172	DISO
25842921_en	SUBCLASS_OF	chronic heart failure	198-219	DISO	heart failure	206-219	DISO
25842921_en	SUBCLASS_OF	irregular diffuse cardiosclerosis	1562-1595	DISO	diffuse cardiosclerosis	1572-1595	DISO
25842921_en	SUBCLASS_OF	diffuse cardiosclerosis	1572-1595	DISO	cardiosclerosis	1580-1595	DISO
25842921_en	SUBCLASS_OF	chronic heart failure	2175-2196	DISO	heart failure	2183-2196	DISO
25842921_en	SUBCLASS_OF	chronic CHD	2093-2104	DISO	CHD	2101-2104	DISO
25842921_en	SUBCLASS_OF	occurring lesions	1534-1551	DISO	lesions	1544-1551	DISO
25842921_en	HAS_CAUSE	morphological changes	1927-1948	PHYS	coronary atherosclerosis progresses	1836-1871	FINDING
25842921_en	ASSOCIATED_WITH	chronic CHD	2093-2104	DISO	progression of chronic CHD	2078-2104	FINDING
25842921_en	SUBCLASS_OF	ischemic cardiomyopathy	26-49	DISO	cardiomyopathy	35-49	DISO
25842921_en	HAS_CAUSE	ischemic cardiomyopathy	26-49	DISO	ischemic	26-34	DISO
25842921_en	ASSOCIATED_WITH	ischemic cardiomyopathy	26-49	DISO	Functional morphology of ischemic cardiomyopathy	1-49	FINDING
25842921_en	HAS_CAUSE	ischemic cardiomyopathy	75-98	DISO	ischemic	75-83	DISO
25842921_en	SUBCLASS_OF	ischemic cardiomyopathy	75-98	DISO	cardiomyopathy	84-98	DISO
25842921_en	SUBCLASS_OF	cardiac biopsies	315-331	LABPROC	biopsies	323-331	LABPROC
25842921_en	SUBCLASS_OF	coronary insufficiency	536-558	DISO	insufficiency	545-558	DISO
25842921_en	HAS_CAUSE	coronary insufficiency	536-558	DISO	vasopressin	565-576	CHEM
25842921_en	ASSOCIATED_WITH	levels	865-871	PHYS	cholesterol	836-847	CHEM
25842921_en	ASSOCIATED_WITH	triglyceride levels	852-871	PHYS	triglyceride	852-864	CHEM
25842921_en	ORIGINS_FROM	cholesterol	836-847	CHEM	blood	830-835	ANATOMY
25842921_en	PHYSIOLOGY_OF	triglyceride levels	852-871	PHYS	blood	830-835	ANATOMY
25842921_en	PHYSIOLOGY_OF	levels	865-871	PHYS	blood	830-835	ANATOMY
25842921_en	USED_IN	ECG	876-879	LABPROC	ECG monitoring	876-890	LABPROC
25842921_en	AFFECTS	impaired blood flow	1103-1122	DISO	blood	1112-1117	ANATOMY
25842921_en	ASSOCIATED_WITH	blood flow	1112-1122	PHYS	impaired blood flow	1103-1122	DISO
25842921_en	PHYSIOLOGY_OF	blood flow	1112-1122	PHYS	blood	1112-1117	ANATOMY
25842921_en	PART_OF	fascicules	1201-1211	ANATOMY	myocardial	1158-1168	ANATOMY
25842921_en	ALTERNATIVE_NAME	myocardia	403-412	ANATOMY	myocardial	1158-1168	ANATOMY
25842921_en	FINDING_OF	changes in secretion	1364-1384	FINDING	secretion	1375-1384	PHYS
25842921_en	PART_OF	nerve endings	1346-1359	ANATOMY	nerve	1346-1351	ANATOMY
25842921_en	PART_OF	lymph capillaries	1323-1340	ANATOMY	lymph	1323-1328	ANATOMY
25842921_en	AFFECTS	symptoms of damage to the vascular bed and myocardial tissue	1442-1502	FINDING	vascular bed	1468-1480	ANATOMY
25842921_en	ASSOCIATED_WITH	damage to the myocardial tissue	1454-1502	DISO	symptoms of damage to the vascular bed and myocardial tissue	1442-1502	FINDING
25842921_en	ASSOCIATED_WITH	damage to the vascular bed	1454-1480	DISO	symptoms of damage to the vascular bed and myocardial tissue	1442-1502	FINDING
25842921_en	ASSOCIATED_WITH	adaptive responses	1404-1422	PHYS	damage to the vascular bed	1454-1480	DISO
25842921_en	HAS_CAUSE	Compensatory responses	1387-1422	PHYS	symptoms of damage to the vascular bed and myocardial tissue	1442-1502	FINDING
25842921_en	HAS_CAUSE	adaptive responses	1404-1422	PHYS	symptoms of damage to the vascular bed and myocardial tissue	1442-1502	FINDING
25842921_en	ASSOCIATED_WITH	conduction	1644-1654	PHYS	conduction disturbances	1644-1667	DISO
25842921_en	ASSOCIATED_WITH	innervation	1627-1638	PHYS	innervation disturbances	1627-1667	DISO
25842921_en	ASSOCIATED_WITH	lymphocirculatory	1608-1625	PHYS	lymphocirculatory disturbances	1608-1667	DISO
25842921_en	AFFECTS	cardiomyocyte damage	1683-1703	DISO	cardiomyocyte	1683-1696	ANATOMY
25842921_en	AFFECTS	myocardial changes	1738-1756	FINDING	myocardial	1738-1748	ANATOMY
25842921_en	ASSOCIATED_WITH	coronary atherosclerosis	1836-1860	DISO	coronary atherosclerosis progresses	1836-1871	FINDING
25842921_en	AFFECTS	coronary atherosclerosis progresses	1836-1871	FINDING	myocardium	1893-1903	ANATOMY
25842921_en	HAS_CAUSE	morphological changes	1927-1948	PHYS	hypoxia	1966-1973	DISO
25842921_en	ASSOCIATED_WITH	CHD	2257-2260	DISO	pathogenesis and morphogenesis of CHD	2223-2260	FINDING
25842923_en	ABBREVIATION	stem cell niches	132-148	ANATOMY	SCN	150-153	ANATOMY
25842923_en	ABBREVIATION	idiopathic interstitial pneumonias	271-305	DISO	IIP	307-310	DISO
25842923_en	ABBREVIATION	idiopathic pulmonary fibrosis	323-352	DISO	IPF	354-357	DISO
25842923_en	ABBREVIATION	DIP	397-400	DISO	desquamative interstitial pneumonia	360-395	DISO
25842923_en	ABBREVIATION	cryptogenic organizing pneumonia	403-435	DISO	COP	437-440	DISO
25842923_en	ABBREVIATION	bronchiolitis obliterans	447-471	DISO	BO	473-475	DISO
25842923_en	ABBREVIATION	nonspecific interstitial pneumonia	482-516	DISO	NSIP	518-522	DISO
25842923_en	AFFECTS	inflammatory infiltrate	1501-1524	DISO	SCN	1565-1568	ANATOMY
25842923_en	AFFECTS	spread of a lesion to different SCN areas	1533-1574	FINDING	SCN	1565-1568	ANATOMY
25842923_en	AFFECTS	damage to the SCN areas	2016-2039	DISO	respiratory acinus	2047-2065	ANATOMY
25842923_en	AFFECTS	respiratory acinus damages	1439-1465	DISO	respiratory acinus	1439-1457	ANATOMY
25842923_en	AFFECTS	SCN damage	1863-1873	DISO	SCN	1863-1866	ANATOMY
25842923_en	AFFECTS	damage to the SCN areas	2016-2039	DISO	SCN areas	2030-2039	ANATOMY
25842923_en	AFFECTS	damage to the stem cell niches	118-148	DISO	respiratory acini	162-179	ANATOMY
25842923_en	AFFECTS	damage to the stem cell niches	118-148	DISO	stem cell niches	132-148	ANATOMY
25842923_en	AFFECTS	idiopathic pulmonary fibrosis	323-352	DISO	pulmonary	334-343	ANATOMY
25842923_en	SUBCLASS_OF	desquamative interstitial pneumonia	360-395	DISO	interstitial pneumonia	373-395	DISO
25842923_en	SUBCLASS_OF	cryptogenic organizing pneumonia	403-435	DISO	organizing pneumonia	415-435	DISO
25842923_en	SUBCLASS_OF	nonspecific interstitial pneumonia	482-516	DISO	interstitial pneumonia	494-516	DISO
25842923_en	PHYSIOLOGY_OF	regeneration of lung tissue	1591-1618	PHYS	lung tissue	1607-1618	ANATOMY
25842923_en	AFFECTS	spread of a lesion to different SCN areas	1533-1574	FINDING	lung tissue	1607-1618	ANATOMY
25842923_en	AFFECTS	inflammatory infiltrate	1501-1524	DISO	lung tissue	1607-1618	ANATOMY
25842923_en	ALTERNATIVE_NAME	vimentin	963-971	CHEM	Vimentin	973-981	CHEM
25842923_en	PART_OF	respiratory acini	162-179	ANATOMY	lung	187-191	ANATOMY
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	MMP-1	911-916	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	MMP-2	918-923	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	MMP-7	925-930	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	Apo-Cas	932-939	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	vimentin	963-971	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	SMA	1004-1007	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	TGF-β	1030-1035	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	TNF-α	1037-1042	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	CD34	1044-1048	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	Ost-4	1050-1055	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	CD117	1061-1066	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	CD68	1083-1087	CHEM
25842923_en	TO_DETECT_OR_STUDY	immunohistochemical reactions	854-883	LABPROC	EMA	1093-1096	CHEM
25842923_en	ALTERNATIVE_NAME	SCN damage	1863-1873	DISO	damage to the stem cell niches	118-148	DISO
25842923_en	ALTERNATIVE_NAME	SCN damage	1863-1873	DISO	damage to the SCN areas	2016-2039	DISO
25842923_en	PART_OF	stem cell niches	132-148	ANATOMY	respiratory acini	162-179	ANATOMY
25842923_en	AFFECTS	idiopathic interstitial pneumonias	271-305	DISO	lung	187-191	ANATOMY
25842923_en	SUBCLASS_OF	idiopathic interstitial pneumonias	271-305	DISO	interstitial pneumonias	282-305	DISO
25842923_en	HAS_CAUSE	respiratory acinus damages	1439-1465	DISO	inflammatory infiltrate	1501-1524	DISO
25842923_en	HAS_CAUSE	respiratory acinus damages	1439-1465	DISO	spread of a lesion to different SCN areas	1533-1574	FINDING
25842923_en	PART_OF	SCN areas	2030-2039	ANATOMY	respiratory acinus	2047-2065	ANATOMY
25842923_en	ORIGINS_FROM	Oct-4	1752-1757	CHEM	mesenchymal stem cell	1713-1734	ANATOMY
25842923_en	ORIGINS_FROM	Vimentin	1759-1767	CHEM	mesenchymal stem cell	1713-1734	ANATOMY
25842923_en	ORIGINS_FROM	SMA	1769-1772	CHEM	mesenchymal stem cell	1713-1734	ANATOMY
25842923_en	ORIGINS_FROM	CD34	1785-1789	CHEM	mesenchymal stem cell	1713-1734	ANATOMY
25842923_en	ORIGINS_FROM	CD117	1774-1779	CHEM	mesenchymal stem cell	1713-1734	ANATOMY
25842923_en	ASSOCIATED_WITH	morphological changes	1942-1963	PHYS	IPP	1967-1970	DISO
25842923_en	SUBCLASS_OF	idiopathic pulmonary fibrosis	323-352	DISO	pulmonary fibrosis	334-352	DISO
25842923_en	PHYSIOLOGY_OF	myofibroblast differentiation	1646-1675	PHYS	mesenchymal cell	1624-1640	ANATOMY
25842923_en	SUBCLASS_OF	idiopathic pulmonary fibrosis	323-352	DISO	chronic idiopathic interstitial pneumonias	263-305	DISO
25842923_en	SUBCLASS_OF	stem cell	132-141	ANATOMY	cell	137-141	ANATOMY
25842923_en	AFFECTS	morphological and molecular biological features	67-114	FINDING	stem cell niches	132-148	ANATOMY
25842923_en	ASSOCIATED_WITH	damage to the stem cell niches	118-148	DISO	morphological and molecular biological features	67-114	FINDING
25842923_en	PHYSIOLOGY_OF	respiratory	162-173	PHYS	respiratory acini	162-179	ANATOMY
25842923_en	ALTERNATIVE_NAME	lung	187-191	ANATOMY	pulmonary	334-343	ANATOMY
25842923_en	SUBCLASS_OF	desquamative interstitial pneumonia	360-395	DISO	chronic idiopathic interstitial pneumonias	263-305	DISO
25842923_en	SUBCLASS_OF	cryptogenic organizing pneumonia	403-435	DISO	chronic idiopathic interstitial pneumonias	263-305	DISO
25842923_en	SUBCLASS_OF	bronchiolitis obliterans	447-471	DISO	chronic idiopathic interstitial pneumonias	263-305	DISO
25842923_en	SUBCLASS_OF	interstitial pneumonia	494-516	DISO	pneumonia	507-516	DISO
25842923_en	SUBCLASS_OF	nonspecific interstitial pneumonia	482-516	DISO	chronic idiopathic interstitial pneumonias	263-305	DISO
25842923_en	HAS_CAUSE	bronchiolitis obliterans	447-471	DISO	bronchiolitis	447-460	DISO
25842923_en	SUBCLASS_OF	cryptogenic organizing pneumonia (COP) with bronchiolitis obliterans	403-471	DISO	cryptogenic organizing pneumonia	403-435	DISO
25842923_en	SUBCLASS_OF	cryptogenic organizing pneumonia (COP) with bronchiolitis obliterans	403-471	DISO	bronchiolitis obliterans	447-471	DISO
25842923_en	PART_OF	lung biopsies	629-642	ANATOMY	lung	629-633	ANATOMY
25842923_en	SUBCLASS_OF	lung biopsies	629-642	ANATOMY	biopsies	634-642	ANATOMY
25842923_en	SUBCLASS_OF	COP + BO	740-748	DISO	COP	740-743	DISO
25842923_en	SUBCLASS_OF	COP + BO	740-748	DISO	BO	746-748	DISO
25842923_en	APPLIED_TO	paraffin	762-770	CHEM	sections	771-779	ANATOMY
25842923_en	USED_IN	hematoxylin	798-809	CHEM	stained	785-792	LABPROC
25842923_en	USED_IN	eosin	814-819	CHEM	stained	785-792	LABPROC
25842923_en	TO_DETECT_OR_STUDY	stained	785-792	LABPROC	sections	771-779	ANATOMY
25842923_en	USED_IN	van Gieson's picrofuchsin	824-849	LABPROC	stained	785-792	LABPROC
25842923_en	TO_DETECT_OR_STUDY	van Gieson's picrofuchsin	824-849	LABPROC	sections	771-779	ANATOMY
25842923_en	SUBCLASS_OF	MMP-1	911-916	CHEM	MMP	911-914	CHEM
25842923_en	SUBCLASS_OF	MMP-2	918-923	CHEM	MMP	918-921	CHEM
25842923_en	SUBCLASS_OF	MMP-7	925-930	CHEM	MMP	925-928	CHEM
25842923_en	ORIGINS_FROM	MMP-1	911-916	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	MMP-2	918-923	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	MMP-7	925-930	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	vimentin	963-971	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	Vimentin	973-981	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	SMA	1004-1007	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	TGF-β	1030-1035	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	TNF-α	1037-1042	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	CD34	1044-1048	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	Ost-4	1050-1055	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	CD117	1061-1066	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	CD68	1083-1087	CHEM	sections	771-779	ANATOMY
25842923_en	ORIGINS_FROM	EMA	1093-1096	CHEM	sections	771-779	ANATOMY
25842923_en	SUBCLASS_OF	immunoglobulin antibodies	1154-1179	CHEM	antibodies	1169-1179	CHEM
25842923_en	TO_DETECT_OR_STUDY	Biotinylated	1114-1126	LABPROC	immunoglobulin antibodies	1154-1179	CHEM
25842923_en	ASSOCIATED_WITH	IPP	1967-1970	DISO	degree of morphological changes	1932-1963	FINDING
25842923_en	FINDING_OF	degree of morphological changes	1932-1963	FINDING	morphological changes	1942-1963	PHYS
25842923_en	ASSOCIATED_WITH	IPP	1967-1970	DISO	clinical course	1912-1927	FINDING
25842923_en	AFFECTS	severity and depth of damage to the SCN areas of the respiratory acinus	1994-2065	FINDING	SCN areas	2030-2039	ANATOMY
25842923_en	PHYSIOLOGY_OF	respiratory	2047-2058	PHYS	respiratory acinus	2047-2065	ANATOMY
25842923_en	ASSOCIATED_WITH	damage to the SCN areas	2016-2039	DISO	severity and depth of damage to the SCN areas of the respiratory acinus	1994-2065	FINDING
25842923_en	HAS_CAUSE	clinical course	1912-1927	FINDING	severity and depth of damage to the SCN areas of the respiratory acinus	1994-2065	FINDING
25842923_en	HAS_CAUSE	degree of morphological changes	1932-1963	FINDING	severity and depth of damage to the SCN areas of the respiratory acinus	1994-2065	FINDING
25842923_en	SUBCLASS_OF	respiratory acinus	1439-1457	ANATOMY	acinus	1451-1457	ANATOMY
25842923_en	SUBCLASS_OF	respiratory acinus	2047-2065	ANATOMY	acinus	2059-2065	ANATOMY
25842923_en	SUBCLASS_OF	respiratory acini	162-179	ANATOMY	acini	174-179	ANATOMY
25842923_en	PART_OF	stem cell niches	132-148	ANATOMY	stem cell	132-141	ANATOMY
25842923_en	ASSOCIATED_WITH	respiratory acinus damages	1439-1465	DISO	differ in the site and degree of initial and secondary respiratory acinus damages	1384-1465	FINDING
25842923_en	ASSOCIATED_WITH	IIPs	1365-1369	DISO	differ in the site and degree of initial and secondary respiratory acinus damages	1384-1465	FINDING
25842923_en	SUBCLASS_OF	inflammatory infiltrate	1501-1524	DISO	infiltrate	1514-1524	DISO
25842923_en	HAS_CAUSE	inflammatory infiltrate	1501-1524	DISO	inflammatory	1501-1513	DISO
25842923_en	ASSOCIATED_WITH	inflammatory infiltrate	1501-1524	DISO	aggressiveness of an inflammatory infiltrate	1480-1524	FINDING
25842923_en	ASSOCIATED_WITH	lesion	1545-1551	DISO	spread of a lesion to different SCN areas	1533-1574	FINDING
25842923_en	SUBCLASS_OF	regeneration of lung tissue	1591-1618	PHYS	regeneration	1591-1603	PHYS
25842923_en	PHYSIOLOGY_OF	regeneration of lung tissue	1591-1618	PHYS	SCN	1565-1568	ANATOMY
25842923_en	PART_OF	mesenchymal cell	1624-1640	ANATOMY	mesenchymal	1624-1635	ANATOMY
25842923_en	SUBCLASS_OF	mesenchymal cell	1624-1640	ANATOMY	cell	1636-1640	ANATOMY
25842923_en	PHYSIOLOGY_OF	myofibroblast differentiation	1646-1675	PHYS	myofibroblast	1646-1659	ANATOMY
25842923_en	SUBCLASS_OF	stem cell	1725-1734	ANATOMY	cell	1730-1734	ANATOMY
25842923_en	SUBCLASS_OF	mesenchymal stem cell	1713-1734	ANATOMY	stem cell	1725-1734	ANATOMY
25842923_en	PART_OF	mesenchymal stem cell	1713-1734	ANATOMY	mesenchymal	1713-1724	ANATOMY
25842923_en	ASSOCIATED_WITH	expression	1790-1800	PHYS	CD34	1785-1789	CHEM
25842923_en	ASSOCIATED_WITH	expression	1790-1800	PHYS	CD117	1774-1779	CHEM
25842923_en	ASSOCIATED_WITH	expression	1790-1800	PHYS	SMA	1769-1772	CHEM
25842923_en	ASSOCIATED_WITH	expression	1790-1800	PHYS	Vimentin	1759-1767	CHEM
25842923_en	ASSOCIATED_WITH	expression	1790-1800	PHYS	Oct-4	1752-1757	CHEM
25842923_en	PHYSIOLOGY_OF	expression	1790-1800	PHYS	cells	1810-1815	ANATOMY
25842923_en	PHYSIOLOGY_OF	marker cell	1843-1854	PHYS	cell	1850-1854	ANATOMY
25842923_en	HAS_CAUSE	marker cell	1843-1854	PHYS	SCN damage	1863-1873	DISO
25872388_en	PART_OF	anterior chamber	289-305	ANATOMY	eye	29-32	ANATOMY
25872388_en	AFFECTS	cytoplasmic swelling	1356-1376	DISO	corneal endothelium	1310-1329	ANATOMY
25872388_en	AFFECTS	fibrin exudation	1446-1462	DISO	posterior chamber	1470-1487	ANATOMY
25872388_en	SUBCLASS_OF	Moxifloxacin	929-941	CHEM	antibiotics	845-856	CHEM
25872388_en	APPLIED_TO	Moxifloxacin	1143-1155	CHEM	anterior chamber	1186-1202	ANATOMY
25872388_en	APPLIED_TO	BSS	1135-1138	CHEM	anterior chamber	1186-1202	ANATOMY
25872388_en	HAS_CAUSE	no toxic effects	1101-1117	FINDING	Moxifloxacin	1143-1155	CHEM
25872388_en	HAS_CAUSE	no toxic effects	1101-1117	FINDING	BSS	1135-1138	CHEM
25872388_en	APPLIED_TO	BSS	718-721	CHEM	fellow eye	744-754	ANATOMY
25872388_en	HAS_CAUSE	absence of toxic reaction	1776-1801	FINDING	Moxifloxacin	1834-1846	CHEM
25872388_en	SUBCLASS_OF	Moxifloxacin	929-941	CHEM	antifungals	861-872	CHEM
25872388_en	SUBCLASS_OF	asketin cefuroxime	623-641	CHEM	generics	613-621	CHEM
25872388_en	SUBCLASS_OF	amikacin	653-661	CHEM	generics	613-621	CHEM
25872388_en	SUBCLASS_OF	gentamicin	672-682	CHEM	generics	613-621	CHEM
25872388_en	SUBCLASS_OF	amphotericin B	693-707	CHEM	generics	613-621	CHEM
25872388_en	PHYSIOLOGY_OF	changes in the corneal endothelium	1295-1329	PHYS	corneal endothelium	1310-1329	ANATOMY
25872388_en	ASSOCIATED_WITH	changes in the corneal endothelium	1295-1329	PHYS	cytoplasmic swelling	1356-1376	DISO
25872388_en	PART_OF	endothelial cells	1384-1401	ANATOMY	endothelial	1384-1395	ANATOMY
25872388_en	PART_OF	cytoplasmic	1356-1367	ANATOMY	endothelial cells	1384-1401	ANATOMY
25872388_en	AFFECTS	cytoplasmic swelling	1356-1376	DISO	cytoplasmic	1356-1367	ANATOMY
25872388_en	AFFECTS	cytoplasmic swelling	1356-1376	DISO	endothelial cells	1384-1401	ANATOMY
25872388_en	USED_IN	antifungals	861-872	CHEM	highly diluted	913-927	LABPROC
25872388_en	USED_IN	antibiotics	845-856	CHEM	highly diluted	913-927	LABPROC
25872388_en	AFFECTS	toxicity	41-49	FINDING	anterior eye segment	20-40	ANATOMY
25872388_en	PART_OF	eye	29-32	ANATOMY	anterior eye segment	20-40	ANATOMY
25872388_en	SUBCLASS_OF	generic antibiotic	86-104	CHEM	antibiotic	94-104	CHEM
25872388_en	SUBCLASS_OF	antifungal drugs brand name	109-81	CHEM	antifungal drugs	109-125	CHEM
25872388_en	SUBCLASS_OF	brand name antibiotic	71-104	CHEM	antibiotic	94-104	CHEM
25872388_en	SUBCLASS_OF	asketin cefuroxime	183-201	CHEM	asketin	183-190	CHEM
25872388_en	SUBCLASS_OF	asketin cefuroxime	183-201	CHEM	cefuroxime	191-201	CHEM
25872388_en	APPLIED_TO	antibiotic	94-104	CHEM	anterior eye segment	20-40	ANATOMY
25872388_en	APPLIED_TO	antifungal drugs	109-125	CHEM	anterior eye segment	20-40	ANATOMY
25872388_en	HAS_CAUSE	toxicity	41-49	FINDING	antibiotic	94-104	CHEM
25872388_en	HAS_CAUSE	toxicity	41-49	FINDING	antifungal drugs	109-125	CHEM
25872388_en	HAS_CAUSE	toxicity	41-49	FINDING	Moxifloxacin	169-181	CHEM
25872388_en	HAS_CAUSE	toxicity	41-49	FINDING	asketin cefuroxime	183-201	CHEM
25872388_en	HAS_CAUSE	toxicity	41-49	FINDING	amikacin	203-211	CHEM
25872388_en	HAS_CAUSE	toxicity	41-49	FINDING	gentamicin	213-223	CHEM
25872388_en	HAS_CAUSE	toxicity	41-49	FINDING	Diflucan	225-233	CHEM
25872388_en	HAS_CAUSE	toxicity	41-49	FINDING	amphotericin B	239-253	CHEM
25872388_en	SUBCLASS_OF	fellow eye	744-754	ANATOMY	eye	751-754	ANATOMY
25872388_en	SUBCLASS_OF	asketin cefuroxime	623-641	CHEM	asketin	623-630	CHEM
25872388_en	SUBCLASS_OF	asketin cefuroxime	623-641	CHEM	cefuroxime	631-641	CHEM
25872388_en	USED_IN	Moxifloxacin	929-941	CHEM	highly diluted	913-927	LABPROC
25872388_en	SUBCLASS_OF	highly diluted	913-927	LABPROC	diluted	920-927	LABPROC
25872388_en	SUBCLASS_OF	asketin cefuroxime	986-1004	CHEM	asketin	986-993	CHEM
25872388_en	SUBCLASS_OF	asketin cefuroxime	986-1004	CHEM	cefuroxime	994-1004	CHEM
25872388_en	HAS_CAUSE	no toxic effects	1101-1117	FINDING	toxic effects	1104-1117	FINDING
25872388_en	USED_IN	Diflucan	967-975	CHEM	highly diluted	913-927	LABPROC
25872388_en	USED_IN	asketin cefuroxime	986-1004	CHEM	highly diluted	913-927	LABPROC
25872388_en	USED_IN	gentamicin	1014-1024	CHEM	highly diluted	913-927	LABPROC
25872388_en	USED_IN	amikacin	1036-1044	CHEM	highly diluted	913-927	LABPROC
25872388_en	USED_IN	antifungal drugs brand name	109-81	CHEM	diluted	63-70	LABPROC
25872388_en	USED_IN	brand name antibiotic	71-104	CHEM	diluted	63-70	LABPROC
25872388_en	USED_IN	antifungal drugs generic	109-93	CHEM	diluted	63-70	LABPROC
25872388_en	USED_IN	generic antibiotic	86-104	CHEM	diluted	63-70	LABPROC
25872388_en	APPLIED_TO	diluted	63-70	LABPROC	anterior eye segment	20-40	ANATOMY
25872388_en	USED_IN	high concentrations	1213-1232	LABPROC	antibiotic	1242-1252	CHEM
25872388_en	USED_IN	high concentrations	1213-1232	LABPROC	antifungal drugs	1257-1273	CHEM
25872388_en	SUBCLASS_OF	high concentrations	1213-1232	LABPROC	concentrations	1218-1232	LABPROC
25872388_en	SUBCLASS_OF	corneal endothelium	1310-1329	ANATOMY	endothelium	1318-1329	ANATOMY
25872388_en	PART_OF	corneal endothelium	1310-1329	ANATOMY	corneal	1310-1317	ANATOMY
25872388_en	HAS_CAUSE	changes in the corneal endothelium	1295-1329	PHYS	antifungal drugs	1257-1273	CHEM
25872388_en	HAS_CAUSE	changes in the corneal endothelium	1295-1329	PHYS	antibiotic	1242-1252	CHEM
25872388_en	SUBCLASS_OF	cytoplasmic swelling	1356-1376	DISO	swelling	1368-1376	DISO
25872388_en	AFFECTS	desquamation	1420-1432	DISO	endothelial cells	1384-1401	ANATOMY
25872388_en	HAS_CAUSE	desquamation	1420-1432	DISO	antibiotic	1242-1252	CHEM
25872388_en	HAS_CAUSE	desquamation	1420-1432	DISO	antifungal drugs	1257-1273	CHEM
25872388_en	ASSOCIATED_WITH	changes in the corneal endothelium	1295-1329	PHYS	desquamation	1420-1432	DISO
25872388_en	SUBCLASS_OF	fibrin exudation	1446-1462	DISO	exudation	1453-1462	DISO
25872388_en	ASSOCIATED_WITH	changes in the corneal endothelium	1295-1329	PHYS	fibrin exudation	1446-1462	DISO
25872388_en	HAS_CAUSE	fibrin exudation	1446-1462	DISO	antibiotic	1242-1252	CHEM
25872388_en	HAS_CAUSE	fibrin exudation	1446-1462	DISO	antifungal drugs	1257-1273	CHEM
25872388_en	ASSOCIATED_WITH	allergic	1541-1549	DISO	neither of injected drugs caused toxic, allergic, or inflammatory reactions	1501-1576	FINDING
25872388_en	ASSOCIATED_WITH	inflammatory	1554-1566	DISO	neither of injected drugs caused toxic, allergic, or inflammatory reactions	1501-1576	FINDING
25872388_en	SUBCLASS_OF	highly diluted	1709-1723	LABPROC	diluted	1716-1723	LABPROC
25872388_en	USED_IN	highly diluted	1709-1723	LABPROC	highly diluted medications	1709-1735	CHEM
25872388_en	HAS_CAUSE	absence of toxic reaction	1776-1801	FINDING	toxic reaction	1787-1801	FINDING
25872388_en	HAS_CAUSE	toxic reaction	1787-1801	FINDING	toxic	1787-1792	INJURY_POISONING
25909792_en	AFFECTS	paranoid syndrome with primary interpretative delusion	1700-1754	DISO	cortical areas	1760-1774	ANATOMY
25909792_en	AFFECTS	delusion disturbances	1589-1610	DISO	frontal areas	1650-1663	ANATOMY
25909792_en	TO_DETECT_OR_STUDY	EEG	1549-1552	LABPROC	psychopathological symptom complexes	1462-1498	DISO
25909792_en	TO_DETECT_OR_STUDY	EEG	1549-1552	LABPROC	delusion disturbances	1589-1610	DISO
25909792_en	HAS_CAUSE	spatially structured EEG patterns in the beta range	1528-1579	FINDING	paranoid syndrome with primary interpretative delusion	1700-1754	DISO
25909792_en	HAS_CAUSE	EEG changes	152-163	FINDING	clinical heterogeneity of the disease	238-275	FINDING
25909792_en	TO_DETECT_OR_STUDY	EEG spectral analysis	327-348	LABPROC	neurophysiological mechanisms	416-445	PHYS
25909792_en	TO_DETECT_OR_STUDY	EEG	1549-1552	LABPROC	paranoid syndrome with primary interpretative delusion	1700-1754	DISO
25909792_en	HAS_CAUSE	spatially structured EEG patterns in the beta range	1528-1579	FINDING	delusion disturbances	1589-1610	DISO
25909792_en	PART_OF	frontal areas	1650-1663	ANATOMY	left hemisphere	1671-1686	ANATOMY
25909792_en	PART_OF	cortical areas	1760-1774	ANATOMY	right hemisphere	1782-1798	ANATOMY
25909792_en	AFFECTS	Deficient states with the predominance of volitional disorders	1118-1180	DISO	left hemisphere	1272-1287	ANATOMY
25909792_en	AFFECTS	Deficient states with the predominance of volitional disorders	1118-1180	DISO	frontal areas	1313-1326	ANATOMY
25909792_en	HAS_CAUSE	spatially structured EEG patterns in the beta range	1528-1579	FINDING	psychopathological symptom complexes	1462-1498	DISO
25909792_en	SUBCLASS_OF	delusion disturbances	1589-1610	DISO	psychopathological symptom complexes	1462-1498	DISO
25909792_en	SUBCLASS_OF	paranoid syndrome with primary interpretative delusion	1700-1754	DISO	psychopathological symptom complexes	1462-1498	DISO
25909792_en	ORIGINS_FROM	Spectral characteristics of background EEG	759-801	FINDING	background EEG	787-801	LABPROC
25909792_en	HAS_CAUSE	EEG changes	152-163	FINDING	state of patients	285-302	PHYS
25909792_en	PHYSIOLOGY_OF	beta-gamma ranges	1247-1264	PHYS	left hemisphere	1272-1287	ANATOMY
25909792_en	PHYSIOLOGY_OF	delta range	1296-1307	PHYS	frontal areas	1313-1326	ANATOMY
25909792_en	ORIGINS_FROM	EEG changes	1404-1415	FINDING	EEG	1404-1407	LABPROC
25909792_en	PART_OF	frontal areas	1313-1326	ANATOMY	left hemisphere	1272-1287	ANATOMY
25909792_en	SUBCLASS_OF	paranoid schizophrenia: effects	56-87	DISO	paranoid	56-64	DISO
25909792_en	ORIGINS_FROM	EEG changes	152-163	FINDING	EEG	152-155	LABPROC
25909792_en	USED_IN	EEG spectral analysis	327-348	LABPROC	EEG	327-330	LABPROC
25909792_en	ASSOCIATED_WITH	neurophysiological mechanisms	416-445	PHYS	schizophrenic	167-180	DISO
25909792_en	SUBCLASS_OF	paranoid schizophrenia	869-891	DISO	paranoid	869-877	DISO
25909792_en	SUBCLASS_OF	paranoid schizophrenia	869-891	DISO	schizophrenia	878-891	DISO
25909792_en	ALTERNATIVE_NAME	schizophrenia: effects	65-87	DISO	schizophrenic	167-180	DISO
25909792_en	ALTERNATIVE_NAME	schizophrenic	167-180	DISO	schizophrenia	878-891	DISO
25909792_en	ALTERNATIVE_NAME	paranoid schizophrenia: effects	56-87	DISO	paranoid schizophrenia	869-891	DISO
25909792_en	TREATED_USING	paranoid schizophrenia	869-891	DISO	psychoactive medication	902-925	CHEM
25909792_en	SUBCLASS_OF	background EEG	787-801	LABPROC	EEG	798-801	LABPROC
25909792_en	ASSOCIATED_WITH	negative disorders	668-686	DISO	summary prevalence of positive/negative disorders	637-686	FINDING
25909792_en	ASSOCIATED_WITH	positive disorders	659-686	DISO	summary prevalence of positive/negative disorders	637-686	FINDING
25909792_en	FINDING_OF	diffuse increase of spectral power of gamma and delta ranges	1056-1116	FINDING	gamma ranges	1094-1116	PHYS
25909792_en	FINDING_OF	diffuse increase of spectral power of gamma and delta ranges	1056-1116	FINDING	delta ranges	1104-1116	PHYS
25909792_en	ASSOCIATED_WITH	negative symptomatology	1006-1029	DISO	diffuse increase of spectral power of gamma and delta ranges	1056-1116	FINDING
25909792_en	SUBCLASS_OF	diffuse increase of spectral power of gamma and delta ranges	1056-1116	FINDING	main index of negative symptomatology	992-1029	FINDING
25909792_en	SUBCLASS_OF	Deficient states with the predominance of volitional disorders	1118-1180	DISO	Deficient states	1118-1134	DISO
25909792_en	HAS_CAUSE	volitional disorders	1160-1180	DISO	Deficient states with the predominance of volitional disorders	1118-1180	DISO
25909792_en	SUBCLASS_OF	left hemisphere	1272-1287	ANATOMY	hemisphere	1277-1287	ANATOMY
25909792_en	PART_OF	frontal areas	1313-1326	ANATOMY	hemisphere	1335-1345	ANATOMY
25909792_en	PART_OF	frontal areas	1313-1326	ANATOMY	frontal	1313-1320	ANATOMY
25909792_en	FINDING_OF	lateralized increase of spectral power	1205-1243	FINDING	beta-gamma ranges	1247-1264	PHYS
25909792_en	FINDING_OF	lateralized increase of spectral power	1205-1243	FINDING	delta range	1296-1307	PHYS
25909792_en	ASSOCIATED_WITH	Deficient states with the predominance of volitional disorders	1118-1180	DISO	lateralized increase of spectral power	1205-1243	FINDING
25909792_en	ASSOCIATED_WITH	Positive symptomatology	1347-1370	DISO	less reflected in EEG changes	1386-1415	FINDING
25909792_en	ASSOCIATED_WITH	negative	1421-1429	DISO	less reflected in EEG changes	1386-1415	FINDING
25909792_en	ORIGINS_FROM	less reflected in EEG changes	1386-1415	FINDING	EEG	1404-1407	LABPROC
25909792_en	HAS_CAUSE	less reflected in EEG changes	1386-1415	FINDING	EEG changes	1404-1415	FINDING
25909792_en	ORIGINS_FROM	spatially structured EEG patterns	1528-1561	FINDING	EEG	1549-1552	LABPROC
25909792_en	ORIGINS_FROM	spatially structured EEG patterns in the beta range	1528-1579	FINDING	EEG	1549-1552	LABPROC
25909792_en	FINDING_OF	spatially structured EEG patterns in the beta range	1528-1579	FINDING	beta range	1569-1579	PHYS
25909792_en	SUBCLASS_OF	delusion disturbances	1589-1610	DISO	delusion	1589-1597	DISO
25909792_en	SUBCLASS_OF	left hemisphere	1671-1686	ANATOMY	hemisphere	1676-1686	ANATOMY
25909792_en	SUBCLASS_OF	paranoid syndrome with primary interpretative delusion	1700-1754	DISO	paranoid syndrome	1700-1717	DISO
25909792_en	SUBCLASS_OF	primary interpretative delusion	1723-1754	DISO	delusion	1746-1754	DISO
25909792_en	HAS_CAUSE	primary interpretative delusion	1723-1754	DISO	paranoid syndrome with primary interpretative delusion	1700-1754	DISO
25909792_en	PART_OF	cortical areas	1760-1774	ANATOMY	cortical	1760-1768	ANATOMY
25909792_en	SUBCLASS_OF	right hemisphere	1782-1798	ANATOMY	hemisphere	1788-1798	ANATOMY
25909792_en	ORIGINS_FROM	frequency and regional EEG	510-536	FINDING	EEG	533-536	LABPROC
25909792_en	ASSOCIATED_WITH	productive disorders	571-604	DISO	frequency and regional EEG	510-536	FINDING
25909792_en	TO_DETECT_OR_STUDY	EEG	533-536	LABPROC	productive disorders	571-604	DISO
25909792_en	ASSOCIATED_WITH	negative disorders	586-604	DISO	frequency and regional EEG	510-536	FINDING
25909792_en	TO_DETECT_OR_STUDY	EEG	533-536	LABPROC	negative disorders	586-604	DISO
25909792_en	ORIGINS_FROM	EEG frequency and regional properties	1-38	FINDING	EEG	1-4	LABPROC
25909792_en	ASSOCIATED_WITH	paranoid schizophrenia: effects	56-87	DISO	EEG frequency and regional properties	1-38	FINDING
25909792_en	ASSOCIATED_WITH	symptomatology positive	113-99	DISO	EEG frequency and regional properties	1-38	FINDING
25909792_en	ASSOCIATED_WITH	negative symptomatology	104-127	DISO	EEG frequency and regional properties	1-38	FINDING
25909792_en	TO_DETECT_OR_STUDY	EEG	1-4	LABPROC	paranoid schizophrenia: effects	56-87	DISO
25909792_en	TO_DETECT_OR_STUDY	EEG	1-4	LABPROC	symptomatology positive	113-99	DISO
25909792_en	TO_DETECT_OR_STUDY	EEG	1-4	LABPROC	negative symptomatology	104-127	DISO
25909792_en	ALTERNATIVE_NAME	EEG frequency and regional properties	1-38	FINDING	frequency and regional EEG	510-536	FINDING
25909792_en	ALTERNATIVE_NAME	frequency and regional EEG	510-536	FINDING	Spectral characteristics of background EEG	759-801	FINDING
26036068_en	AFFECTS	injuries	49-57	INJURY_POISONING	sublungual bone	65-80	ANATOMY
26036068_en	AFFECTS	breaks of the connections	1051-1076	INJURY_POISONING	hyoid bone body	1089-1104	ANATOMY
26036068_en	AFFECTS	breaks of the connections	1051-1076	INJURY_POISONING	greater horns	1113-1126	ANATOMY
26036068_en	AFFECTS	external defects	1862-1878	INJURY_POISONING	constituents of the hyoid-laryngeal-tracheal complex	1904-1956	ANATOMY
26036068_en	AFFECTS	fractures	1887-1896	INJURY_POISONING	constituents of the hyoid-laryngeal-tracheal complex	1904-1956	ANATOMY
26036068_en	AFFECTS	blunt neck trauma	169-186	INJURY_POISONING	neck	175-179	ANATOMY
26036068_en	AFFECTS	neck injuries	390-403	INJURY_POISONING	neck	390-394	ANATOMY
26036068_en	AFFECTS	blunt neck trauma	603-620	INJURY_POISONING	neck	609-613	ANATOMY
26036068_en	AFFECTS	injuries in the neck region	1145-1172	INJURY_POISONING	neck region	1161-1172	ANATOMY
26036068_en	AFFECTS	blunt neck trauma	1263-1280	INJURY_POISONING	neck	1269-1273	ANATOMY
26036068_en	AFFECTS	blunt neck trauma	1771-1788	INJURY_POISONING	neck	1777-1781	ANATOMY
26036068_en	PART_OF	constituents of the hyoid-laryngeal-tracheal complex	1904-1956	ANATOMY	hyoid-laryngeal-tracheal complex	1924-1956	ANATOMY
26036068_en	AFFECTS	fractures	748-757	INJURY_POISONING	sublingual bone	765-780	ANATOMY
26036068_en	PART_OF	entire complex of the neck organs	1574-1607	ANATOMY	neck	1596-1600	ANATOMY
26036068_en	PART_OF	cervical portion of the trachea	1650-1681	ANATOMY	trachea	1674-1681	ANATOMY
26036068_en	HAS_CAUSE	scope of the injuries in the neck region is large	1132-1181	FINDING	blunt neck trauma	1263-1280	INJURY_POISONING
26036068_en	HAS_CAUSE	severity higher	1193-1208	FINDING	blunt neck trauma	1263-1280	INJURY_POISONING
26036068_en	HAS_CAUSE	death	379-384	PHYS	neck injuries	390-403	INJURY_POISONING
26036068_en	PART_OF	hyoid bone body	1089-1104	ANATOMY	hyoid bone	1089-1099	ANATOMY
26036068_en	PART_OF	tracheal cartilages	1026-1045	ANATOMY	tracheal	1026-1034	ANATOMY
26036068_en	PART_OF	thyroid cartilage	913-930	ANATOMY	thyroid	913-920	ANATOMY
26036068_en	PART_OF	greater horns of the hyoid bone	851-882	ANATOMY	hyoid bone	872-882	ANATOMY
26036068_en	PART_OF	inferior horns of the thyroid cartilage	891-930	ANATOMY	thyroid cartilage	913-930	ANATOMY
26036068_en	PART_OF	hyoid bone	872-882	ANATOMY	bone	878-882	ANATOMY
26036068_en	PART_OF	hyoid bone	1089-1099	ANATOMY	bone	1095-1099	ANATOMY
26036068_en	PART_OF	cervical portion of the trachea	1650-1681	ANATOMY	corpses	1456-1463	ANATOMY
26036068_en	SUBCLASS_OF	sublungual bone	65-80	ANATOMY	bone	76-80	ANATOMY
26036068_en	PART_OF	larynx	82-88	ANATOMY	neck	175-179	ANATOMY
26036068_en	AFFECTS	fractures	748-757	INJURY_POISONING	laryngeal	782-791	ANATOMY
26036068_en	AFFECTS	fractures	748-757	INJURY_POISONING	tracheal cartilages	796-815	ANATOMY
26036068_en	AFFECTS	complete fractures	1000-1018	INJURY_POISONING	tracheal cartilages	1026-1045	ANATOMY
26036068_en	AFFECTS	cracks	989-995	INJURY_POISONING	tracheal cartilages	1026-1045	ANATOMY
26036068_en	AFFECTS	injuries	49-57	INJURY_POISONING	larynx	82-88	ANATOMY
26036068_en	AFFECTS	injuries	49-57	INJURY_POISONING	trachea	94-101	ANATOMY
26036068_en	SUBCLASS_OF	neck trauma	175-186	INJURY_POISONING	trauma	180-186	INJURY_POISONING
26036068_en	SUBCLASS_OF	blunt neck trauma	169-186	INJURY_POISONING	neck trauma	175-186	INJURY_POISONING
26036068_en	FINDING_OF	harm to human health	334-354	FINDING	health	348-354	PHYS
26036068_en	HAS_CAUSE	harm to human health	334-354	FINDING	injuries	302-310	INJURY_POISONING
26036068_en	SUBCLASS_OF	neck injuries	390-403	INJURY_POISONING	injuries	395-403	INJURY_POISONING
26036068_en	SUBCLASS_OF	blunt neck trauma	603-620	INJURY_POISONING	neck trauma	609-620	INJURY_POISONING
26036068_en	SUBCLASS_OF	neck trauma	609-620	INJURY_POISONING	trauma	614-620	INJURY_POISONING
26036068_en	SUBCLASS_OF	sublingual bone	765-780	ANATOMY	bone	776-780	ANATOMY
26036068_en	SUBCLASS_OF	inferior horns of the thyroid cartilage	891-930	ANATOMY	inferior horns	891-905	ANATOMY
26036068_en	SUBCLASS_OF	thyroid cartilage	913-930	ANATOMY	cartilage	921-930	ANATOMY
26036068_en	SUBCLASS_OF	tracheal cartilages	796-815	ANATOMY	cartilages	805-815	ANATOMY
26036068_en	PART_OF	tracheal cartilages	796-815	ANATOMY	tracheal	796-804	ANATOMY
26036068_en	AFFECTS	injuries	835-843	INJURY_POISONING	inferior horns of the thyroid cartilage	891-930	ANATOMY
26036068_en	SUBCLASS_OF	injuries to the greater horns of the hyoid bone	835-882	INJURY_POISONING	injuries	835-843	INJURY_POISONING
26036068_en	SUBCLASS_OF	greater horns of the hyoid bone	851-882	ANATOMY	greater horns	851-864	ANATOMY
26036068_en	AFFECTS	injuries to the greater horns of the hyoid bone	835-882	INJURY_POISONING	greater horns of the hyoid bone	851-882	ANATOMY
26036068_en	PART_OF	arch of the cricoid cartilage	948-977	ANATOMY	cricoid cartilage	960-977	ANATOMY
26036068_en	SUBCLASS_OF	cricoid cartilage	960-977	ANATOMY	cartilage	968-977	ANATOMY
26036068_en	AFFECTS	fissures	932-940	INJURY_POISONING	arch of the cricoid cartilage	948-977	ANATOMY
26036068_en	SUBCLASS_OF	tracheal cartilages	1026-1045	ANATOMY	cartilages	1035-1045	ANATOMY
26036068_en	SUBCLASS_OF	hyoid bone	1089-1099	ANATOMY	bone	1095-1099	ANATOMY
26036068_en	PART_OF	greater horns	1113-1126	ANATOMY	hyoid bone	1089-1099	ANATOMY
26036068_en	SUBCLASS_OF	breaks of the connections	1051-1076	INJURY_POISONING	breaks	1051-1057	INJURY_POISONING
26036068_en	SUBCLASS_OF	injuries in the neck region	1145-1172	INJURY_POISONING	injuries	1145-1153	INJURY_POISONING
26036068_en	SUBCLASS_OF	blunt neck trauma	1263-1280	INJURY_POISONING	neck trauma	1269-1280	INJURY_POISONING
26036068_en	SUBCLASS_OF	neck trauma	1269-1280	INJURY_POISONING	trauma	1274-1280	INJURY_POISONING
26036068_en	FINDING_OF	scope of the injuries in the neck region is large	1132-1181	FINDING	injuries in the neck region	1145-1172	INJURY_POISONING
26036068_en	FINDING_OF	severity higher	1193-1208	FINDING	injuries in the neck region	1145-1172	INJURY_POISONING
26036068_en	HAS_CAUSE	absence of previous external injurious impacts	1337-1383	FINDING	external injurious impacts	1357-1383	FINDING
26036068_en	PART_OF	neck organs	1596-1607	ANATOMY	neck	1596-1600	ANATOMY
26036068_en	PART_OF	larynx	1635-1641	ANATOMY	entire complex of the neck organs	1574-1607	ANATOMY
26036068_en	PART_OF	cervical portion of the trachea	1650-1681	ANATOMY	entire complex of the neck organs	1574-1607	ANATOMY
26036068_en	PART_OF	cervical portion of the trachea	1650-1681	ANATOMY	cervical	1650-1658	ANATOMY
26036068_en	ALTERNATIVE_NAME	neck	1596-1600	ANATOMY	cervical	1650-1658	ANATOMY
26036068_en	SUBCLASS_OF	blunt neck trauma	1771-1788	INJURY_POISONING	neck trauma	1777-1788	INJURY_POISONING
26036068_en	SUBCLASS_OF	neck trauma	1777-1788	INJURY_POISONING	trauma	1782-1788	INJURY_POISONING
26036068_en	PART_OF	hyoid	1924-1929	ANATOMY	hyoid-laryngeal-tracheal complex	1924-1956	ANATOMY
26036068_en	PART_OF	laryngeal	1930-1939	ANATOMY	hyoid-laryngeal-tracheal complex	1924-1956	ANATOMY
26036068_en	PART_OF	tracheal	1940-1948	ANATOMY	hyoid-laryngeal-tracheal complex	1924-1956	ANATOMY
26081319_en	HAS_CAUSE	Neuropathic pain	1130-1146	DISO	central canal stenosis	1246-1268	DISO
26081319_en	HAS_CAUSE	depression	1151-1161	DISO	lateral stenosis	1295-1311	DISO
26081319_en	HAS_CAUSE	Neuropathic pain	1130-1146	DISO	lateral stenosis	1295-1311	DISO
26081319_en	TO_DETECT_OR_STUDY	ELISA	760-765	LABPROC	thrombocytic serotonin	716-738	CHEM
26081319_en	AFFECTS	stenosis	1260-1268	DISO	central canal	1246-1259	ANATOMY
26081319_en	HAS_CAUSE	depression	1151-1161	DISO	central canal stenosis	1246-1268	DISO
26081319_en	HAS_CAUSE	reduced quality of life and daily activities	1163-1207	FINDING	central canal stenosis	1246-1268	DISO
26081319_en	HAS_CAUSE	reduced quality of life and daily activities	1163-1207	FINDING	lateral stenosis	1295-1311	DISO
26081319_en	AFFECTS	lumbar vertebral canal stenosis	82-113	DISO	lumbar vertebral canal	82-104	ANATOMY
26081319_en	AFFECTS	lumbar vertebral canal stenosis	176-207	DISO	lumbar vertebral canal	176-198	ANATOMY
26081319_en	AFFECTS	lumbar vertebral canal stenosis	409-440	DISO	lumbar vertebral canal	409-431	ANATOMY
26081319_en	AFFECTS	low back pain disability	586-610	DISO	low back	586-594	ANATOMY
26081319_en	HAS_CAUSE	low back pain	586-599	DISO	low back pain disability	586-610	DISO
26081319_en	TO_DETECT_OR_STUDY	ELISA	760-765	LABPROC	Blood serum	700-711	ANATOMY
26081319_en	AFFECTS	lumbar vertebral canal stenosis	1346-1377	DISO	lumbar vertebral canal	1346-1368	ANATOMY
26081319_en	SUBCLASS_OF	nociceptive	1008-1019	DISO	chronic pain syndrome of mixed etiology	967-1006	DISO
26081319_en	SUBCLASS_OF	neurotic type	1024-1037	DISO	chronic pain syndrome of mixed etiology	967-1006	DISO
26081319_en	PART_OF	lumbar vertebral	82-98	ANATOMY	lumbar vertebral canal	82-104	ANATOMY
26081319_en	PART_OF	lumbar vertebral	176-192	ANATOMY	lumbar vertebral canal	176-198	ANATOMY
26081319_en	PART_OF	lumbar vertebral	409-425	ANATOMY	lumbar vertebral canal	409-431	ANATOMY
26081319_en	PART_OF	lumbar vertebral	1346-1362	ANATOMY	lumbar vertebral canal	1346-1368	ANATOMY
26081319_en	PART_OF	Blood serum	700-711	ANATOMY	Blood	700-705	ANATOMY
26081319_en	ORIGINS_FROM	thrombocytic serotonin	716-738	CHEM	thrombocytic	716-728	ANATOMY
26081319_en	SUBCLASS_OF	Neuropathic pain	1130-1146	DISO	pain	1142-1146	DISO
26081319_en	PHYSIOLOGY_OF	decompression of nervous structures	1391-1426	PHYS	nervous structures	1408-1426	ANATOMY
26081319_en	ASSOCIATED_WITH	pain syndrome	1455-1468	DISO	significant reduction of pain syndrome and the level of depression	1430-1496	FINDING
26081319_en	ASSOCIATED_WITH	quality of life	23-38	PHYS	life	34-38	PHYS
26081319_en	ASSOCIATED_WITH	quality of life	23-38	PHYS	pain	15-19	DISO
26081319_en	SUBCLASS_OF	lumbar vertebral canal stenosis	82-113	DISO	stenosis	105-113	DISO
26081319_en	PART_OF	lumbar vertebral	82-98	ANATOMY	vertebral	89-98	ANATOMY
26081319_en	PART_OF	lumbar vertebral canal	82-104	ANATOMY	lumbar vertebral	82-98	ANATOMY
26081319_en	SUBCLASS_OF	lumbar vertebral canal stenosis	176-207	DISO	stenosis	199-207	DISO
26081319_en	ASSOCIATED_WITH	quality of life	267-282	PHYS	life	278-282	PHYS
26081319_en	ASSOCIATED_WITH	disability	296-306	DISO	level of disability before and after surgical treatment.	287-343	FINDING
26081319_en	PART_OF	lumbar vertebral	176-192	ANATOMY	vertebral	183-192	ANATOMY
26081319_en	ASSOCIATED_WITH	lumbar vertebral canal stenosis	176-207	DISO	efficacy of surgical treatment	142-172	FINDING
26081319_en	PART_OF	lumbar vertebral	409-425	ANATOMY	vertebral	416-425	ANATOMY
26081319_en	SUBCLASS_OF	lumbar vertebral canal stenosis	409-440	DISO	stenosis	432-440	DISO
26081319_en	PART_OF	low back	586-594	ANATOMY	back	590-594	ANATOMY
26081319_en	SUBCLASS_OF	low back pain disability	586-610	DISO	disability	600-610	DISO
26081319_en	ALTERNATIVE_NAME	Blood serum	700-711	ANATOMY	serum	706-711	ANATOMY
26081319_en	SUBCLASS_OF	thrombocytic serotonin	716-738	CHEM	serotonin	729-738	CHEM
26081319_en	PART_OF	thrombocytic	716-728	ANATOMY	Blood	700-705	ANATOMY
26081319_en	HAS_CAUSE	pain syndrome	975-988	DISO	pain	975-979	DISO
26081319_en	FINDING_OF	significantly affected quality of life and work capacity	1071-1127	FINDING	quality of life	1094-1109	PHYS
26081319_en	FINDING_OF	significantly affected quality of life and work capacity	1071-1127	FINDING	work capacity	1114-1127	PHYS
26081319_en	HAS_CAUSE	significantly affected quality of life and work capacity	1071-1127	FINDING	chronic pain syndrome of mixed etiology	967-1006	DISO
26081319_en	HAS_CAUSE	significantly affected quality of life and work capacity	1071-1127	FINDING	neurological disorders	1043-1065	DISO
26081319_en	SUBCLASS_OF	chronic pain syndrome of mixed etiology	967-1006	DISO	pain	975-979	DISO
26081319_en	SUBCLASS_OF	chronic pain syndrome of mixed etiology	967-1006	DISO	chronic pain syndrome	967-988	DISO
26081319_en	SUBCLASS_OF	chronic pain syndrome	967-988	DISO	pain syndrome	975-988	DISO
26081319_en	HAS_CAUSE	pain syndrome	975-988	DISO	chronic pain syndrome	967-988	DISO
26081319_en	FINDING_OF	reduced quality of life and daily activities	1163-1207	FINDING	quality of life	1171-1186	PHYS
26081319_en	ASSOCIATED_WITH	quality of life	1171-1186	PHYS	life	1182-1186	PHYS
26081319_en	SUBCLASS_OF	central canal stenosis	1246-1268	DISO	stenosis	1260-1268	DISO
26081319_en	SUBCLASS_OF	lateral stenosis	1295-1311	DISO	stenosis	1303-1311	DISO
26081319_en	PART_OF	lumbar vertebral	1346-1362	ANATOMY	vertebral	1353-1362	ANATOMY
26081319_en	PART_OF	lumbar vertebral canal	1346-1368	ANATOMY	lumbar vertebral	1346-1362	ANATOMY
26081319_en	SUBCLASS_OF	lumbar vertebral canal stenosis	1346-1377	DISO	stenosis	1369-1377	DISO
26081319_en	SUBCLASS_OF	decompression of nervous structures	1391-1426	PHYS	decompression	1391-1404	PHYS
26081319_en	PART_OF	nervous structures	1408-1426	ANATOMY	nervous	1408-1415	ANATOMY
26081319_en	HAS_CAUSE	pain syndrome	1455-1468	DISO	pain	1455-1459	DISO
26081319_en	ASSOCIATED_WITH	depression	1486-1496	DISO	significant reduction of pain syndrome and the level of depression	1430-1496	FINDING
26081319_en	ASSOCIATED_WITH	quality of life	1527-1542	PHYS	life	1538-1542	PHYS
26081319_en	FINDING_OF	improvement of quality of life	1512-1542	FINDING	quality of life	1527-1542	PHYS
26146046_en	AFFECTS	aneurysm	990-998	DISO	middle cerebral artery	1006-1028	ANATOMY
26146046_en	APPLIED_TO	cerebral angiography	233-253	LABPROC	cerebral	233-241	ANATOMY
26146046_en	TO_DETECT_OR_STUDY	angiographic examination	541-565	LABPROC	de novo aneurysms	578-595	DISO
26146046_en	AFFECTS	cerebral aneurysms	295-313	DISO	cerebral	295-303	ANATOMY
26146046_en	AFFECTS	cerebral aneurysms	112-130	DISO	cerebral	112-120	ANATOMY
26146046_en	HAS_CAUSE	de novo aneurysm	143-159	DISO	cerebral aneurysms	112-130	DISO
26146046_en	PART_OF	middle cerebral artery	1006-1028	ANATOMY	cerebral artery	1013-1028	ANATOMY
26146046_en	SUBCLASS_OF	main artery	1358-1369	ANATOMY	artery	1363-1369	ANATOMY
26146046_en	PART_OF	anterior part of the circle of Willis	809-846	ANATOMY	circle of Willis	830-846	ANATOMY
26146046_en	PART_OF	cerebral artery	1013-1028	ANATOMY	cerebral	1013-1021	ANATOMY
26146046_en	USED_IN	cerebral angiography	233-253	LABPROC	angiographic examination	207-231	LABPROC
26146046_en	USED_IN	SCT angiography	258-273	LABPROC	angiographic examination	207-231	LABPROC
26146046_en	TO_DETECT_OR_STUDY	angiographic examination	207-231	LABPROC	de novo aneurysm	143-159	DISO
26146046_en	SUBCLASS_OF	de novo aneurysms	644-661	DISO	aneurysms	652-661	DISO
26146046_en	SUBCLASS_OF	De novo aneurysms	848-865	DISO	aneurysms	856-865	DISO
26146046_en	SUBCLASS_OF	de novo aneurysm	909-925	DISO	aneurysm	917-925	DISO
26146046_en	USED_IN	SCT angiography	1470-1485	LABPROC	Dynamic angiographic follow-up	1438-1468	LABPROC
26146046_en	USED_IN	magnetic resonance angiography	1489-1519	LABPROC	Dynamic angiographic follow-up	1438-1468	LABPROC
26146046_en	ASSOCIATED_WITH	de novo aneurysm	143-159	DISO	de novo aneurysm formation	143-169	FINDING
26146046_en	SUBCLASS_OF	cerebral angiography	233-253	LABPROC	angiography	242-253	LABPROC
26146046_en	ALTERNATIVE_NAME	angiographic examination	207-231	LABPROC	angiography	242-253	LABPROC
26146046_en	SUBCLASS_OF	SCT angiography	258-273	LABPROC	angiography	262-273	LABPROC
26146046_en	ALTERNATIVE_NAME	SCT angiography	258-273	LABPROC	SCT	258-261	LABPROC
26146046_en	SUBCLASS_OF	cerebral angiography	233-253	LABPROC	angiographic examination	207-231	LABPROC
26146046_en	SUBCLASS_OF	SCT angiography	258-273	LABPROC	angiographic examination	207-231	LABPROC
26146046_en	SUBCLASS_OF	cerebral aneurysms	295-313	DISO	aneurysms	304-313	DISO
26146046_en	SUBCLASS_OF	cerebral aneurysms	112-130	DISO	aneurysms	121-130	DISO
26146046_en	SUBCLASS_OF	de novo aneurysms	578-595	DISO	aneurysms	586-595	DISO
26146046_en	SUBCLASS_OF	de novo aneurysm	143-159	DISO	aneurysm	151-159	DISO
26146046_en	TO_DETECT_OR_STUDY	angiographic examination	541-565	LABPROC	de novo aneurysms were formed	578-607	FINDING
26146046_en	ASSOCIATED_WITH	de novo aneurysms	578-595	DISO	de novo aneurysms were formed	578-607	FINDING
26146046_en	SUBCLASS_OF	cerebral artery	1013-1028	ANATOMY	artery	1022-1028	ANATOMY
26146046_en	SUBCLASS_OF	middle cerebral artery	1006-1028	ANATOMY	cerebral artery	1013-1028	ANATOMY
26146046_en	HAS_CAUSE	Neither lethal nor unfavorable outcomes were recorded	1046-1099	FINDING	unfavorable outcomes	1065-1085	FINDING
26146046_en	HAS_CAUSE	Neither lethal nor unfavorable outcomes were recorded	1046-1099	FINDING	lethal	1054-1060	FINDING
26146046_en	SUBCLASS_OF	lethal	1054-1060	FINDING	outcomes	1077-1085	FINDING
26146046_en	SUBCLASS_OF	unfavorable outcomes	1065-1085	FINDING	outcomes	1077-1085	FINDING
26146046_en	SUBCLASS_OF	de novo aneurysm	1154-1170	DISO	aneurysm	1162-1170	DISO
26146046_en	ASSOCIATED_WITH	de novo aneurysm	1154-1170	DISO	high risk of de novo aneurysm formation	1141-1180	FINDING
26146046_en	SUBCLASS_OF	Dynamic angiographic follow-up	1438-1468	LABPROC	angiographic	1446-1458	LABPROC
26146046_en	SUBCLASS_OF	SCT angiography	1470-1485	LABPROC	angiography	1474-1485	LABPROC
26146046_en	ALTERNATIVE_NAME	SCT angiography	1470-1485	LABPROC	SCT	1470-1473	LABPROC
26146046_en	SUBCLASS_OF	magnetic resonance angiography	1489-1519	LABPROC	angiography	1508-1519	LABPROC
26226776_en	AFFECTS	colorectal cancer	72-89	DISO	colorectal	72-82	ANATOMY
26226776_en	AFFECTS	liver metastases	90-106	DISO	liver	90-95	ANATOMY
26226776_en	ABBREVIATION	colorectal cancer	167-184	DISO	CRC	186-189	DISO
26226776_en	AFFECTS	liver metastases	191-207	DISO	liver	191-196	ANATOMY
26226776_en	AFFECTS	colorectal cancer	167-184	DISO	colorectal	167-177	ANATOMY
26226776_en	ABBREVIATION	vascular endothelial growth factor	488-522	CHEM	VEGF	482-486	CHEM
26226776_en	PHYSIOLOGY_OF	proliferation	1830-1843	PHYS	cell	1825-1829	ANATOMY
26226776_en	USED_IN	antibodies	574-584	CHEM	immunohistochemically examined	537-567	LABPROC
26226776_en	PHYSIOLOGY_OF	E-cadherin and β-catenin localization	1266-1303	PHYS	cells	1313-1318	ANATOMY
26226776_en	HAS_CAUSE	decrease in the number of cases of abnormal nuclear localization of the protein	1095-1174	FINDING	anti-VEGF agent	1067-1082	CHEM
26226776_en	PHYSIOLOGY_OF	adhesive properties	280-299	PHYS	cells	309-314	ANATOMY
26226776_en	APPLIED_TO	immunohistochemically examined	537-567	LABPROC	metastatic CRC samples	352-374	ANATOMY
26226776_en	TREATED_USING	metastatic CRC	1628-1642	DISO	anti-VEGF agent	1589-1604	CHEM
26226776_en	HAS_CAUSE	positive impact on the cadherin-catenin complex	1649-1696	FINDING	anti-VEGF agent	1589-1604	CHEM
26226776_en	HAS_CAUSE	increased intercellular contacts	1709-1741	FINDING	anti-VEGF agent	1589-1604	CHEM
26226776_en	HAS_CAUSE	suppressed β-catenin functioning as a transcription factor	1746-1804	FINDING	anti-VEGF agent	1589-1604	CHEM
26226776_en	HAS_CAUSE	expression	58-68	PHYS	liver metastases	90-106	DISO
26226776_en	HAS_CAUSE	expression	153-163	PHYS	liver metastases	191-207	DISO
26226776_en	SUBCLASS_OF	metastatic CRC	352-366	DISO	CRC	363-366	DISO
26226776_en	FINDING_OF	decrease in the number of cases of abnormal nuclear localization of the protein	1095-1174	FINDING	nuclear localization of the protein	1139-1174	PHYS
26226776_en	FINDING_OF	combination of normal E-cadherin membrane localization and β-catenin membrane-cytoplasmic expression prevailed	1333-1443	FINDING	membrane localization	1366-1387	PHYS
26226776_en	FINDING_OF	combination of normal E-cadherin membrane localization and β-catenin membrane-cytoplasmic expression prevailed	1333-1443	FINDING	membrane-cytoplasmic expression	1402-1433	PHYS
26226776_en	ASSOCIATED_WITH	membrane localization	832-853	PHYS	E-cadherin	857-867	CHEM
26226776_en	ASSOCIATED_WITH	nuclear localization of the protein	1139-1174	PHYS	protein	1167-1174	CHEM
26226776_en	FINDING_OF	no significant differences	1020-1046	FINDING	β-catenin levels	970-986	PHYS
26226776_en	ASSOCIATED_WITH	membrane localization	1366-1387	PHYS	E-cadherin	1355-1365	CHEM
26226776_en	ASSOCIATED_WITH	membrane-cytoplasmic expression	1402-1433	PHYS	β-catenin	1392-1401	CHEM
26226776_en	ASSOCIATED_WITH	expression	58-68	PHYS	adhesion molecule	40-57	CHEM
26226776_en	HAS_CAUSE	liver metastases	90-106	DISO	colorectal cancer	72-89	DISO
26226776_en	SUBCLASS_OF	liver metastases	90-106	DISO	metastases	96-106	DISO
26226776_en	ASSOCIATED_WITH	expression	58-68	PHYS	liver metastases	90-106	DISO
26226776_en	PHYSIOLOGY_OF	expression	58-68	PHYS	liver	90-95	ANATOMY
26226776_en	ORIGINS_FROM	adhesion molecule	40-57	CHEM	liver	90-95	ANATOMY
26226776_en	SUBCLASS_OF	colorectal cancer	72-89	DISO	cancer	83-89	DISO
26226776_en	SUBCLASS_OF	E-cadherin	128-138	CHEM	cadherin	130-138	CHEM
26226776_en	SUBCLASS_OF	β-catenin	143-152	CHEM	catenin	145-152	CHEM
26226776_en	ASSOCIATED_WITH	expression	153-163	PHYS	β-catenin	143-152	CHEM
26226776_en	ASSOCIATED_WITH	expression	153-163	PHYS	E-cadherin	128-138	CHEM
26226776_en	HAS_CAUSE	colorectal cancer	167-184	DISO	liver metastases	191-207	DISO
26226776_en	SUBCLASS_OF	liver metastases	191-207	DISO	metastases	197-207	DISO
26226776_en	PHYSIOLOGY_OF	expression	153-163	PHYS	liver	191-196	ANATOMY
26226776_en	ASSOCIATED_WITH	expression	153-163	PHYS	liver metastases	191-207	DISO
26226776_en	ORIGINS_FROM	β-catenin	143-152	CHEM	liver	191-196	ANATOMY
26226776_en	ORIGINS_FROM	E-cadherin	128-138	CHEM	liver	191-196	ANATOMY
26226776_en	SUBCLASS_OF	metastatic CRC	352-366	DISO	metastatic	352-362	DISO
26226776_en	ALTERNATIVE_NAME	metastases	197-207	DISO	metastatic	352-362	DISO
26226776_en	SUBCLASS_OF	vascular endothelial growth factor	488-522	CHEM	growth factor	509-522	CHEM
26226776_en	SUBCLASS_OF	E-cadherin	588-598	CHEM	cadherin	590-598	CHEM
26226776_en	SUBCLASS_OF	β-catenin	603-612	CHEM	catenin	605-612	CHEM
26226776_en	SUBCLASS_OF	metastatic CRC samples	352-374	ANATOMY	samples	367-374	ANATOMY
26226776_en	APPLIED_TO	vascular endothelial growth factor	488-522	CHEM	vascular	488-496	ANATOMY
26226776_en	APPLIED_TO	vascular endothelial growth factor	488-522	CHEM	endothelial	497-508	ANATOMY
26226776_en	ORIGINS_FROM	E-cadherin	588-598	CHEM	metastatic CRC samples	352-374	ANATOMY
26226776_en	ORIGINS_FROM	β-catenin	603-612	CHEM	metastatic CRC samples	352-374	ANATOMY
26226776_en	TO_DETECT_OR_STUDY	immunohistochemically examined	537-567	LABPROC	metastatic CRC samples	352-374	ANATOMY
26226776_en	TO_DETECT_OR_STUDY	immunohistochemically examined	537-567	LABPROC	E-cadherin	588-598	CHEM
26226776_en	TO_DETECT_OR_STUDY	immunohistochemically examined	537-567	LABPROC	β-catenin	603-612	CHEM
26226776_en	SUBCLASS_OF	E-cadherin	857-867	CHEM	cadherin	859-867	CHEM
26226776_en	FINDING_OF	significant increase in the number of cases of normal membrane localization of E-cadherin	778-867	FINDING	membrane localization	832-853	PHYS
26226776_en	PHYSIOLOGY_OF	membrane localization	832-853	PHYS	membrane	832-840	ANATOMY
26226776_en	SUBCLASS_OF	β-catenin	970-979	CHEM	catenin	972-979	CHEM
26226776_en	PHYSIOLOGY_OF	nuclear localization of the protein	1139-1174	PHYS	nuclear	1139-1146	ANATOMY
26226776_en	HAS_CAUSE	decrease in the number of cases of abnormal nuclear localization of the protein	1095-1174	FINDING	abnormal nuclear localization of the protein	1130-1174	FINDING
26226776_en	FINDING_OF	abnormal nuclear localization of the protein	1130-1174	FINDING	nuclear localization of the protein	1139-1174	PHYS
26226776_en	AFFECTS	abnormal nuclear localization of the protein	1130-1174	FINDING	nuclear	1139-1146	ANATOMY
26226776_en	ASSOCIATED_WITH	E-cadherin and β-catenin localization	1266-1303	PHYS	E-cadherin	1266-1276	CHEM
26226776_en	ASSOCIATED_WITH	E-cadherin and β-catenin localization	1266-1303	PHYS	β-catenin	1281-1290	CHEM
26226776_en	SUBCLASS_OF	β-catenin	1281-1290	CHEM	catenin	1283-1290	CHEM
26226776_en	SUBCLASS_OF	E-cadherin	1266-1276	CHEM	cadherin	1268-1276	CHEM
26226776_en	ORIGINS_FROM	β-catenin	1281-1290	CHEM	cells	1313-1318	ANATOMY
26226776_en	ORIGINS_FROM	E-cadherin	1266-1276	CHEM	cells	1313-1318	ANATOMY
26226776_en	PHYSIOLOGY_OF	membrane-cytoplasmic expression	1402-1433	PHYS	membrane	1402-1410	ANATOMY
26226776_en	PHYSIOLOGY_OF	membrane-cytoplasmic expression	1402-1433	PHYS	cytoplasmic	1411-1422	ANATOMY
26226776_en	PHYSIOLOGY_OF	membrane localization	1366-1387	PHYS	membrane	1366-1374	ANATOMY
26226776_en	SUBCLASS_OF	E-cadherin	1355-1365	CHEM	cadherin	1357-1365	CHEM
26226776_en	SUBCLASS_OF	β-catenin	1392-1401	CHEM	catenin	1394-1401	CHEM
26226776_en	SUBCLASS_OF	metastatic CRC	1628-1642	DISO	CRC	1639-1642	DISO
26226776_en	SUBCLASS_OF	metastatic CRC	1628-1642	DISO	metastatic	1628-1638	DISO
26226776_en	USED_IN	cadherin	1672-1680	CHEM	cadherin-catenin complex	1672-1696	CHEM
26226776_en	USED_IN	catenin	1681-1688	CHEM	cadherin-catenin complex	1672-1696	CHEM
26226776_en	HAS_CAUSE	positive impact on the cadherin-catenin complex	1649-1696	FINDING	cadherin-catenin complex	1672-1696	CHEM
26226776_en	SUBCLASS_OF	β-catenin	1757-1766	CHEM	catenin	1759-1766	CHEM
26226776_en	FINDING_OF	increased intercellular contacts	1709-1741	FINDING	intercellular contacts	1719-1741	PHYS
26226776_en	ASSOCIATED_WITH	transcription	1784-1797	PHYS	a transcription facto	1782-1803	CHEM
26226776_en	SUBCLASS_OF	β-catenin	1757-1766	CHEM	a transcription facto	1782-1803	CHEM
26226776_en	AFFECTS	enhances tumor cell proliferation	1810-1843	FINDING	cell	1825-1829	ANATOMY
26226776_en	ASSOCIATED_WITH	tumor	1819-1824	DISO	enhances tumor cell proliferation	1810-1843	FINDING
26226776_en	PART_OF	membrane	1402-1410	ANATOMY	cells	1313-1318	ANATOMY
26226776_en	PART_OF	cytoplasmic	1411-1422	ANATOMY	cells	1313-1318	ANATOMY
26226776_en	PART_OF	nuclear	1139-1146	ANATOMY	cells	1313-1318	ANATOMY
26245096_en	AFFECTS	craniovertebral injuries	593-617	INJURY_POISONING	craniovertebral	593-608	ANATOMY
26245096_en	AFFECTS	craniovertebral injury	331-353	INJURY_POISONING	craniovertebral	331-346	ANATOMY
26245096_en	AFFECTS	acute coronary insufficiency	382-410	DISO	coronary	388-396	ANATOMY
26245096_en	AFFECTS	lesions	522-529	DISO	jugular ganglia	537-552	ANATOMY
26245096_en	AFFECTS	atrophic changes	736-752	DISO	ganglia	771-778	ANATOMY
26245096_en	AFFECTS	atrophic changes	736-752	DISO	vagus nerve system	786-804	ANATOMY
26245096_en	AFFECTS	hemosiderosis	892-905	DISO	pial soft tissues	913-930	ANATOMY
26245096_en	PART_OF	vagus nerve system	18-36	ANATOMY	vagus nerve	18-29	ANATOMY
26245096_en	PART_OF	vagus nerve system	173-191	ANATOMY	vagus nerve	173-184	ANATOMY
26245096_en	HAS_CAUSE	sympathetic imbalance	66-87	DISO	sudden cardiac death	103-123	PHYS
26245096_en	SUBCLASS_OF	acute coronary insufficiency	382-410	DISO	coronary insufficiency	388-410	DISO
26245096_en	AFFECTS	craniovertebral injury	331-353	INJURY_POISONING	vagus nerve system	173-191	ANATOMY
26245096_en	AFFECTS	craniovertebral injury	331-353	INJURY_POISONING	atrioventricular ganglion	193-218	ANATOMY
26245096_en	AFFECTS	craniovertebral injury	331-353	INJURY_POISONING	cardiomyocytes	235-249	ANATOMY
26245096_en	AFFECTS	acute coronary insufficiency	382-410	DISO	vagus nerve system	173-191	ANATOMY
26245096_en	AFFECTS	acute coronary insufficiency	382-410	DISO	atrioventricular ganglion	193-218	ANATOMY
26245096_en	AFFECTS	acute coronary insufficiency	382-410	DISO	cardiomyocytes	235-249	ANATOMY
26245096_en	PART_OF	vagus nerve system	483-501	ANATOMY	vagus nerve	483-494	ANATOMY
26245096_en	PART_OF	soft tissues	680-692	ANATOMY	jugular foramina	700-716	ANATOMY
26245096_en	SUBCLASS_OF	acute coronary insufficiency	835-863	DISO	coronary insufficiency	841-863	DISO
26245096_en	PART_OF	pial soft tissues	913-930	ANATOMY	medulla oblongata	938-955	ANATOMY
26245096_en	HAS_CAUSE	atrophic changes	736-752	DISO	acute coronary insufficiency	835-863	DISO
26245096_en	ASSOCIATED_WITH	morphological marker	42-62	PHYS	sympathetic imbalance	66-87	DISO
26245096_en	PART_OF	atrioventricular ganglion	193-218	ANATOMY	atrioventricular	193-209	ANATOMY
26245096_en	PART_OF	vagus nerve system	786-804	ANATOMY	vagus nerve	786-797	ANATOMY
26245096_en	AFFECTS	sympathetic imbalance	66-87	DISO	vagus nerve system	18-36	ANATOMY
26245096_en	AFFECTS	hemorrhage	633-643	DISO	ganglia	653-660	ANATOMY
26245096_en	AFFECTS	hemorrhage	633-643	DISO	nerve trunks	662-674	ANATOMY
26245096_en	AFFECTS	hemorrhage	633-643	DISO	soft tissues	680-692	ANATOMY
26245096_en	HAS_CAUSE	lesions	522-529	DISO	craniovertebral injuries	593-617	INJURY_POISONING
26245096_en	HAS_CAUSE	lesions	522-529	DISO	hemorrhage	633-643	DISO
26245096_en	SUBCLASS_OF	vagus nerve	18-29	ANATOMY	nerve	24-29	ANATOMY
26245096_en	SUBCLASS_OF	cardiac death	110-123	PHYS	death	118-123	PHYS
26245096_en	SUBCLASS_OF	sudden cardiac death	103-123	PHYS	cardiac death	110-123	PHYS
26245096_en	PHYSIOLOGY_OF	cardiac death	110-123	PHYS	cardiac	110-117	ANATOMY
26245096_en	AFFECTS	Pathology of the vagus nerve system	1-36	DISO	vagus nerve system	18-36	ANATOMY
26245096_en	SUBCLASS_OF	vagus nerve	173-184	ANATOMY	nerve	179-184	ANATOMY
26245096_en	SUBCLASS_OF	atrioventricular ganglion	193-218	ANATOMY	ganglion	210-218	ANATOMY
26245096_en	SUBCLASS_OF	craniovertebral injury	331-353	INJURY_POISONING	injury	347-353	INJURY_POISONING
26245096_en	SUBCLASS_OF	coronary insufficiency	388-410	DISO	insufficiency	397-410	DISO
26245096_en	SUBCLASS_OF	vagus nerve	483-494	ANATOMY	nerve	489-494	ANATOMY
26245096_en	SUBCLASS_OF	jugular ganglia	537-552	ANATOMY	ganglia	545-552	ANATOMY
26245096_en	PART_OF	jugular ganglia	537-552	ANATOMY	jugular	537-544	ANATOMY
26245096_en	SUBCLASS_OF	craniovertebral injuries	593-617	INJURY_POISONING	injuries	609-617	INJURY_POISONING
26245096_en	PART_OF	nerve trunks	662-674	ANATOMY	nerve	662-667	ANATOMY
26245096_en	SUBCLASS_OF	soft tissues	680-692	ANATOMY	tissues	685-692	ANATOMY
26245096_en	SUBCLASS_OF	jugular foramina	700-716	ANATOMY	foramina	708-716	ANATOMY
26245096_en	PART_OF	jugular foramina	700-716	ANATOMY	jugular	700-707	ANATOMY
26245096_en	AFFECTS	coronary insufficiency	841-863	DISO	coronary	841-849	ANATOMY
26245096_en	SUBCLASS_OF	coronary insufficiency	841-863	DISO	insufficiency	850-863	DISO
26245096_en	HAS_CAUSE	died	825-829	PHYS	acute coronary insufficiency	835-863	DISO
26245096_en	SUBCLASS_OF	vagus nerve	786-797	ANATOMY	nerve	792-797	ANATOMY
26245096_en	SUBCLASS_OF	pial soft tissues	913-930	ANATOMY	soft tissues	918-930	ANATOMY
26245096_en	SUBCLASS_OF	soft tissues	918-930	ANATOMY	tissues	923-930	ANATOMY
26245096_en	PART_OF	pial soft tissues	913-930	ANATOMY	pial	913-917	ANATOMY
26271422_en	AFFECTS	abdomen ptosis	316-330	DISO	abdomen	316-323	ANATOMY
26271422_en	AFFECTS	abdominal wall defect	441-462	DISO	abdominal wall	441-455	ANATOMY
26271422_en	SUBCLASS_OF	postoperative ventral hernias	89-118	DISO	hernias	111-118	DISO
26271422_en	APPLIED_TO	ultrasonic investigation	159-183	LABPROC	abdominal wall	187-201	ANATOMY
26271422_en	PART_OF	abdominal wall	44-58	ANATOMY	abdominal	44-53	ANATOMY
26271422_en	PART_OF	abdominal wall	187-201	ANATOMY	abdominal	187-196	ANATOMY
26271422_en	TO_DETECT_OR_STUDY	ultrasonic investigation	159-183	LABPROC	abdomen ptosis	316-330	DISO
26271422_en	SUBCLASS_OF	super lightweight polypropylenepolyvinylidenefluoride prosthesis	635-699	DEVICE	Polypropylene endoprosthesis	720-748	DEVICE
26271422_en	AFFECTS	hernias umbilical	111-84	DISO	umbilical	75-84	ANATOMY
26271422_en	AFFECTS	umbilical hernias	252-301	DISO	umbilical	252-261	ANATOMY
26271422_en	PART_OF	abdominal wall	441-455	ANATOMY	abdominal	441-450	ANATOMY
26271422_en	HAS_CAUSE	number of excellent results increased	1036-1073	FINDING	number of excellent results	1036-1063	FINDING
26271422_en	HAS_CAUSE	amount of satisfactory outcomes reduced	1087-1126	FINDING	amount of satisfactory outcomes	1087-1118	FINDING
26271422_en	SUBCLASS_OF	abdomen ptosis	316-330	DISO	ptosis	324-330	DISO
26271422_en	AFFECTS	ventral hernias	286-301	DISO	ventral	286-293	ANATOMY
26271422_en	TO_DETECT_OR_STUDY	ultrasonic investigation	159-183	LABPROC	umbilical hernias	252-301	DISO
26271422_en	TO_DETECT_OR_STUDY	ultrasonic investigation	159-183	LABPROC	postoperative large ventral hernias	266-301	DISO
26271422_en	SUBCLASS_OF	ventral hernias	286-301	DISO	hernias	294-301	DISO
26271422_en	SUBCLASS_OF	umbilical hernias	252-301	DISO	hernias	294-301	DISO
26271422_en	SUBCLASS_OF	musculoaponeurotic tissues	565-591	ANATOMY	tissues	584-591	ANATOMY
26271422_en	PART_OF	musculoaponeurotic tissues	565-591	ANATOMY	hypogastric area	603-619	ANATOMY
26271422_en	SUBCLASS_OF	physical health	949-964	PHYS	health	958-964	PHYS
26271558_en	AFFECTS	upper esophageal sphincter achalasia	14-50	DISO	upper esophageal sphincter	14-40	ANATOMY
26271558_en	AFFECTS	upper esophageal sphincter achalasia	162-198	DISO	upper esophageal sphincter	162-188	ANATOMY
26271558_en	AFFECTS	stroke in brain stem	244-264	DISO	brain stem	254-264	ANATOMY
26271558_en	HAS_CAUSE	achalasia	215-224	DISO	stroke in brain stem	244-264	DISO
26271558_en	ALTERNATIVE_NAME	stroke in brain stem	244-264	DISO	Zakharchenko-Wallenberg syndrome	266-298	DISO
26271558_en	SUBCLASS_OF	upper esophageal sphincter	14-40	ANATOMY	esophageal sphincter	20-40	ANATOMY
26271558_en	SUBCLASS_OF	esophageal sphincter	20-40	ANATOMY	sphincter	31-40	ANATOMY
26271558_en	SUBCLASS_OF	esophageal sphincter	168-188	ANATOMY	sphincter	179-188	ANATOMY
26271558_en	SUBCLASS_OF	upper esophageal sphincter	162-188	ANATOMY	esophageal sphincter	168-188	ANATOMY
26271558_en	PHYSIOLOGY_OF	innervation	547-558	PHYS	muscles	562-569	ANATOMY
26271558_en	PHYSIOLOGY_OF	innervation	547-558	PHYS	epiglottis	592-602	ANATOMY
26271558_en	PHYSIOLOGY_OF	innervation	547-558	PHYS	pharyngeal constrictors	607-630	ANATOMY
26271558_en	SUBCLASS_OF	upper esophageal sphincter achalasia	14-50	DISO	achalasia	41-50	DISO
26271558_en	PART_OF	esophageal sphincter	20-40	ANATOMY	esophageal	20-30	ANATOMY
26271558_en	PART_OF	esophageal sphincter	168-188	ANATOMY	esophageal	168-178	ANATOMY
26271558_en	SUBCLASS_OF	upper esophageal sphincter achalasia	162-198	DISO	achalasia	189-198	DISO
26271558_en	SUBCLASS_OF	stroke in brain stem	244-264	DISO	stroke	244-250	DISO
26271558_en	PART_OF	brain stem	254-264	ANATOMY	brain	254-259	ANATOMY
26271558_en	PART_OF	pharyngoesophageal junction	401-428	ANATOMY	pharyngoesophageal	401-419	ANATOMY
26271558_en	SUBCLASS_OF	pharyngeal constrictors	607-630	ANATOMY	constrictors	618-630	ANATOMY
26271558_en	PART_OF	pharyngeal constrictors	607-630	ANATOMY	pharyngeal	607-617	ANATOMY
26271558_en	SUBCLASS_OF	elderly age	665-676	PHYS	age	673-676	PHYS
26271558_en	PART_OF	muscles	562-569	ANATOMY	epiglottis	592-602	ANATOMY
26271558_en	PART_OF	muscles	562-569	ANATOMY	pharyngeal constrictors	607-630	ANATOMY
26271558_en	FINDING_OF	preservation of innervation	531-558	FINDING	innervation	547-558	PHYS
26310014_en	ABBREVIATION	Vogt-Koyanagi-Harada (VKH) syndrome	92-127	DISO	VKH	114-117	DISO
26310014_en	AFFECTS	unilateral keratomalacia	208-232	DISO	left eye	234-242	ANATOMY
26310014_en	AFFECTS	bilateral panuveitis	183-203	DISO	eye	239-242	ANATOMY
26310014_en	ALTERNATIVE_NAME	Methylprednisolone	293-311	CHEM	Metypred	313-321	CHEM
26310014_en	AFFECTS	cataract	492-500	DISO	right eye	508-517	ANATOMY
26310014_en	AFFECTS	bilateral detachment of neuroepithelium	553-592	DISO	neuroepithelium	577-592	ANATOMY
26310014_en	TREATED_USING	VKH syndrome	1075-1087	DISO	Metypred	1030-1038	CHEM
26310014_en	AFFECTS	retinal detachment	458-476	DISO	right eye	508-517	ANATOMY
26310014_en	SUBCLASS_OF	right eye	508-517	ANATOMY	eye	514-517	ANATOMY
26310014_en	TREATED_USING	bilateral detachment of neuroepithelium	553-592	DISO	Metypred	648-656	CHEM
26310014_en	TREATED_USING	bilateral detachment of neuroepithelium	553-592	DISO	prednisolone	681-693	CHEM
26310014_en	TREATED_USING	bilateral detachment of neuroepithelium	553-592	DISO	azathioprine	698-710	CHEM
26310014_en	AFFECTS	pupil occlusion	738-753	DISO	pupil	738-743	ANATOMY
26310014_en	HAS_CAUSE	side effects	1238-1250	DISO	prednisolone	1217-1229	CHEM
26310014_en	SUBCLASS_OF	left eye	234-242	ANATOMY	eye	239-242	ANATOMY
26310014_en	TREATED_USING	uveitis	408-415	DISO	azathioprine	327-339	CHEM
26310014_en	TREATED_USING	uveitis	408-415	DISO	Methylprednisolone	293-311	CHEM
26310014_en	HAS_CAUSE	pupil occlusion	738-753	DISO	cessation of prednisolone	783-808	FINDING
26310014_en	SUBCLASS_OF	bilateral panuveitis	183-203	DISO	panuveitis	193-203	DISO
26310014_en	SUBCLASS_OF	unilateral keratomalacia	208-232	DISO	keratomalacia	219-232	DISO
26310014_en	ASSOCIATED_WITH	uveitis	408-415	DISO	regression of uveitis	394-415	FINDING
26310014_en	HAS_CAUSE	regression of uveitis	394-415	FINDING	Methylprednisolone	293-311	CHEM
26310014_en	HAS_CAUSE	regression of uveitis	394-415	FINDING	azathioprine	327-339	CHEM
26310014_en	SUBCLASS_OF	bilateral detachment of neuroepithelium	553-592	DISO	detachment of neuroepithelium	563-592	DISO
26310014_en	HAS_CAUSE	reattachment	604-616	FINDING	Metypred	648-656	CHEM
26310014_en	AFFECTS	reattachment	604-616	FINDING	eyes	625-629	ANATOMY
26310014_en	SUBCLASS_OF	Bilateral panuveitis	712-732	DISO	panuveitis	722-732	DISO
26310014_en	SUBCLASS_OF	pupil occlusion	738-753	DISO	occlusion	744-753	DISO
26310014_en	HAS_CAUSE	cessation of prednisolone	783-808	FINDING	prednisolone	796-808	CHEM
26310014_en	HAS_CAUSE	Bilateral panuveitis	712-732	DISO	cessation of prednisolone	783-808	FINDING
26310014_en	SUBCLASS_OF	autoimmune uveitis	1120-1138	DISO	uveitis	1131-1138	DISO
26310014_en	TREATED_USING	autoimmune uveitis	1120-1138	DISO	azathioprine	1157-1169	CHEM
26310014_en	HAS_CAUSE	slows progression of the disease	1170-1202	FINDING	azathioprine	1157-1169	CHEM
26310014_en	HAS_CAUSE	minimizes prednisolone-induced side effects	1207-1250	FINDING	azathioprine	1157-1169	CHEM
26355937_en	AFFECTS	bone lesions	80-92	DISO	bone	80-84	ANATOMY
26355937_en	TREATED_USING	arteriovenous angiodysplasia	46-74	DISO	polymethylmethacrylate	7-29	CHEM
26355937_en	AFFECTS	arteriovenous angiodysplasia	559-587	DISO	lower limb	595-605	ANATOMY
26355937_en	AFFECTS	arteriovenous reflux	765-785	DISO	arteriovenous	765-778	ANATOMY
26355937_en	AFFECTS	Arteriovenous dysplasia	95-118	DISO	Arteriovenous	95-108	ANATOMY
26355937_en	ABBREVIATION	polymethylmethacrylate	1016-1038	CHEM	PMMA	1040-1044	CHEM
26355937_en	AFFECTS	angiomatous tissues	1200-1219	DISO	tissues	1212-1219	ANATOMY
26355937_en	SUBCLASS_OF	lower limb	595-605	ANATOMY	limb	601-605	ANATOMY
26355937_en	PHYSIOLOGY_OF	supporting function of limbs	1307-1335	PHYS	limbs	1330-1335	ANATOMY
26355937_en	AFFECTS	angiomatous tissues	824-843	DISO	tissues	836-843	ANATOMY
26355937_en	SUBCLASS_OF	affected limb	340-353	ANATOMY	limb	349-353	ANATOMY
26355937_en	SUBCLASS_OF	tibial bone	615-626	ANATOMY	bone	622-626	ANATOMY
26355937_en	AFFECTS	arteriovenous angiodysplasia	559-587	DISO	arteriovenous	559-572	ANATOMY
26355937_en	AFFECTS	arteriovenous angiodysplasia	46-74	DISO	arteriovenous	46-59	ANATOMY
26355937_en	TREATED_USING	bone lesions	80-92	DISO	polymethylmethacrylate	7-29	CHEM
26355937_en	PART_OF	tibial bone	615-626	ANATOMY	lower limb	595-605	ANATOMY
26355937_en	ASSOCIATED_WITH	arteriovenous reflux	765-785	DISO	failing however to achieve complete liquidation of the arteriovenous reflux	710-785	FINDING
26355937_en	SUBCLASS_OF	young age	199-208	PHYS	age	205-208	PHYS
26355937_en	HAS_CAUSE	failing however to achieve complete liquidation of the arteriovenous reflux	710-785	FINDING	liquidation of the arteriovenous reflux	746-785	FINDING
26355937_en	SUBCLASS_OF	tibial bone	949-960	ANATOMY	bone	956-960	ANATOMY
26355937_en	SUBCLASS_OF	arteriovenous angiodysplasia	46-74	DISO	angiodysplasia	60-74	DISO
26355937_en	SUBCLASS_OF	Arteriovenous dysplasia	95-118	DISO	dysplasia	109-118	DISO
26355937_en	PART_OF	osseous	229-236	ANATOMY	osseous apparatus	229-246	ANATOMY
26355937_en	AFFECTS	arteriovenous shunt	406-425	DISO	arteriovenous	406-419	ANATOMY
26355937_en	ASSOCIATED_WITH	arteriovenous shunt	406-425	DISO	removing arteriovenous shunt and trophic impairments	397-449	FINDING
26355937_en	ASSOCIATED_WITH	trophic impairments	430-449	DISO	removing arteriovenous shunt and trophic impairments	397-449	FINDING
26355937_en	AFFECTS	salvage of the extremity	366-390	FINDING	extremity	381-390	ANATOMY
26355937_en	ALTERNATIVE_NAME	limb	349-353	ANATOMY	extremity	381-390	ANATOMY
26355937_en	ASSOCIATED_WITH	young age	199-208	PHYS	complications	177-190	DISO
26355937_en	HAS_CAUSE	complications	177-190	DISO	Arteriovenous dysplasia	95-118	DISO
26355937_en	SUBCLASS_OF	arteriovenous angiodysplasia	559-587	DISO	angiodysplasia	573-587	DISO
26355937_en	PART_OF	axis of the tibial bone	937-960	ANATOMY	tibial bone	949-960	ANATOMY
26355937_en	PART_OF	intramedullary canal	965-985	ANATOMY	tibial bone	949-960	ANATOMY
26355937_en	FINDING_OF	salvage of the supporting function of limbs	1292-1335	FINDING	supporting function of limbs	1307-1335	PHYS
26355937_en	SUBCLASS_OF	afferent arteries	1167-1184	ANATOMY	arteries	1176-1184	ANATOMY
26355937_en	AFFECTS	Arteriovenous dysplasia	95-118	DISO	affected limb	340-353	ANATOMY
26356060_en	AFFECTS	distal occlusion	27-43	DISO	lower limbs	51-62	ANATOMY
26356060_en	AFFECTS	critical ischemia of lower extremities	331-369	DISO	lower extremities	352-369	ANATOMY
26356060_en	TREATED_USING	critical ischemia of lower extremities	331-369	DISO	actovegin	305-314	CHEM
26356060_en	AFFECTS	necrotic processes	555-573	DISO	toes	585-589	ANATOMY
26356060_en	AFFECTS	critical limb ischemia	514-536	DISO	limb	523-527	ANATOMY
26356060_en	AFFECTS	distal occlusion	1806-1822	DISO	lower limbs	1830-1841	ANATOMY
26356060_en	TREATED_USING	distal occlusion	1806-1822	DISO	actovegin	1735-1744	CHEM
26356060_en	ALTERNATIVE_NAME	lower limbs	51-62	ANATOMY	lower extremities	352-369	ANATOMY
26356060_en	TO_DETECT_OR_STUDY	polarography	1112-1124	LABPROC	microcirculation	1089-1105	PHYS
26356060_en	TO_DETECT_OR_STUDY	laser Doppler imaging	1129-1150	LABPROC	microcirculation	1089-1105	PHYS
26356060_en	PHYSIOLOGY_OF	skin perfusion	1590-1604	PHYS	skin	1590-1594	ANATOMY
26356060_en	HAS_CAUSE	activated microcirculation	1629-1655	FINDING	actovegin	1571-1580	CHEM
26356060_en	PHYSIOLOGY_OF	tissue oxygenation	1684-1702	PHYS	tissue	1684-1690	ANATOMY
26356060_en	HAS_CAUSE	increased tissue oxygenation	1674-1702	FINDING	actovegin	1571-1580	CHEM
26356060_en	PHYSIOLOGY_OF	collateral blood flow	1767-1788	PHYS	lower limbs	1830-1841	ANATOMY
26356060_en	HAS_CAUSE	Positive effect of actovegin	1716-1744	FINDING	actovegin	1735-1744	CHEM
26356060_en	SUBCLASS_OF	lower limbs	51-62	ANATOMY	limbs	57-62	ANATOMY
26356060_en	SUBCLASS_OF	critical limb ischemia stage III-IV	514-549	DISO	critical limb ischemia	514-536	DISO
26356060_en	SUBCLASS_OF	lower limbs	1830-1841	ANATOMY	limbs	1836-1841	ANATOMY
26356060_en	SUBCLASS_OF	critical limb ischemia stage III-IV	514-549	DISO	atherosclerosis obliterans	486-512	DISO
26356060_en	HAS_CAUSE	necrotic processes	555-573	DISO	critical limb ischemia stage III-IV	514-549	DISO
26356060_en	SUBCLASS_OF	distal occlusion	27-43	DISO	occlusion	34-43	DISO
26356060_en	SUBCLASS_OF	lower extremities	352-369	ANATOMY	extremities	358-369	ANATOMY
26356060_en	ALTERNATIVE_NAME	limbs	57-62	ANATOMY	extremities	358-369	ANATOMY
26356060_en	HAS_CAUSE	effectiveness of actovegin	288-314	FINDING	actovegin	305-314	CHEM
26356060_en	SUBCLASS_OF	critical ischemia of lower extremities	331-369	DISO	critical ischemia	331-348	DISO
26356060_en	SUBCLASS_OF	critical ischemia	331-348	DISO	ischemia	340-348	DISO
26356060_en	SUBCLASS_OF	critical ischemia of lower extremities	331-369	DISO	ischemia of lower extremities	340-369	DISO
26356060_en	SUBCLASS_OF	ischemia of lower extremities	340-369	DISO	ischemia	340-348	DISO
26356060_en	SUBCLASS_OF	limb ischemia	523-536	DISO	ischemia	528-536	DISO
26356060_en	SUBCLASS_OF	critical limb ischemia	514-536	DISO	limb ischemia	523-536	DISO
26356060_en	SUBCLASS_OF	atherosclerosis obliterans	486-512	DISO	atherosclerosis	486-501	DISO
26356060_en	SUBCLASS_OF	low molecular weight heparins	792-821	CHEM	heparins	813-821	CHEM
26356060_en	HAS_CAUSE	double control of therapy's effectiveness	1236-1277	FINDING	therapy's effectiveness	1254-1277	FINDING
26356060_en	ORIGINS_FROM	double control of therapy's effectiveness	1236-1277	FINDING	Cytological	1182-1193	LABPROC
26356060_en	ORIGINS_FROM	double control of therapy's effectiveness	1236-1277	FINDING	histological studies	1198-1218	LABPROC
26356060_en	ORIGINS_FROM	therapy's effectiveness	1254-1277	FINDING	Cytological	1182-1193	LABPROC
26356060_en	ORIGINS_FROM	therapy's effectiveness	1254-1277	FINDING	histological studies	1198-1218	LABPROC
26356060_en	FINDING_OF	pain-free walking distance	1058-1084	FINDING	microcirculation	1089-1105	PHYS
26356060_en	ASSOCIATED_WITH	microcirculation	1313-1329	PHYS	index of regional tissue perfusion	1366-1400	PHYS
26356060_en	SUBCLASS_OF	regional tissue perfusion	1375-1400	PHYS	perfusion	1391-1400	PHYS
26356060_en	PHYSIOLOGY_OF	index of regional tissue perfusion	1366-1400	PHYS	tissue	1384-1390	ANATOMY
26356060_en	ASSOCIATED_WITH	index of regional tissue perfusion	1366-1400	PHYS	regional tissue perfusion	1375-1400	PHYS
26356060_en	PHYSIOLOGY_OF	regional tissue perfusion	1375-1400	PHYS	tissue	1384-1390	ANATOMY
26356060_en	FINDING_OF	improvement of transcutaneous oxygen tension has not been received	1451-1517	FINDING	transcutaneous oxygen tension	1466-1495	PHYS
26356060_en	SUBCLASS_OF	transcutaneous oxygen tension	1466-1495	PHYS	oxygen tension	1481-1495	PHYS
26356060_en	ASSOCIATED_WITH	transcutaneous oxygen tension	1466-1495	PHYS	oxygen	1481-1487	CHEM
26356060_en	SUBCLASS_OF	distal occlusion	1806-1822	DISO	occlusion	1813-1822	DISO
26356060_en	SUBCLASS_OF	collateral blood flow	1767-1788	PHYS	blood flow	1778-1788	PHYS
26356060_en	PHYSIOLOGY_OF	collateral blood flow	1767-1788	PHYS	blood	1778-1783	ANATOMY
26356060_en	FINDING_OF	Positive effect of actovegin	1716-1744	FINDING	collateral blood flow	1767-1788	PHYS
26356060_en	SUBCLASS_OF	skin perfusion	1590-1604	PHYS	perfusion	1595-1604	PHYS
26356060_en	FINDING_OF	improved skin perfusion	1581-1604	FINDING	skin perfusion	1590-1604	PHYS
26356060_en	FINDING_OF	activated microcirculation	1629-1655	FINDING	microcirculation	1639-1655	PHYS
26356060_en	FINDING_OF	increased tissue oxygenation	1674-1702	FINDING	tissue oxygenation	1684-1702	PHYS
26356060_en	HAS_CAUSE	improved skin perfusion	1581-1604	FINDING	actovegin	1571-1580	CHEM
26356162_en	SUBCLASS_OF	diabetes mellitus type2	351-374	DISO	carbohydrate metabolism disorders	316-349	DISO
26356162_en	TREATED_USING	post stroke aphasia	1006-1025	DISO	cerebrolysin	821-833	CHEM
26356162_en	TREATED_USING	post stroke aphasia	1535-1554	DISO	cerebrolysin	1480-1492	CHEM
26356162_en	SUBCLASS_OF	post stroke aphasia	1006-1025	DISO	aphasia	1018-1025	DISO
26356162_en	HAS_CAUSE	speech impairment	1141-1158	DISO	post stroke aphasia	1006-1025	DISO
26356162_en	SUBCLASS_OF	post stroke aphasia	1535-1554	DISO	aphasia	1547-1554	DISO
26356162_en	HAS_CAUSE	increase in BDNF concentrations	1378-1409	FINDING	cerebrolysin	1480-1492	CHEM
26356162_en	HAS_CAUSE	improves the prognosis of their rehabilitation	1577-1623	FINDING	cerebrolysin	1480-1492	CHEM
26356162_en	AFFECTS	left-hemisphere stroke	289-311	DISO	left-hemisphere	289-304	ANATOMY
26356162_en	SUBCLASS_OF	prediabetes	378-389	DISO	carbohydrate metabolism disorders	316-349	DISO
26356162_en	HAS_CAUSE	speech impairment	731-748	DISO	aphasia	641-648	DISO
26356162_en	SUBCLASS_OF	post stroke aphasia	69-88	DISO	aphasia	81-88	DISO
26356162_en	TREATED_USING	left-hemisphere stroke	289-311	DISO	cerebrolysin	404-416	CHEM
26356162_en	AFFECTS	cerebrolysin effect	18-37	FINDING	BDNF level	41-51	PHYS
26356162_en	ASSOCIATED_WITH	BDNF level	41-51	PHYS	BDNF	41-45	CHEM
26356162_en	HAS_CAUSE	post stroke aphasia	69-88	DISO	stroke	74-80	DISO
26356162_en	ASSOCIATED_WITH	carbohydrate metabolism	102-125	PHYS	carbohydrate metabolism disorders	102-135	DISO
26356162_en	ASSOCIATED_WITH	carbohydrate metabolism	102-125	PHYS	carbohydrate	102-114	CHEM
26356162_en	ASSOCIATED_WITH	BDNF concentrations	252-271	PHYS	BDNF	252-256	CHEM
26356162_en	SUBCLASS_OF	left-hemisphere stroke	289-311	DISO	stroke	305-311	DISO
26356162_en	HAS_CAUSE	changes in the rate of speech recovery and BDNF concentrations	209-271	FINDING	speech recovery	232-247	FINDING
26356162_en	FINDING_OF	changes in the rate of speech recovery and BDNF concentrations	209-271	FINDING	BDNF concentrations	252-271	PHYS
26356162_en	SUBCLASS_OF	diabetes mellitus	351-368	DISO	diabetes	351-359	DISO
26356162_en	SUBCLASS_OF	diabetes mellitus type2	351-374	DISO	diabetes mellitus	351-368	DISO
26356162_en	ASSOCIATED_WITH	carbohydrate metabolism	316-339	PHYS	carbohydrate	316-328	CHEM
26356162_en	SUBCLASS_OF	carbohydrate metabolism	316-339	PHYS	metabolism	329-339	PHYS
26356162_en	ASSOCIATED_WITH	speech impairment	731-748	DISO	severity of speech impairment	719-748	FINDING
26356162_en	PHYSIOLOGY_OF	BDNF serum concentrations	750-775	PHYS	serum	755-760	ANATOMY
26356162_en	ORIGINS_FROM	BDNF	750-754	CHEM	serum	755-760	ANATOMY
26356162_en	ASSOCIATED_WITH	BDNF serum concentrations	750-775	PHYS	BDNF	750-754	CHEM
26356162_en	HAS_CAUSE	Clinical efficacy of cerebrolysin	800-833	FINDING	cerebrolysin	821-833	CHEM
26356162_en	SUBCLASS_OF	physiological solution	876-898	CHEM	solution	890-898	CHEM
26356162_en	HAS_CAUSE	post stroke aphasia	1006-1025	DISO	stroke	1011-1017	DISO
26356162_en	ASSOCIATED_WITH	carbohydrate metabolism	1329-1352	PHYS	carbohydrate	1329-1341	CHEM
26356162_en	ASSOCIATED_WITH	carbohydrate metabolism	1329-1352	PHYS	carbohydrate metabolism disorders	1329-1362	DISO
26356162_en	SUBCLASS_OF	carbohydrate metabolism	1329-1352	PHYS	metabolism	1342-1352	PHYS
26356162_en	HAS_CAUSE	increase in BDNF concentrations	1378-1409	FINDING	BDNF	1390-1394	CHEM
26356162_en	FINDING_OF	increase in BDNF concentrations	1378-1409	FINDING	BDNF concentrations	1390-1409	PHYS
26356162_en	HAS_CAUSE	post stroke aphasia	1535-1554	DISO	stroke	1540-1546	DISO
26356162_en	HAS_CAUSE	cerebrolysin effect	18-37	FINDING	cerebrolysin	18-30	CHEM
26356515_en	HAS_CAUSE	benzodiazepine withdrawal syndrome	940-974	DISO	drug dependence	836-851	DISO
26356515_en	HAS_CAUSE	increase in tolerability to benzodiazepine	1046-1088	FINDING	drug dependence	836-851	DISO
26356515_en	SUBCLASS_OF	hypnotic benzodiazepines	267-291	CHEM	hypnotic	267-275	CHEM
26356515_en	HAS_CAUSE	benzodiazepine dependence	769-794	DISO	benzodiazepine	769-783	CHEM
26356515_en	HAS_CAUSE	pathological dependence of benzodiazepine	897-938	DISO	benzodiazepine	924-938	CHEM
26356515_en	SUBCLASS_OF	benzodiazepine dependence	769-794	DISO	drug dependence	836-851	DISO
26356515_en	HAS_CAUSE	benzodiazepine withdrawal syndrome	940-974	DISO	benzodiazepine	940-954	CHEM
26356515_en	HAS_CAUSE	exacerbation of dependence	1018-1044	FINDING	benzodiazepine withdrawal syndrome	940-974	DISO
26356515_en	HAS_CAUSE	drug dependence	836-851	DISO	pathological dependence of benzodiazepine	897-938	DISO
26356515_en	HAS_CAUSE	somatic/autonomic symptoms	987-1013	DISO	benzodiazepine withdrawal syndrome	940-974	DISO
26356515_en	SUBCLASS_OF	anxiolytic	252-262	CHEM	benzodiazepines	276-291	CHEM
26356515_en	ALTERNATIVE_NAME	anxiolytics	68-79	CHEM	anxiolytic	252-262	CHEM
26356515_en	ALTERNATIVE_NAME	hypnotics	84-93	CHEM	hypnotic	267-275	CHEM
26356515_en	ALTERNATIVE_NAME	psychiatric	210-221	DISO	psychiatric disorder	412-432	DISO
26356515_en	FINDING_OF	increase in tolerability to benzodiazepine	1046-1088	FINDING	tolerability	1058-1070	PHYS
26356515_en	ASSOCIATED_WITH	tolerability	1058-1070	PHYS	anxiolytics	1089-1100	CHEM
26356515_en	ASSOCIATED_WITH	tolerability	1058-1070	PHYS	hypnotics	1105-1114	CHEM
26356515_en	SUBCLASS_OF	anxiolytics	1089-1100	CHEM	benzodiazepine	1074-1088	CHEM
26356515_en	SUBCLASS_OF	hypnotics	1105-1114	CHEM	benzodiazepine	1074-1088	CHEM
26356515_en	HAS_CAUSE	higher risk in patients aged ≤ 60 years	1231-1270	FINDING	diazepam	1293-1301	CHEM
26356515_en	ALTERNATIVE_NAME	benzodiazepine dependence	769-794	DISO	pathological dependence of benzodiazepine	897-938	DISO
26356515_en	SUBCLASS_OF	pathological dependence of benzodiazepine	897-938	DISO	pathological dependence	897-920	DISO
26356515_en	HAS_CAUSE	drug dependence	119-134	DISO	hypnotics	84-93	CHEM
26356515_en	HAS_CAUSE	drug dependence	119-134	DISO	anxiolytics	68-79	CHEM
26356515_en	FINDING_OF	clinical/psychopathological characteristics	158-201	FINDING	aged	205-209	PHYS
26356515_en	HAS_CAUSE	risk was higher	1307-1322	FINDING	phenazepam	1349-1359	CHEM
26356615_en	AFFECTS	brain infarction	115-131	DISO	brain	115-120	ANATOMY
26356615_en	AFFECTS	cerebral ischemic lesion	1104-1128	DISO	cerebral	1104-1112	ANATOMY
26356615_en	TREATED_USING	cerebral ischemic lesion	1104-1128	DISO	cytoflavin	1157-1167	CHEM
26356615_en	TREATED_USING	ischemic lesion	1268-1283	DISO	ascorbic acid	1338-1351	CHEM
26356615_en	TREATED_USING	ischemic lesion	1268-1283	DISO	cytoflavin	1370-1380	CHEM
26356615_en	TREATED_USING	cerebral ischemic lesion	1104-1128	DISO	ascorbic acid	1215-1228	CHEM
26356615_en	TO_DETECT_OR_STUDY	CT	1028-1030	LABPROC	cerebral ischemic lesion	1104-1128	DISO
26356615_en	HAS_CAUSE	significant 1,5-1,7- fold decrease	1062-1096	FINDING	cytoflavin	1157-1167	CHEM
26356615_en	AFFECTS	ischemic stroke	512-527	DISO	carotid territory	535-552	ANATOMY
26356615_en	FINDING_OF	more prominent improvement	1576-1602	FINDING	neurologic	1606-1616	PHYS
26356615_en	FINDING_OF	more prominent improvement	1576-1602	FINDING	functional	1618-1628	PHYS
26356615_en	SUBCLASS_OF	ischemic stroke	244-259	DISO	stroke	253-259	DISO
26356615_en	HAS_CAUSE	ischemic stroke	244-259	DISO	ischemic	244-252	DISO
26356615_en	SUBCLASS_OF	brain infarction	115-131	DISO	infarction	121-131	DISO
26356615_en	SUBCLASS_OF	ischemic stroke	512-527	DISO	stroke	521-527	DISO
26356615_en	HAS_CAUSE	ischemic stroke	512-527	DISO	ischemic	512-520	DISO
26356615_en	SUBCLASS_OF	ascorbic acid	697-710	CHEM	acid	706-710	CHEM
26356615_en	ASSOCIATED_WITH	ischemic stroke	244-259	DISO	clinical and morphological results	193-227	FINDING
26356615_en	SUBCLASS_OF	ascorbic acid	1215-1228	CHEM	acid	1224-1228	CHEM
26356615_en	SUBCLASS_OF	ischemic lesion	1113-1128	DISO	lesion	1122-1128	DISO
26356615_en	SUBCLASS_OF	cerebral ischemic lesion	1104-1128	DISO	ischemic lesion	1113-1128	DISO
26356615_en	HAS_CAUSE	ischemic lesion	1113-1128	DISO	ischemic	1113-1121	DISO
26356615_en	HAS_CAUSE	no significant morphologic changes	1173-1207	FINDING	ascorbic acid	1215-1228	CHEM
26356615_en	ORIGINS_FROM	significant 1,5-1,7- fold decrease	1062-1096	FINDING	CT	1028-1030	LABPROC
26356615_en	ORIGINS_FROM	no significant morphologic changes	1173-1207	FINDING	CT	1028-1030	LABPROC
26356615_en	SUBCLASS_OF	ischemic lesion	1268-1283	DISO	lesion	1277-1283	DISO
26356615_en	HAS_CAUSE	ischemic lesion	1268-1283	DISO	ischemic	1268-1276	DISO
26356615_en	SUBCLASS_OF	ascorbic acid	1338-1351	CHEM	acid	1347-1351	CHEM
26356615_en	ASSOCIATED_WITH	ischemic lesion	1268-1283	DISO	percentage of patients with ischemic lesion, increased	1240-1294	FINDING
26356615_en	HAS_CAUSE	2-fold higher	1317-1330	FINDING	percentage of patients with ischemic lesion, increased	1240-1294	FINDING
26356615_en	HAS_CAUSE	2-fold higher	1317-1330	FINDING	ascorbic acid	1338-1351	CHEM
26356615_en	HAS_CAUSE	more prominent improvement	1576-1602	FINDING	cytoflavin	1535-1545	CHEM
26356616_en	SUBCLASS_OF	chronic brain ischemia	156-178	DISO	brain ischemia	164-178	DISO
26356616_en	AFFECTS	chronic brain ischemia	156-178	DISO	brain	164-169	ANATOMY
26356616_en	HAS_CAUSE	moderate cognitive dysfunction	109-139	DISO	chronic brain ischemia	156-178	DISO
26356616_en	TREATED_USING	dementia	68-76	DISO	escitalopram	34-46	CHEM
26356616_en	ALTERNATIVE_NAME	escitalopram	222-234	CHEM	cipralex	236-244	CHEM
26356616_en	TREATED_USING	dementia	267-275	DISO	escitalopram	222-234	CHEM
26356616_en	SUBCLASS_OF	chronic brain ischemia	355-377	DISO	brain ischemia	363-377	DISO
26356616_en	AFFECTS	chronic brain ischemia	355-377	DISO	brain	363-368	ANATOMY
26356616_en	HAS_CAUSE	moderate cognitive dysfunction	308-338	DISO	chronic brain ischemia	355-377	DISO
26356616_en	TREATED_USING	depression	94-104	DISO	escitalopram	34-46	CHEM
26356616_en	TREATED_USING	depression	293-303	DISO	escitalopram	222-234	CHEM
26356616_en	TREATED_USING	depression	916-926	DISO	escitalopram	857-869	CHEM
26356616_en	SUBCLASS_OF	chronic brain ischemia	448-470	DISO	brain ischemia	456-470	DISO
26356616_en	AFFECTS	chronic brain ischemia	448-470	DISO	brain	456-461	ANATOMY
26356616_en	HAS_CAUSE	cognitive dysfunction	943-964	DISO	chronic brain ischemia	982-1004	DISO
26356616_en	AFFECTS	chronic brain ischemia	982-1004	DISO	brain	990-995	ANATOMY
26356616_en	TREATED_USING	dementia	1037-1045	DISO	escitalopram	857-869	CHEM
26356616_en	SUBCLASS_OF	brain ischemia	164-178	DISO	ischemia	170-178	DISO
26356616_en	SUBCLASS_OF	brain ischemia	363-377	DISO	ischemia	369-377	DISO
26356616_en	SUBCLASS_OF	brain ischemia	456-470	DISO	ischemia	462-470	DISO
26356616_en	HAS_CAUSE	depression	916-926	DISO	cognitive dysfunction	943-964	DISO
26356616_en	HAS_CAUSE	decrease of the risk of dementia	1013-1045	FINDING	escitalopram	857-869	CHEM
26356616_en	SUBCLASS_OF	moderate cognitive dysfunction	308-338	DISO	cognitive dysfunction	317-338	DISO
26356616_en	SUBCLASS_OF	moderate cognitive dysfunction	109-139	DISO	cognitive dysfunction	118-139	DISO
26356616_en	SUBCLASS_OF	cognitive dysfunction	118-139	DISO	dysfunction	128-139	DISO
26356616_en	SUBCLASS_OF	cognitive dysfunction	943-964	DISO	dysfunction	953-964	DISO
26356616_en	HAS_CAUSE	efficacy of escitalopram	845-869	FINDING	escitalopram	857-869	CHEM
26356616_en	SUBCLASS_OF	brain ischemia	990-1004	DISO	ischemia	996-1004	DISO
26356616_en	SUBCLASS_OF	chronic brain ischemia	982-1004	DISO	brain ischemia	990-1004	DISO
26356616_en	HAS_CAUSE	decrease of the risk of dementia	1013-1045	FINDING	dementia	1037-1045	DISO
26356616_en	SUBCLASS_OF	cognitive dysfunction	317-338	DISO	dysfunction	327-338	DISO
26356616_en	SUBCLASS_OF	mild or moderate depression	475-502	DISO	depression	492-502	DISO
26356616_en	SUBCLASS_OF	cognitive dysfunction	517-538	DISO	dysfunction	527-538	DISO
26356616_en	ASSOCIATED_WITH	depression	916-926	DISO	efficacy of escitalopram	845-869	FINDING
26356616_en	ASSOCIATED_WITH	cognitive dysfunction	943-964	DISO	efficacy of escitalopram	845-869	FINDING
26390722_en	ABBREVIATION	acute myeloid leukemias	186-209	DISO	AML	211-214	DISO
26390722_en	ABBREVIATION	complete remissions	472-491	PHYS	CR	493-495	PHYS
26390722_en	SUBCLASS_OF	non-M3 types	725-737	DISO	AML	720-723	DISO
26390722_en	ABBREVIATION	low-dose cytarabine	1028-1047	CHEM	LDC	1049-1052	CHEM
26390722_en	ABBREVIATION	hypomethylating agents	1076-1098	CHEM	HA	1100-1102	CHEM
26390722_en	HAS_CAUSE	CR	1436-1438	PHYS	LDC	1503-1506	CHEM
26390722_en	HAS_CAUSE	CR	1436-1438	PHYS	HA	1523-1525	CHEM
26390722_en	HAS_CAUSE	Four-year OS	1637-1649	FINDING	LDC	1756-1759	CHEM
26390722_en	HAS_CAUSE	4-year RFS	1771-1781	FINDING	LDC	1860-1863	CHEM
26390722_en	SUBCLASS_OF	myeloid leukemias	55-72	DISO	leukemias	63-72	DISO
26390722_en	SUBCLASS_OF	acute myeloid leukemias	49-72	DISO	myeloid leukemias	55-72	DISO
26390722_en	AFFECTS	myeloid leukemias	55-72	DISO	myeloid	55-62	ANATOMY
26390722_en	AFFECTS	myeloid leukemias	192-209	DISO	myeloid	192-199	ANATOMY
26390722_en	SUBCLASS_OF	myeloid leukemias	192-209	DISO	leukemias	200-209	DISO
26390722_en	SUBCLASS_OF	acute myeloid leukemias	186-209	DISO	myeloid leukemias	192-209	DISO
26390722_en	ASSOCIATED_WITH	acute myeloid leukemias	186-209	DISO	efficiency of their treatment	253-282	FINDING
26390722_en	ASSOCIATED_WITH	acute myeloid leukemias	49-72	DISO	Clinical and epidemiological characteristics	1-45	FINDING
26390722_en	SUBCLASS_OF	complete remissions	472-491	PHYS	remissions	481-491	PHYS
26390722_en	ALTERNATIVE_NAME	recurrences	498-509	DISO	relapse	547-554	DISO
26390722_en	ABBREVIATION	relapse-free survival	547-568	FINDING	RFS	570-573	FINDING
26390722_en	ABBREVIATION	4-year overall survival	523-568	FINDING	OS	539-541	FINDING
26390722_en	SUBCLASS_OF	4-year overall survival	523-568	FINDING	survival	560-568	FINDING
26390722_en	SUBCLASS_OF	relapse-free survival	547-568	FINDING	survival	560-568	FINDING
26390722_en	HAS_CAUSE	efficiency of their treatment	410-439	FINDING	4-year overall survival	523-568	FINDING
26390722_en	HAS_CAUSE	efficiency of their treatment	410-439	FINDING	deaths	511-517	PHYS
26390722_en	HAS_CAUSE	efficiency of their treatment	410-439	FINDING	relapse-free survival	547-568	FINDING
26390722_en	ASSOCIATED_WITH	relapse	547-554	DISO	relapse-free survival	547-568	FINDING
26390722_en	HAS_CAUSE	efficiency of their treatment	410-439	FINDING	recurrences	498-509	DISO
26390722_en	FINDING_OF	rates of complete remissions	463-491	FINDING	complete remissions	472-491	PHYS
26390722_en	HAS_CAUSE	efficiency of their treatment	410-439	FINDING	rates of complete remissions	463-491	FINDING
26390722_en	SUBCLASS_OF	low-dose cytarabine	1028-1047	CHEM	cytarabine	1037-1047	CHEM
26390722_en	SUBCLASS_OF	allogeneic hematopoietic stem cell	1205-1239	ANATOMY	hematopoietic stem cell	1216-1239	ANATOMY
26390722_en	PHYSIOLOGY_OF	hematopoietic	1216-1229	PHYS	hematopoietic stem cell	1216-1239	ANATOMY
26390722_en	FINDING_OF	mortality	1327-1336	FINDING	deaths	1357-1363	PHYS
26390722_en	HAS_CAUSE	deaths	1427-1433	PHYS	primary refractory disease	1388-1414	DISO
26390722_en	SUBCLASS_OF	Four-year OS	1637-1649	FINDING	OS	1647-1649	FINDING
26390722_en	SUBCLASS_OF	4-year RFS	1771-1781	FINDING	RFS	1778-1781	FINDING
26390722_en	ALTERNATIVE_NAME	4-year overall survival	523-568	FINDING	Four-year OS	1637-1649	FINDING
26390722_en	SUBCLASS_OF	High mortality rates in the induction	1884-1921	FINDING	mortality	1889-1898	FINDING
26390722_en	HAS_CAUSE	High mortality rates in the induction	1884-1921	FINDING	limited resources of accompanying therapy	1947-1988	FINDING
26390722_en	HAS_CAUSE	High mortality rates in the induction	1884-1921	FINDING	poor sanitary conditions	1990-2014	FINDING
26390722_en	HAS_CAUSE	High mortality rates in the induction	1884-1921	FINDING	no own opportunities to perform allo-HSCT	2020-2061	FINDING
26485778_en	AFFECTS	psoriasis	286-295	DISO	skin	242-246	ANATOMY
26485778_en	AFFECTS	atopic dermatitis	300-317	DISO	skin	242-246	ANATOMY
26485778_en	AFFECTS	dermatoses	104-114	DISO	skin	13-17	ANATOMY
26485778_en	HAS_CAUSE	itch	209-213	DISO	psoriasis	286-295	DISO
26485778_en	HAS_CAUSE	itch	209-213	DISO	atopic dermatitis	300-317	DISO
26485778_en	AFFECTS	dermatitis	307-317	DISO	skin	242-246	ANATOMY
26485778_en	AFFECTS	psoriasis	385-394	DISO	Skin	341-345	ANATOMY
26485778_en	AFFECTS	atopic dermatitis	416-433	DISO	Skin	341-345	ANATOMY
26485778_en	SUBCLASS_OF	atopic dermatitis	416-433	DISO	dermatitis	423-433	DISO
26485778_en	SUBCLASS_OF	atopic dermatitis	300-317	DISO	dermatitis	307-317	DISO
26485778_en	SUBCLASS_OF	psoriasis	286-295	DISO	dermatoses	104-114	DISO
26485778_en	SUBCLASS_OF	atopic dermatitis	300-317	DISO	dermatoses	104-114	DISO
26485778_en	ABBREVIATION	protein gene product 9.5	575-599	CHEM	PGP9.5	601-607	CHEM
26485778_en	ABBREVIATION	calcitonin gene-related peptide	639-670	CHEM	CGRP	672-676	CHEM
26485778_en	SUBCLASS_OF	CGRP-R	696-702	CHEM	calcitonin gene-related peptide	639-670	CHEM
26485778_en	ABBREVIATION	nerve growth factor	705-724	CHEM	NGF	726-729	CHEM
26485778_en	SUBCLASS_OF	TrkA	748-752	CHEM	nerve growth factor	705-724	CHEM
26485778_en	ABBREVIATION	substance P	758-769	CHEM	SP	771-773	CHEM
26485778_en	SUBCLASS_OF	SP-R	792-796	CHEM	substance P	758-769	CHEM
26485778_en	SUBCLASS_OF	atopic dermatitis	1030-1047	DISO	dermatitis	1037-1047	DISO
26485778_en	AFFECTS	atopic dermatitis	1030-1047	DISO	skin	989-993	ANATOMY
26485778_en	AFFECTS	dermatitis	1037-1047	DISO	skin	989-993	ANATOMY
26485778_en	AFFECTS	psoriasis	1052-1061	DISO	skin	989-993	ANATOMY
26485778_en	SUBCLASS_OF	atopic dermatitis	1284-1301	DISO	dermatitis	1291-1301	DISO
26485778_en	AFFECTS	larger number of epidermal nerve fibers	1567-1606	FINDING	epidermal nerve fibers	1584-1606	ANATOMY
26485778_en	HAS_CAUSE	psoriasis	1534-1543	DISO	larger number of epidermal nerve fibers	1567-1606	FINDING
26485778_en	HAS_CAUSE	atopic dermatitis	1512-1529	DISO	larger number of epidermal nerve fibers	1567-1606	FINDING
26485778_en	SUBCLASS_OF	atopic dermatitis	1512-1529	DISO	dermatitis	1519-1529	DISO
26485778_en	HAS_CAUSE	itch	1681-1685	DISO	psoriasis	1534-1543	DISO
26485778_en	HAS_CAUSE	itch	1681-1685	DISO	atopic dermatitis	1512-1529	DISO
26485778_en	ORIGINS_FROM	neuropeptides	32-45	CHEM	skin	13-17	ANATOMY
26485778_en	ORIGINS_FROM	neurotrophins	47-60	CHEM	skin	13-17	ANATOMY
26485778_en	APPLIED_TO	Immunoperoxidase examination	953-981	LABPROC	skin biopsy specimens	989-1010	ANATOMY
26485778_en	ORIGINS_FROM	amphiregulin	1094-1106	CHEM	skin biopsy specimens	989-1010	ANATOMY
26485778_en	ORIGINS_FROM	NGF	1108-1111	CHEM	skin biopsy specimens	989-1010	ANATOMY
26485778_en	ORIGINS_FROM	PGP9.5	1117-1123	CHEM	skin biopsy specimens	989-1010	ANATOMY
26485778_en	HAS_CAUSE	psoriasis	1052-1061	DISO	amphiregulin	1094-1106	CHEM
26485778_en	HAS_CAUSE	psoriasis	1052-1061	DISO	NGF	1108-1111	CHEM
26485778_en	HAS_CAUSE	psoriasis	1052-1061	DISO	PGP9.5	1117-1123	CHEM
26485778_en	HAS_CAUSE	atopic dermatitis	1030-1047	DISO	amphiregulin	1094-1106	CHEM
26485778_en	HAS_CAUSE	atopic dermatitis	1030-1047	DISO	NGF	1108-1111	CHEM
26485778_en	HAS_CAUSE	atopic dermatitis	1030-1047	DISO	PGP9.5	1117-1123	CHEM
26485778_en	HAS_CAUSE	psoriasis	1306-1315	DISO	CGRP	1347-1351	CHEM
26485778_en	HAS_CAUSE	psoriasis	1306-1315	DISO	CGRP-R	1356-1362	CHEM
26485778_en	HAS_CAUSE	psoriasis	1306-1315	DISO	SP	1364-1366	CHEM
26485778_en	HAS_CAUSE	psoriasis	1306-1315	DISO	SP-R	1368-1372	CHEM
26485778_en	HAS_CAUSE	psoriasis	1306-1315	DISO	TrkA	1378-1382	CHEM
26485778_en	HAS_CAUSE	atopic dermatitis	1284-1301	DISO	CGRP	1347-1351	CHEM
26485778_en	HAS_CAUSE	atopic dermatitis	1284-1301	DISO	CGRP-R	1356-1362	CHEM
26485778_en	HAS_CAUSE	atopic dermatitis	1284-1301	DISO	SP	1364-1366	CHEM
26485778_en	HAS_CAUSE	atopic dermatitis	1284-1301	DISO	SP-R	1368-1372	CHEM
26485778_en	HAS_CAUSE	atopic dermatitis	1284-1301	DISO	TrkA	1378-1382	CHEM
26485778_en	SUBCLASS_OF	epidermal nerve fibers	1584-1606	ANATOMY	nerve fibers	1594-1606	ANATOMY
26485778_en	PHYSIOLOGY_OF	body's sensitization	1903-1923	PHYS	body's	1903-1909	ANATOMY
26485778_en	SUBCLASS_OF	semaphorin 3A	624-637	CHEM	semaphorin	624-634	CHEM
26485778_en	SUBCLASS_OF	semaphorin 3A	1237-1250	CHEM	nerve reduction factor	1214-1236	CHEM
26485778_en	HAS_CAUSE	direct correlation	1616-1634	FINDING	disease severity	1659-1675	FINDING
26485778_en	HAS_CAUSE	psoriasis	1534-1543	DISO	direct correlation	1616-1634	FINDING
26485778_en	HAS_CAUSE	atopic dermatitis	1512-1529	DISO	direct correlation	1616-1634	FINDING
26485778_en	PART_OF	Skin biopsy specimens	341-362	ANATOMY	Skin	341-345	ANATOMY
26485778_en	TO_DETECT_OR_STUDY	histological	455-467	LABPROC	Skin biopsy specimens	341-362	ANATOMY
26485778_en	TO_DETECT_OR_STUDY	immunoperoxidase	469-485	LABPROC	Skin biopsy specimens	341-362	ANATOMY
26485778_en	APPLIED_TO	indirect immunofluorescence assays	491-525	LABPROC	Skin biopsy specimens	341-362	ANATOMY
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	TrkA	748-752	CHEM
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	substance P	758-769	CHEM
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	SP-R	792-796	CHEM
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	protein gene product 9.5	575-599	CHEM
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	amphiregulin	610-622	CHEM
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	semaphorin 3A	624-637	CHEM
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	calcitonin gene-related peptide	639-670	CHEM
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	CGRP-R	696-702	CHEM
26485778_en	TO_DETECT_OR_STUDY	indirect immunofluorescence assay	802-835	LABPROC	nerve growth factor	705-724	CHEM
26485778_en	PART_OF	skin biopsy specimens	989-1010	ANATOMY	skin	989-993	ANATOMY
26485778_en	ORIGINS_FROM	nerve reduction factor	1214-1236	CHEM	skin biopsy specimens	989-1010	ANATOMY
26485778_en	HAS_CAUSE	pathogenesis	88-100	DISO	dermatoses	104-114	DISO
26485778_en	AFFECTS	inflammatory response	247-268	DISO	skin	242-246	ANATOMY
26485778_en	HAS_CAUSE	inflammatory response	247-268	DISO	psoriasis	286-295	DISO
26485778_en	HAS_CAUSE	inflammatory response	247-268	DISO	atopic dermatitis	300-317	DISO
26485778_en	ORIGINS_FROM	receptors	71-80	CHEM	skin	13-17	ANATOMY
26485778_en	SUBCLASS_OF	indirect immunofluorescence assay	802-835	LABPROC	immunofluorescence assay	811-835	LABPROC
26485778_en	SUBCLASS_OF	indirect immunofluorescence assays	491-525	LABPROC	immunofluorescence assays	500-525	LABPROC
26485778_en	APPLIED_TO	biopsy	346-352	LABPROC	Skin biopsy specimens	341-362	ANATOMY
26485778_en	APPLIED_TO	biopsy	994-1000	LABPROC	skin biopsy specimens	989-1010	ANATOMY
26485778_en	FINDING_OF	enhanced expression	1071-1090	FINDING	expression	1080-1090	PHYS
26485778_en	ASSOCIATED_WITH	expression	1080-1090	PHYS	amphiregulin	1094-1106	CHEM
26485778_en	ASSOCIATED_WITH	expression	1080-1090	PHYS	NGF	1108-1111	CHEM
26485778_en	ASSOCIATED_WITH	expression	1080-1090	PHYS	PGP9.5	1117-1123	CHEM
26485778_en	PART_OF	epidermal nerve fibers	1158-1180	ANATOMY	epidermal	1158-1167	ANATOMY
26485778_en	AFFECTS	appearance of positively stained epidermal nerve fibers	1125-1180	FINDING	epidermal nerve fibers	1158-1180	ANATOMY
26485778_en	SUBCLASS_OF	epidermal nerve fibers	1158-1180	ANATOMY	nerve fibers	1168-1180	ANATOMY
26485778_en	PART_OF	nerve fibers	1168-1180	ANATOMY	nerve	1168-1173	ANATOMY
26485778_en	SUBCLASS_OF	nerve reduction factor	1214-1236	CHEM	reduction factor	1220-1236	CHEM
26485778_en	APPLIED_TO	nerve reduction factor	1214-1236	CHEM	nerve	1214-1219	ANATOMY
26485778_en	SUBCLASS_OF	semaphorin 3A	1237-1250	CHEM	semaphorin	1237-1247	CHEM
26485778_en	ASSOCIATED_WITH	expression	1196-1206	PHYS	nerve reduction factor	1214-1236	CHEM
26485778_en	FINDING_OF	decreased expression of the nerve reduction factor	1186-1236	FINDING	expression	1196-1206	PHYS
26485778_en	FINDING_OF	increased expression	1323-1343	FINDING	expression	1333-1343	PHYS
26485778_en	ASSOCIATED_WITH	expression	1333-1343	PHYS	CGRP	1347-1351	CHEM
26485778_en	SUBCLASS_OF	CGRP-R	1356-1362	CHEM	CGRP	1356-1360	CHEM
26485778_en	SUBCLASS_OF	SP-R	1368-1372	CHEM	SP	1368-1370	CHEM
26485778_en	ASSOCIATED_WITH	expression	1333-1343	PHYS	CGRP-R	1356-1362	CHEM
26485778_en	ASSOCIATED_WITH	expression	1333-1343	PHYS	SP	1364-1366	CHEM
26485778_en	ASSOCIATED_WITH	expression	1333-1343	PHYS	SP-R	1368-1372	CHEM
26485778_en	ASSOCIATED_WITH	expression	1333-1343	PHYS	TrkA	1378-1382	CHEM
26485778_en	HAS_CAUSE	inflammatory response	1397-1418	DISO	atopic dermatitis	1284-1301	DISO
26485778_en	HAS_CAUSE	inflammatory response	1397-1418	DISO	psoriasis	1306-1315	DISO
26485778_en	HAS_CAUSE	itch intensity	1681-1695	FINDING	itch	1681-1685	DISO
26485778_en	HAS_CAUSE	direct correlation	1616-1634	FINDING	itch intensity	1681-1695	FINDING
26485778_en	HAS_CAUSE	disease severity	1659-1675	FINDING	atopic dermatitis	1512-1529	DISO
26485778_en	HAS_CAUSE	disease severity	1659-1675	FINDING	psoriasis	1534-1543	DISO
26485778_en	PART_OF	epidermal nerve fibers	1584-1606	ANATOMY	epidermal	1584-1593	ANATOMY
26485778_en	PART_OF	nerve fibers	1594-1606	ANATOMY	nerve	1594-1599	ANATOMY
26485778_en	FINDING_OF	larger number of epidermal nerve fibers	1567-1606	FINDING	number of epidermal nerve fibers	1574-1606	PHYS
26485778_en	PHYSIOLOGY_OF	number of epidermal nerve fibers	1574-1606	PHYS	epidermal nerve fibers	1584-1606	ANATOMY
26485778_en	SUBCLASS_OF	body's sensitization	1903-1923	PHYS	sensitization	1910-1923	PHYS
26485778_en	AFFECTS	inflammatory response	1795-1816	DISO	skin	1790-1794	ANATOMY
26485778_en	ASSOCIATED_WITH	production of neuropeptides and neurotrophins	1701-1746	PHYS	neuropeptides	1715-1728	CHEM
26485778_en	ASSOCIATED_WITH	production of neuropeptides and neurotrophins	1701-1746	PHYS	neurotrophins	1733-1746	CHEM
26485778_en	HAS_CAUSE	closely related to the development of a skin inflammatory response	1750-1816	FINDING	production of neuropeptides and neurotrophins	1701-1746	PHYS
26485778_en	HAS_CAUSE	inflammatory response	1795-1816	DISO	production of neuropeptides and neurotrophins	1701-1746	PHYS
26485778_en	ASSOCIATED_WITH	inflammatory response	1795-1816	DISO	closely related to the development of a skin inflammatory response	1750-1816	FINDING
26485778_en	FINDING_OF	favor the body's sensitization and the chronic pattern the course of diseases	1893-1970	FINDING	body's sensitization	1903-1923	PHYS
26525622_en	HAS_CAUSE	cognitive impairment	29-49	DISO	epilepsy	81-89	DISO
26525622_en	ALTERNATIVE_NAME	hopantenic acid	152-167	CHEM	pantogam	169-177	CHEM
26525622_en	TREATED_USING	epilepsy	221-229	DISO	hopantenic acid	152-167	CHEM
26525622_en	TREATED_USING	epilepsy	314-322	DISO	pantogam	336-344	CHEM
26525622_en	SUBCLASS_OF	cryptogenic epilepsy	478-498	DISO	epilepsy	490-498	DISO
26525622_en	SUBCLASS_OF	symptomatic epilepsy	503-523	DISO	epilepsy	515-523	DISO
26525622_en	TREATED_USING	cognitive impairment	658-678	DISO	pantogam	769-777	CHEM
26525622_en	TREATED_USING	cognitive impairment	111-131	DISO	hopantenic acid	152-167	CHEM
26525622_en	APPLIED_TO	brain MRI	632-641	LABPROC	brain	632-637	ANATOMY
26525622_en	SUBCLASS_OF	brain MRI	632-641	LABPROC	MRI	638-641	LABPROC
26525622_en	SUBCLASS_OF	hopantenic acid	152-167	CHEM	acid	163-167	CHEM
26525622_en	SUBCLASS_OF	preschool age	53-66	PHYS	age	63-66	PHYS
26525622_en	ASSOCIATED_WITH	cognitive impairment	984-1004	DISO	decrease in cognitive impairment	972-1004	FINDING
26525622_en	ORIGINS_FROM	improvement of EEG	1101-1119	FINDING	EEG	1116-1119	LABPROC
26525622_en	ASSOCIATED_WITH	seizures	1242-1250	DISO	no increase in the frequency of seizures	1210-1250	FINDING
26525622_en	USED_IN	EEG	613-616	LABPROC	video-EEG monitoring	607-627	LABPROC
26525622_en	HAS_CAUSE	efficacy of hopantenic acid	140-167	FINDING	hopantenic acid	152-167	CHEM
26525622_en	HAS_CAUSE	did not receive pantogam	396-420	FINDING	pantogam	412-420	CHEM
26525622_en	FINDING_OF	age normalization	1079-1096	FINDING	age	1079-1082	PHYS
26525625_en	TREATED_USING	burnout syndrome	48-64	DISO	cytoflavin	17-27	CHEM
26525625_en	TREATED_USING	burnout syndrome	150-166	DISO	cytoflavin	105-115	CHEM
26525625_en	HAS_CAUSE	higher efficacy of cytoflavin	598-627	FINDING	efficacy of cytoflavin	605-627	FINDING
26525625_en	HAS_CAUSE	higher efficacy of cytoflavin	598-627	FINDING	cytoflavin	617-627	CHEM
26525625_en	HAS_CAUSE	efficacy of cytoflavin	605-627	FINDING	cytoflavin	617-627	CHEM
26525625_en	HAS_CAUSE	higher efficacy of cytoflavin	598-627	FINDING	improvement	629-640	FINDING
26525625_en	USED_IN	ethylmethylhydroxypyridine	673-699	CHEM	ethylmethylhydroxypyridine succinate	673-709	CHEM
26525625_en	USED_IN	succinate	700-709	CHEM	ethylmethylhydroxypyridine succinate	673-709	CHEM
26525625_en	USED_IN	ethylmethylhydroxypyridine	371-397	CHEM	ethylmethylhydroxypyridine succinate	371-407	CHEM
26525625_en	USED_IN	succinate	398-407	CHEM	ethylmethylhydroxypyridine succinate	371-407	CHEM
26525625_en	HAS_CAUSE	higher efficacy of cytoflavin	598-627	FINDING	ethylmethylhydroxypyridine succinate	673-709	CHEM
26525625_en	HAS_CAUSE	improvement	711-722	FINDING	ethylmethylhydroxypyridine succinate	673-709	CHEM
26525625_en	HAS_CAUSE	improvement	629-640	FINDING	cytoflavin	617-627	CHEM
26525625_en	HAS_CAUSE	improvement was more persisten	788-818	FINDING	cytoflavin	762-772	CHEM
26525625_en	HAS_CAUSE	efficacy of cytoflavin	5-27	FINDING	cytoflavin	17-27	CHEM
26525625_en	HAS_CAUSE	efficacy of cytoflavin	93-115	FINDING	cytoflavin	105-115	CHEM
26525625_en	ASSOCIATED_WITH	burnout syndrome	48-64	DISO	efficacy of cytoflavin	5-27	FINDING
26525625_en	ASSOCIATED_WITH	burnout syndrome	150-166	DISO	efficacy of cytoflavin	93-115	FINDING
26525628_en	AFFECTS	trophic changes	517-532	DISO	skin	540-544	ANATOMY
26525628_en	AFFECTS	bone deformations	556-573	DISO	bone	556-560	ANATOMY
26525628_en	HAS_CAUSE	Clinical characteristics	1-25	DISO	syringomyelia	29-42	DISO
26525628_en	AFFECTS	trophic changes	517-532	DISO	joint	546-551	ANATOMY
26525628_en	HAS_CAUSE	clinical characteristics	97-121	DISO	syringomyelia	125-138	DISO
26525628_en	PART_OF	cervical-thoracic region	620-644	ANATOMY	spine	652-657	ANATOMY
26525628_en	ASSOCIATED_WITH	syringomyelia	125-138	DISO	Disease duration	308-324	FINDING
26525628_en	PART_OF	cervical	620-628	ANATOMY	cervical-thoracic region	620-644	ANATOMY
26525628_en	PART_OF	thoracic	629-637	ANATOMY	cervical-thoracic region	620-644	ANATOMY
26525628_en	ASSOCIATED_WITH	lesion	593-599	DISO	slowly progressive course was most frequent	662-705	FINDING
26525628_en	AFFECTS	slowly progressive course was most frequent	662-705	FINDING	spine	652-657	ANATOMY
26525628_en	AFFECTS	slowly progressive course was most frequent	662-705	FINDING	cervical-thoracic region	620-644	ANATOMY
26528618_en	PART_OF	clivus	153-159	ANATOMY	craniovertebral region	129-151	ANATOMY
26528618_en	PART_OF	body of the C2 vertebra	200-223	ANATOMY	craniovertebral region	129-151	ANATOMY
26528618_en	PART_OF	C0-C1-C2 segments	230-247	ANATOMY	craniovertebral region	129-151	ANATOMY
26528618_en	AFFECTS	craniovertebral junction instability	296-332	DISO	craniovertebral junction	296-320	ANATOMY
26528618_en	AFFECTS	lesion of C1-C2 segments	374-398	DISO	C1-C2 segments	384-398	ANATOMY
26528618_en	HAS_CAUSE	craniovertebral junction instability	296-332	DISO	lesion of C1-C2 segments	374-398	DISO
26528618_en	AFFECTS	compression of the spinal cord	484-514	DISO	spinal cord	503-514	ANATOMY
26528618_en	HAS_CAUSE	compression of the spinal cord	484-514	DISO	chordoma	552-560	DISO
26528618_en	HAS_CAUSE	compression of the spinal cord	484-514	DISO	giant cell tumor	562-578	DISO
26528618_en	HAS_CAUSE	compression of the spinal cord	484-514	DISO	osteoblastoma	580-593	DISO
26528618_en	HAS_CAUSE	compression of the spinal cord	484-514	DISO	rheumatoid lesion	595-612	DISO
26528618_en	HAS_CAUSE	compression of the spinal cord	484-514	DISO	metastases	614-624	DISO
26528618_en	HAS_CAUSE	compression of the spinal cord	484-514	DISO	platybasia	626-636	DISO
26528618_en	HAS_CAUSE	compression of the spinal cord	484-514	DISO	basilar impression	642-660	DISO
26528618_en	AFFECTS	destruction of the clivus structures	423-459	DISO	clivus structures	442-459	ANATOMY
26528618_en	HAS_CAUSE	destruction of the clivus structures	423-459	DISO	chordoma	552-560	DISO
26528618_en	HAS_CAUSE	destruction of the clivus structures	423-459	DISO	giant cell tumor	562-578	DISO
26528618_en	HAS_CAUSE	destruction of the clivus structures	423-459	DISO	osteoblastoma	580-593	DISO
26528618_en	HAS_CAUSE	destruction of the clivus structures	423-459	DISO	rheumatoid lesion	595-612	DISO
26528618_en	HAS_CAUSE	destruction of the clivus structures	423-459	DISO	metastases	614-624	DISO
26528618_en	HAS_CAUSE	destruction of the clivus structures	423-459	DISO	platybasia	626-636	DISO
26528618_en	HAS_CAUSE	destruction of the clivus structures	423-459	DISO	basilar impression	642-660	DISO
26528618_en	AFFECTS	instability of the craniovertebral junction	699-742	DISO	craniovertebral junction	718-742	ANATOMY
26528618_en	HAS_CAUSE	neurological disorders	771-793	DISO	instability of the craniovertebral junction	699-742	DISO
26528618_en	AFFECTS	invagination	934-946	DISO	C2 vertebra	978-989	ANATOMY
26528618_en	AFFECTS	bone defect	1720-1731	DISO	clivus	1763-1769	ANATOMY
26528618_en	AFFECTS	spinal canal stenosis	1873-1894	DISO	spinal canal	1873-1885	ANATOMY
26528618_en	SUBCLASS_OF	C2 vertebra	73-84	ANATOMY	vertebra	76-84	ANATOMY
26528618_en	PART_OF	body of the C2 vertebra	200-223	ANATOMY	C2 vertebra	212-223	ANATOMY
26528618_en	SUBCLASS_OF	C2 vertebra	212-223	ANATOMY	vertebra	215-223	ANATOMY
26528618_en	SUBCLASS_OF	C2 vertebra	978-989	ANATOMY	vertebra	981-989	ANATOMY
26528618_en	PHYSIOLOGY_OF	strength and range of motions	1269-1298	PHYS	arms	1306-1310	ANATOMY
26528618_en	PHYSIOLOGY_OF	strength and range of motions	1269-1298	PHYS	distal legs	1315-1326	ANATOMY
26528618_en	TO_DETECT_OR_STUDY	spiral CT	1685-1694	LABPROC	postoperative bone defect	1706-1731	DISO
26528618_en	TO_DETECT_OR_STUDY	MRI	1677-1680	LABPROC	postoperative bone defect	1706-1731	DISO
26528618_en	AFFECTS	bone defect	1720-1731	DISO	bone	1720-1724	ANATOMY
26528618_en	AFFECTS	wound surface	2327-2340	INJURY_POISONING	oropharynx area	2348-2363	ANATOMY
26528618_en	AFFECTS	inflammatory complications	2486-2512	DISO	oral cavity	2520-2531	ANATOMY
26528618_en	PART_OF	C1 anterior arch	161-177	ANATOMY	craniovertebral region	129-151	ANATOMY
26528618_en	PART_OF	odontoid process	179-195	ANATOMY	craniovertebral region	129-151	ANATOMY
26528618_en	AFFECTS	destruction	423-434	DISO	C1-C2 vertebrae	464-479	ANATOMY
26528618_en	HAS_CAUSE	destruction	423-434	DISO	chordoma	552-560	DISO
26528618_en	HAS_CAUSE	destruction	423-434	DISO	giant cell tumor	562-578	DISO
26528618_en	HAS_CAUSE	destruction	423-434	DISO	osteoblastoma	580-593	DISO
26528618_en	HAS_CAUSE	destruction	423-434	DISO	rheumatoid lesion	595-612	DISO
26528618_en	HAS_CAUSE	destruction	423-434	DISO	metastases	614-624	DISO
26528618_en	HAS_CAUSE	destruction	423-434	DISO	platybasia	626-636	DISO
26528618_en	HAS_CAUSE	destruction	423-434	DISO	basilar impression	642-660	DISO
26528618_en	PHYSIOLOGY_OF	sensitivity	1457-1468	PHYS	arms	1476-1480	ANATOMY
26528618_en	PHYSIOLOGY_OF	sensitivity	1457-1468	PHYS	legs	1482-1486	ANATOMY
26528618_en	PHYSIOLOGY_OF	sensitivity	1457-1468	PHYS	torso	1492-1497	ANATOMY
26528618_en	AFFECTS	complete decompression	1771-1793	FINDING	medulla oblongata	1801-1818	ANATOMY
26528618_en	AFFECTS	complete decompression	1771-1793	FINDING	upper cervical spine segments	1823-1852	ANATOMY
26528618_en	PART_OF	spinal cord	503-514	ANATOMY	spinal	503-509	ANATOMY
26528618_en	FINDING_OF	improvement in all kinds of sensitivity	1429-1468	FINDING	sensitivity	1457-1468	PHYS
26528618_en	SUBCLASS_OF	Postoperative liquorrhea	1500-1524	DISO	liquorrhea	1514-1524	DISO
26528618_en	ALTERNATIVE_NAME	C2 vertebra	73-84	ANATOMY	C2	73-75	ANATOMY
26528618_en	AFFECTS	invaginated	37-48	DISO	odontoid process	49-65	ANATOMY
26528618_en	PART_OF	C1 anterior arch	161-177	ANATOMY	C1	161-163	ANATOMY
26528618_en	SUBCLASS_OF	craniovertebral junction	718-742	ANATOMY	junction	734-742	ANATOMY
26528618_en	PART_OF	craniovertebral junction	718-742	ANATOMY	craniovertebral	718-733	ANATOMY
26528618_en	ALTERNATIVE_NAME	C2 vertebra	978-989	ANATOMY	C2	978-980	ANATOMY
26528618_en	FINDING_OF	increase in the strength and range of motions	1253-1298	FINDING	strength and range of motions	1269-1298	PHYS
26528618_en	SUBCLASS_OF	spiral CT	1685-1694	LABPROC	CT	1692-1694	LABPROC
26528618_en	PART_OF	C1	384-386	ANATOMY	C1-C2 segments	384-398	ANATOMY
26528618_en	PART_OF	C2	387-389	ANATOMY	C1-C2 segments	384-398	ANATOMY
26528618_en	SUBCLASS_OF	lesion of C1-C2 segments	374-398	DISO	lesion	374-380	DISO
26528618_en	ALTERNATIVE_NAME	C2 vertebra	212-223	ANATOMY	C2	212-214	ANATOMY
26528618_en	PART_OF	C0	230-232	ANATOMY	C0-C1-C2 segments	230-247	ANATOMY
26528618_en	PART_OF	C1	233-235	ANATOMY	C0-C1-C2 segments	230-247	ANATOMY
26528618_en	PART_OF	C2	236-238	ANATOMY	C0-C1-C2 segments	230-247	ANATOMY
26528618_en	SUBCLASS_OF	craniovertebral junction	296-320	ANATOMY	junction	312-320	ANATOMY
26528618_en	PART_OF	craniovertebral junction	296-320	ANATOMY	craniovertebral	296-311	ANATOMY
26528618_en	PART_OF	odontoid process	49-65	ANATOMY	C2 vertebra	73-84	ANATOMY
26528618_en	ALTERNATIVE_NAME	craniovertebral region	129-151	ANATOMY	craniovertebral	296-311	ANATOMY
26528618_en	SUBCLASS_OF	destruction of the clivus structures	423-459	DISO	destruction	423-434	DISO
26528618_en	SUBCLASS_OF	C1-C2 vertebrae	464-479	ANATOMY	vertebrae	470-479	ANATOMY
26528618_en	PART_OF	C1	464-466	ANATOMY	C1-C2 vertebrae	464-479	ANATOMY
26528618_en	PART_OF	C2	467-469	ANATOMY	C1-C2 vertebrae	464-479	ANATOMY
26528618_en	SUBCLASS_OF	giant cell tumor	562-578	DISO	tumor	573-578	DISO
26528618_en	SUBCLASS_OF	giant cell	562-572	ANATOMY	cell	568-572	ANATOMY
26528618_en	AFFECTS	giant cell tumor	562-578	DISO	giant cell	562-572	ANATOMY
26528618_en	SUBCLASS_OF	rheumatoid lesion	595-612	DISO	lesion	606-612	DISO
26528618_en	HAS_CAUSE	instability of the craniovertebral junction	699-742	DISO	chordoma	552-560	DISO
26528618_en	HAS_CAUSE	instability of the craniovertebral junction	699-742	DISO	giant cell tumor	562-578	DISO
26528618_en	HAS_CAUSE	instability of the craniovertebral junction	699-742	DISO	osteoblastoma	580-593	DISO
26528618_en	HAS_CAUSE	instability of the craniovertebral junction	699-742	DISO	rheumatoid lesion	595-612	DISO
26528618_en	HAS_CAUSE	instability of the craniovertebral junction	699-742	DISO	metastases	614-624	DISO
26528618_en	HAS_CAUSE	instability of the craniovertebral junction	699-742	DISO	platybasia	626-636	DISO
26528618_en	HAS_CAUSE	instability of the craniovertebral junction	699-742	DISO	basilar impression	642-660	DISO
26528618_en	HAS_CAUSE	neurological disorders	771-793	DISO	chordoma	552-560	DISO
26528618_en	HAS_CAUSE	neurological disorders	771-793	DISO	osteoblastoma	580-593	DISO
26528618_en	HAS_CAUSE	neurological disorders	771-793	DISO	giant cell tumor	562-578	DISO
26528618_en	HAS_CAUSE	neurological disorders	771-793	DISO	rheumatoid lesion	595-612	DISO
26528618_en	HAS_CAUSE	neurological disorders	771-793	DISO	metastases	614-624	DISO
26528618_en	HAS_CAUSE	neurological disorders	771-793	DISO	platybasia	626-636	DISO
26528618_en	HAS_CAUSE	neurological disorders	771-793	DISO	basilar impression	642-660	DISO
26528618_en	HAS_CAUSE	complicates the diagnosis and surgical treatment	801-849	FINDING	neurological disorders	771-793	DISO
26528618_en	HAS_CAUSE	complicates the diagnosis and surgical treatment	801-849	FINDING	instability of the craniovertebral junction	699-742	DISO
26528618_en	PART_OF	odontoid process	954-970	ANATOMY	C2 vertebra	978-989	ANATOMY
26528618_en	AFFECTS	invagination	934-946	DISO	odontoid process	954-970	ANATOMY
26528618_en	PART_OF	odontoid process	1120-1136	ANATOMY	C2	1117-1119	ANATOMY
26528618_en	ASSOCIATED_WITH	neurological symptoms	1201-1222	DISO	partial regression of the neurological symptoms	1175-1222	FINDING
26528618_en	ASSOCIATED_WITH	strength and range of motions	1269-1298	PHYS	motions	1291-1298	PHYS
26528618_en	PHYSIOLOGY_OF	motions	1291-1298	PHYS	arms	1306-1310	ANATOMY
26528618_en	PART_OF	distal legs	1315-1326	ANATOMY	legs	1322-1326	ANATOMY
26528618_en	PHYSIOLOGY_OF	motions	1291-1298	PHYS	distal legs	1315-1326	ANATOMY
26528618_en	AFFECTS	spasticity	1338-1348	DISO	arms	1356-1360	ANATOMY
26528618_en	AFFECTS	regressed spasticity	1328-1348	FINDING	arms	1356-1360	ANATOMY
26528618_en	ASSOCIATED_WITH	spasticity	1338-1348	DISO	regressed spasticity	1328-1348	FINDING
26528618_en	ALTERNATIVE_NAME	regressed spasticity	1328-1348	FINDING	reduced spasticity	1379-1397	FINDING
26528618_en	ASSOCIATED_WITH	spasticity	1387-1397	DISO	reduced spasticity	1379-1397	FINDING
26528618_en	AFFECTS	spasticity	1387-1397	DISO	legs	1405-1409	ANATOMY
26528618_en	AFFECTS	reduced spasticity	1379-1397	FINDING	legs	1405-1409	ANATOMY
26528618_en	AFFECTS	improvement in all kinds of sensitivity	1429-1468	FINDING	arms	1476-1480	ANATOMY
26528618_en	AFFECTS	improvement in all kinds of sensitivity	1429-1468	FINDING	legs	1482-1486	ANATOMY
26528618_en	AFFECTS	improvement in all kinds of sensitivity	1429-1468	FINDING	torso	1492-1497	ANATOMY
26528618_en	SUBCLASS_OF	CSF fistula	1585-1596	DISO	fistula	1589-1596	DISO
26528618_en	ASSOCIATED_WITH	liquorrhea	1631-1641	DISO	no signs of liquorrhea	1619-1641	FINDING
26528618_en	PART_OF	odontoid process	1742-1758	ANATOMY	C2	1739-1741	ANATOMY
26528618_en	AFFECTS	postoperative bone defect	1706-1731	DISO	odontoid process	1742-1758	ANATOMY
26528618_en	PART_OF	upper cervical spine segments	1823-1852	ANATOMY	cervical	1829-1837	ANATOMY
26528618_en	PART_OF	upper cervical spine segments	1823-1852	ANATOMY	spine	1838-1843	ANATOMY
26528618_en	SUBCLASS_OF	spinal canal stenosis	1873-1894	DISO	stenosis	1886-1894	DISO
26528618_en	PART_OF	spinal canal	1873-1885	ANATOMY	spinal	1873-1879	ANATOMY
26528618_en	AFFECTS	no evidence of spinal canal stenosis	1858-1894	FINDING	spinal canal	1873-1885	ANATOMY
26528618_en	ASSOCIATED_WITH	spinal canal stenosis	1873-1894	DISO	no evidence of spinal canal stenosis	1858-1894	FINDING
26528618_en	TO_DETECT_OR_STUDY	MRI	1677-1680	LABPROC	complete decompression	1771-1793	FINDING
26528618_en	TO_DETECT_OR_STUDY	spiral CT	1685-1694	LABPROC	complete decompression	1771-1793	FINDING
26528618_en	TO_DETECT_OR_STUDY	MRI	1677-1680	LABPROC	no evidence of spinal canal stenosis	1858-1894	FINDING
26528618_en	TO_DETECT_OR_STUDY	spiral CT	1685-1694	LABPROC	no evidence of spinal canal stenosis	1858-1894	FINDING
26528618_en	SUBCLASS_OF	soft palate	2085-2096	ANATOMY	palate	2090-2096	ANATOMY
26528618_en	AFFECTS	soft palate remains intact	2085-2111	FINDING	soft palate	2085-2096	ANATOMY
26528618_en	HAS_CAUSE	significant advantages	2050-2072	FINDING	soft palate remains intact	2085-2111	FINDING
26528618_en	HAS_CAUSE	significant advantages	2050-2072	FINDING	oropharynx area is less damaged	2117-2148	FINDING
26528618_en	HAS_CAUSE	significant advantages	2050-2072	FINDING	hospitalization and rehabilitation duration is reduced	2158-2212	FINDING
26528618_en	PART_OF	oral cavity	2303-2314	ANATOMY	oral	2303-2307	ANATOMY
26528618_en	USED_IN	stomach tube	2450-2462	DEVICE	stomach	2450-2457	ANATOMY
26528618_en	SUBCLASS_OF	inflammatory complications	2486-2512	DISO	complications	2499-2512	DISO
26528618_en	SUBCLASS_OF	inflammatory complications	2486-2512	DISO	inflammatory	2486-2498	DISO
26528618_en	PART_OF	oropharynx area	2348-2363	ANATOMY	oropharynx	2348-2358	ANATOMY
26528618_en	PART_OF	oral cavity	2520-2531	ANATOMY	oral	2520-2524	ANATOMY
26528618_en	PART_OF	C2	2613-2615	ANATOMY	C1-C2 segment	2610-2623	ANATOMY
26528618_en	PART_OF	C1	2610-2612	ANATOMY	C1-C2 segment	2610-2623	ANATOMY
26528618_en	ASSOCIATED_WITH	complications	2246-2259	DISO	no problems and complications	2230-2259	FINDING
26528618_en	AFFECTS	failure of sutures in the oral cavity	2277-2314	DISO	sutures	2288-2295	ANATOMY
26528618_en	PART_OF	sutures	2288-2295	ANATOMY	oral cavity	2303-2314	ANATOMY
26591552_en	SUBCLASS_OF	coronary heart disease	109-131	DISO	heart disease	118-131	DISO
26591552_en	AFFECTS	coronary heart disease	109-131	DISO	coronary	109-117	ANATOMY
26591552_en	AFFECTS	heart disease	118-131	DISO	heart	118-123	ANATOMY
26591552_en	ABBREVIATION	coronary heart disease	266-288	DISO	CHD	290-293	DISO
26591552_en	ABBREVIATION	External respiratory function	398-427	PHYS	ERF	429-432	PHYS
26591552_en	ABBREVIATION	blood pressure	455-469	PHYS	BP	471-473	PHYS
26591552_en	ABBREVIATION	high-sensitivity C-reactive protein	581-616	CHEM	hs-CRP	618-624	CHEM
26591552_en	ABBREVIATION	C-reactive protein	598-616	CHEM	CRP	621-624	CHEM
26591552_en	ABBREVIATION	endothelium-independent vasodilation	729-765	PHYS	EIVD	776-780	PHYS
26591552_en	ALTERNATIVE_NAME	endothelium-dependent vasodilation	703-765	PHYS	EDVD	767-771	PHYS
26591552_en	AFFECTS	bronchial obstruction	1560-1581	DISO	bronchial	1560-1569	ANATOMY
26591552_en	ABBREVIATION	reactive hyperemia	1804-1822	PHYS	RH	1824-1826	PHYS
26591552_en	ABBREVIATION	index of reactivity	1829-1848	PHYS	IR	1850-1852	PHYS
26591552_en	ABBREVIATION	brachial artery	1862-1877	ANATOMY	BA	1879-1881	ANATOMY
26591552_en	TREATED_USING	asthma	86-92	DISO	pioglitazone	27-39	CHEM
26591552_en	TREATED_USING	coronary heart disease	109-131	DISO	pioglitazone	27-39	CHEM
26591552_en	TREATED_USING	asthma	243-249	DISO	pioglitazone	184-196	CHEM
26591552_en	TREATED_USING	coronary heart disease	266-288	DISO	pioglitazone	184-196	CHEM
26591552_en	ORIGINS_FROM	high-sensitivity C-reactive protein	581-616	CHEM	urine	553-558	ANATOMY
26591552_en	ORIGINS_FROM	high-sensitivity C-reactive protein	581-616	CHEM	Blood	543-548	ANATOMY
26591552_en	PHYSIOLOGY_OF	endothelial function	657-677	PHYS	endothelial	657-668	ANATOMY
26591552_en	SUBCLASS_OF	angina pain	1603-1614	DISO	angina	1603-1609	DISO
26591552_en	SUBCLASS_OF	angina attacks	1318-1332	DISO	angina	1318-1324	DISO
26591552_en	PHYSIOLOGY_OF	blood flow	1776-1786	PHYS	blood	1776-1781	ANATOMY
26591552_en	TO_DETECT_OR_STUDY	test for reactive hyperemia	1795-1822	LABPROC	reactive hyperemia	1804-1822	PHYS
26591552_en	HAS_CAUSE	decreased	1536-1545	FINDING	nitroglycerin	1640-1653	CHEM
26591552_en	HAS_CAUSE	decreased	1536-1545	FINDING	salbutamol	1658-1668	CHEM
26591552_en	TO_DETECT_OR_STUDY	test for reactive hyperemia	1795-1822	LABPROC	linear velocity of blood flow	1757-1786	PHYS
26591552_en	AFFECTS	coronary heart disease	109-131	DISO	heart	118-123	ANATOMY
26591552_en	PHYSIOLOGY_OF	blood pressure	455-469	PHYS	blood	455-460	ANATOMY
26591552_en	HAS_CAUSE	clinical effectiveness of pioglitazone	158-196	FINDING	pioglitazone	184-196	CHEM
26591552_en	HAS_CAUSE	Clinical effectiveness of pioglitazone	1-39	FINDING	pioglitazone	27-39	CHEM
26591552_en	ASSOCIATED_WITH	External respiratory function	398-427	PHYS	External respiratory	398-418	PHYS
26591552_en	SUBCLASS_OF	External respiratory	398-418	PHYS	respiratory	407-418	PHYS
26591552_en	AFFECTS	coronary heart disease	266-288	DISO	coronary	266-274	ANATOMY
26591552_en	AFFECTS	coronary heart disease	266-288	DISO	heart	275-280	ANATOMY
26591552_en	SUBCLASS_OF	coronary heart disease	266-288	DISO	heart disease	275-288	DISO
26591552_en	SUBCLASS_OF	high-sensitivity C-reactive protein	581-616	CHEM	C-reactive protein	598-616	CHEM
26591552_en	SUBCLASS_OF	C-reactive protein	598-616	CHEM	protein	609-616	CHEM
26591552_en	SUBCLASS_OF	hs-CRP	618-624	CHEM	CRP	621-624	CHEM
26591552_en	SUBCLASS_OF	endothelium-independent vasodilation	729-765	PHYS	vasodilation	753-765	PHYS
26591552_en	SUBCLASS_OF	endothelium-dependent vasodilation	703-765	PHYS	vasodilation	753-765	PHYS
26591552_en	TO_DETECT_OR_STUDY	measuring endothelium-dependent and endothelium-independent vasodilation	693-765	LABPROC	endothelium-dependent vasodilation	703-765	PHYS
26591552_en	TO_DETECT_OR_STUDY	measuring endothelium-dependent and endothelium-independent vasodilation	693-765	LABPROC	endothelium-independent vasodilation	729-765	PHYS
26591552_en	TO_DETECT_OR_STUDY	Blood and urine laboratory values	543-576	LABPROC	urine	553-558	ANATOMY
26591552_en	TO_DETECT_OR_STUDY	Blood and urine laboratory values	543-576	LABPROC	Blood	543-548	ANATOMY
26591552_en	FINDING_OF	stabilization of ERF and endothelial function	1172-1217	FINDING	ERF	1189-1192	PHYS
26591552_en	AFFECTS	stabilization of ERF and endothelial function	1172-1217	FINDING	endothelial	1197-1208	ANATOMY
26591552_en	FINDING_OF	stabilization of ERF and endothelial function	1172-1217	FINDING	endothelial function	1197-1217	PHYS
26591552_en	PHYSIOLOGY_OF	endothelial function	1197-1217	PHYS	endothelial	1197-1208	ANATOMY
26591552_en	HAS_CAUSE	frequency of asthma symptoms	1269-1297	FINDING	increases	1252-1261	FINDING
26591552_en	SUBCLASS_OF	angina attacks	1318-1332	DISO	attacks	1325-1332	DISO
26591552_en	ASSOCIATED_WITH	angina attacks	1318-1332	DISO	duration of angina attacks	1306-1332	FINDING
26591552_en	HAS_CAUSE	duration of angina attacks	1306-1332	FINDING	increases	1252-1261	FINDING
26591552_en	FINDING_OF	decline in hs-CRP levels	1355-1379	FINDING	hs-CRP levels	1366-1379	PHYS
26591552_en	ASSOCIATED_WITH	hs-CRP levels	1366-1379	PHYS	hs-CRP	1366-1372	CHEM
26591552_en	SUBCLASS_OF	hs-CRP	1366-1372	CHEM	CRP	1369-1372	CHEM
26591552_en	TREATED_USING	asthma attacks	1619-1633	DISO	nitroglycerin	1640-1653	CHEM
26591552_en	SUBCLASS_OF	systolic blood pressure	1678-1715	PHYS	blood pressure	1701-1715	PHYS
26591552_en	SUBCLASS_OF	diastolic blood pressure	1691-1715	PHYS	blood pressure	1701-1715	PHYS
26591552_en	PHYSIOLOGY_OF	blood pressure	1701-1715	PHYS	blood	1701-1706	ANATOMY
26591552_en	FINDING_OF	lowered systolic and diastolic blood pressure	1670-1715	FINDING	systolic blood pressure	1678-1715	PHYS
26591552_en	FINDING_OF	lowered systolic and diastolic blood pressure	1670-1715	FINDING	diastolic blood pressure	1691-1715	PHYS
26591552_en	ASSOCIATED_WITH	angina pain	1603-1614	DISO	frequency	1590-1599	FINDING
26591552_en	ASSOCIATED_WITH	asthma attacks	1619-1633	DISO	frequency	1590-1599	FINDING
26591552_en	ASSOCIATED_WITH	bronchial obstruction	1560-1581	DISO	decreased	1536-1545	FINDING
26591552_en	HAS_CAUSE	decreased	1536-1545	FINDING	frequency	1590-1599	FINDING
26591552_en	SUBCLASS_OF	angina pain	1603-1614	DISO	pain	1610-1614	DISO
26591552_en	SUBCLASS_OF	asthma attacks	1619-1633	DISO	attacks	1626-1633	DISO
26591552_en	HAS_CAUSE	asthma attacks	1619-1633	DISO	asthma	1619-1625	DISO
26591552_en	SUBCLASS_OF	reactive hyperemia	1804-1822	PHYS	hyperemia	1813-1822	PHYS
26591552_en	SUBCLASS_OF	brachial artery	1862-1877	ANATOMY	artery	1871-1877	ANATOMY
26591552_en	PART_OF	brachial artery	1862-1877	ANATOMY	brachial	1862-1870	ANATOMY
26591552_en	PHYSIOLOGY_OF	BA diameter	1926-1937	PHYS	BA	1926-1928	ANATOMY
26591552_en	FINDING_OF	increases in IR and A% BA diameter	1903-1937	FINDING	IR	1916-1918	PHYS
26591552_en	FINDING_OF	increases in IR and A% BA diameter	1903-1937	FINDING	BA diameter	1926-1937	PHYS
26591552_en	ASSOCIATED_WITH	hs-CRP values	1979-1992	PHYS	hs-CRP	1979-1985	CHEM
26591552_en	SUBCLASS_OF	hs-CRP	1979-1985	CHEM	CRP	1982-1985	CHEM
26591552_en	ASSOCIATED_WITH	total cholesterol levels	2033-2057	PHYS	total cholesterol	2033-2050	CHEM
26591552_en	SUBCLASS_OF	total cholesterol	2033-2050	CHEM	cholesterol	2039-2050	CHEM
26591552_en	ASSOCIATED_WITH	systemic inflammation	1952-1973	DISO	reduced systemic inflammation	1944-1973	FINDING
26591552_en	SUBCLASS_OF	systemic inflammation	1952-1973	DISO	inflammation	1961-1973	DISO
26591552_en	SUBCLASS_OF	systemic inflammation	2266-2287	DISO	inflammation	2275-2287	DISO
26591552_en	FINDING_OF	improves endothelial functional activity	2293-2333	FINDING	endothelial functional activity	2302-2333	PHYS
26591552_en	PHYSIOLOGY_OF	endothelial functional activity	2302-2333	PHYS	endothelial	2302-2313	ANATOMY
26591552_en	AFFECTS	improves endothelial functional activity	2293-2333	FINDING	endothelial	2302-2313	ANATOMY
26591552_en	ASSOCIATED_WITH	systemic inflammation	2266-2287	DISO	reduces systemic inflammation	2258-2287	FINDING
26600613_en	SUBCLASS_OF	Podoconiosis	46-58	DISO	inflammatory disease	65-85	DISO
26600613_en	AFFECTS	swelling of the lower limb	169-195	DISO	lower limb	185-195	ANATOMY
26600613_en	HAS_CAUSE	swelling of the lower limb	169-195	DISO	Podoconiosis	46-58	DISO
26600613_en	SUBCLASS_OF	swelling of the lower limb	169-195	DISO	lymphoedema	197-208	DISO
26600613_en	HAS_CAUSE	acute pain	214-224	DISO	Podoconiosis	46-58	DISO
26600613_en	HAS_CAUSE	Podoconiosis	46-58	DISO	irritant minerals in soil	119-144	CHEM
26600613_en	SUBCLASS_OF	lower limb	185-195	ANATOMY	limb	191-195	ANATOMY
26600613_en	SUBCLASS_OF	acute pain	214-224	DISO	pain	220-224	DISO
26600613_en	SUBCLASS_OF	irritant minerals in soil	119-144	CHEM	minerals	128-136	CHEM
26600613_en	ASSOCIATED_WITH	podoconiosis	543-555	DISO	reduce podoconiosis incidence	536-565	FINDING
26600613_en	SUBCLASS_OF	acute infections	874-890	DISO	infections	880-890	DISO
26600613_en	SUBCLASS_OF	swelling of the lower limb	169-195	DISO	swelling	169-177	DISO
26753198_en	PART_OF	mediastinal structures	379-401	ANATOMY	mediastinal	379-390	ANATOMY
26753198_en	FINDING_OF	maximize the efficiency of gas exchange	618-657	FINDING	gas exchange	645-657	PHYS
26753198_en	SUBCLASS_OF	main bronchi	1380-1392	ANATOMY	bronchi	1385-1392	ANATOMY
26753198_en	PHYSIOLOGY_OF	gas exchange	1314-1326	PHYS	trachea	1368-1375	ANATOMY
26753198_en	PHYSIOLOGY_OF	gas exchange	1314-1326	PHYS	main bronchi	1380-1392	ANATOMY
26753198_en	ASSOCIATED_WITH	gas exchange	128-140	PHYS	gas	128-131	CHEM
26753198_en	ASSOCIATED_WITH	gas exchange	645-657	PHYS	gas	645-648	CHEM
26753198_en	ASSOCIATED_WITH	cardiorespiratory	1234-1251	PHYS	cardiorespiratory pathology	1234-1261	DISO
26753198_en	ASSOCIATED_WITH	gas exchange	1314-1326	PHYS	gas	1314-1317	CHEM
26821417_en	ABBREVIATION	acute respiratory viral infections	248-282	DISO	ARVI	284-288	DISO
26821417_en	SUBCLASS_OF	acute respiratory viral infections	248-282	DISO	respiratory viral infections	254-282	DISO
26821417_en	TREATED_USING	uncomplicated mild and moderate ARVI	364-400	DISO	Rinza	516-521	CHEM
26821417_en	HAS_CAUSE	rapider alleviation of fever and other ARVI symptoms	715-767	FINDING	Influnet	683-691	CHEM
26821417_en	TREATED_USING	fever	738-743	DISO	Rinza	838-843	CHEM
26821417_en	TREATED_USING	ARVI symptoms	754-767	DISO	Rinza	838-843	CHEM
26821417_en	TREATED_USING	fever	738-743	DISO	monocomponent drugs	865-884	CHEM
26821417_en	TREATED_USING	ARVI symptoms	754-767	DISO	monocomponent drugs	865-884	CHEM
26821417_en	TREATED_USING	acute respiratory viral infections	37-71	DISO	Combination drugs	1-18	CHEM
26821417_en	SUBCLASS_OF	Influnet	219-227	CHEM	combination drug	202-218	CHEM
26821417_en	TREATED_USING	acute respiratory viral infections	248-282	DISO	Influnet	219-227	CHEM
26821417_en	HAS_CAUSE	shorter temporary disability	976-1004	FINDING	ARVI	1022-1026	DISO
26821417_en	HAS_CAUSE	fewer adverse reactions	1250-1273	FINDING	Combination drugs	1226-1243	CHEM
26821417_en	TREATED_USING	ARVI	1330-1334	DISO	monocomponent drugs	1296-1315	CHEM
26821417_en	TREATED_USING	ARVI	1330-1334	DISO	Combination drugs	1226-1243	CHEM
26821417_en	ASSOCIATED_WITH	respiratory	43-54	PHYS	acute respiratory viral infections	37-71	DISO
26821417_en	SUBCLASS_OF	acute respiratory viral infections	37-71	DISO	respiratory viral infections	43-71	DISO
26821417_en	SUBCLASS_OF	respiratory viral infections	43-71	DISO	infections	61-71	DISO
26821417_en	SUBCLASS_OF	viral infections	266-282	DISO	infections	272-282	DISO
26821417_en	SUBCLASS_OF	respiratory viral infections	254-282	DISO	viral infections	266-282	DISO
26821417_en	ASSOCIATED_WITH	respiratory	254-265	PHYS	acute respiratory viral infections	248-282	DISO
26821417_en	HAS_CAUSE	clinical effectiveness of the drugs	622-657	FINDING	Influnet	683-691	CHEM
26821417_en	ASSOCIATED_WITH	fever	738-743	DISO	rapider alleviation of fever and other ARVI symptoms	715-767	FINDING
26821417_en	HAS_CAUSE	ARVI symptoms	754-767	DISO	ARVI	754-758	DISO
26821417_en	ASSOCIATED_WITH	ARVI symptoms	754-767	DISO	rapider alleviation of fever and other ARVI symptoms	715-767	FINDING
26821417_en	TREATED_USING	fever	738-743	DISO	Influnet	683-691	CHEM
26821417_en	TREATED_USING	ARVI symptoms	754-767	DISO	Influnet	683-691	CHEM
26821417_en	HAS_CAUSE	clinical effectiveness of the drugs	622-657	FINDING	Rinza	838-843	CHEM
26821417_en	HAS_CAUSE	clinical effectiveness of the drugs	622-657	FINDING	monocomponent drugs	865-884	CHEM
26821417_en	ASSOCIATED_WITH	temporary disability	984-1004	DISO	shorter temporary disability	976-1004	FINDING
26821417_en	HAS_CAUSE	temporary disability	984-1004	DISO	ARVI	1022-1026	DISO
26821417_en	SUBCLASS_OF	temporary disability	984-1004	DISO	disability	994-1004	DISO
26821417_en	TREATED_USING	ARVI	1022-1026	DISO	Influnet	1028-1036	CHEM
26821417_en	TREATED_USING	ARVI	1188-1192	DISO	Influnet	1167-1175	CHEM
26821417_en	HAS_CAUSE	more economically sound	1049-1072	FINDING	Influnet	1028-1036	CHEM
26821417_en	HAS_CAUSE	more cost- effective	1343-1363	FINDING	Combination drugs	1226-1243	CHEM
26821417_en	SUBCLASS_OF	uncomplicated mild and moderate ARVI	364-400	DISO	mild and moderate ARVI	378-400	DISO
26821417_en	SUBCLASS_OF	mild and moderate ARVI	378-400	DISO	ARVI	396-400	DISO
26821417_en	HAS_CAUSE	higher clinical and economic feasibility of Influnet therapy	1123-1183	FINDING	Influnet	1167-1175	CHEM
26821417_en	ASSOCIATED_WITH	ARVI	1188-1192	DISO	higher clinical and economic feasibility of Influnet therapy	1123-1183	FINDING
26821419_en	TREATED_USING	pulmonary arterial hypertension	13-44	DISO	sildenafil	101-111	CHEM
26821419_en	SUBCLASS_OF	pulmonary arterial hypertension	13-44	DISO	hypertension	32-44	DISO
26821419_en	ABBREVIATION	pulmonary arterial hypertension	226-257	DISO	PAH	259-262	DISO
26821419_en	ABBREVIATION	connective tissue diseases	280-306	DISO	CTD	308-311	DISO
26821419_en	HAS_CAUSE	pulmonary arterial hypertension	226-257	DISO	connective tissue diseases	280-306	DISO
26821419_en	HAS_CAUSE	PAH	436-439	DISO	CTD	456-459	DISO
26821419_en	SUBCLASS_OF	sildenafil	771-781	CHEM	phosphodiesterase type 5 inhibitor	785-819	CHEM
26821419_en	TREATED_USING	PAH	895-898	DISO	potent vasodilator	823-841	CHEM
26821419_en	TREATED_USING	PAH	895-898	DISO	sildenafil	771-781	CHEM
26821419_en	TREATED_USING	CTD	1474-1477	DISO	sildenafil	1394-1404	CHEM
26821419_en	TREATED_USING	PAH	1454-1457	DISO	sildenafil	1394-1404	CHEM
26821419_en	HAS_CAUSE	PAH	1454-1457	DISO	CTD	1474-1477	DISO
26821419_en	AFFECTS	connective tissue diseases	62-88	DISO	connective tissue	62-79	ANATOMY
26821419_en	AFFECTS	connective tissue diseases	280-306	DISO	connective tissue	280-297	ANATOMY
26821419_en	SUBCLASS_OF	right heart	702-713	ANATOMY	heart	708-713	ANATOMY
26821419_en	PHYSIOLOGY_OF	right atrial pressure	1261-1282	PHYS	atrial	1267-1273	ANATOMY
26821419_en	HAS_CAUSE	survival	200-208	PHYS	sildenafil	182-192	CHEM
26821419_en	HAS_CAUSE	Survival	1-9	PHYS	sildenafil	101-111	CHEM
26821419_en	HAS_CAUSE	pulmonary arterial hypertension	13-44	DISO	connective tissue diseases	62-88	DISO
26821419_en	SUBCLASS_OF	phosphodiesterase type 5 inhibitor	785-819	CHEM	potent vasodilator	823-841	CHEM
26821419_en	HAS_CAUSE	improves survival	1419-1436	FINDING	sildenafil	1394-1404	CHEM
26821419_en	HAS_CAUSE	survival	1428-1436	PHYS	sildenafil	1394-1404	CHEM
26821419_en	SUBCLASS_OF	connective tissue	62-79	ANATOMY	tissue	73-79	ANATOMY
26821419_en	PART_OF	pulmonary arterial	13-31	ANATOMY	pulmonary	13-22	ANATOMY
26821419_en	SUBCLASS_OF	pulmonary arterial	13-31	ANATOMY	arterial	23-31	ANATOMY
26821419_en	SUBCLASS_OF	pulmonary arterial hypertension	13-44	DISO	arterial hypertension	23-44	DISO
26821419_en	ALTERNATIVE_NAME	arterial hypertension	23-44	DISO	hypertension	32-44	DISO
26821419_en	AFFECTS	pulmonary arterial hypertension	13-44	DISO	pulmonary	13-22	ANATOMY
26821419_en	AFFECTS	pulmonary arterial hypertension	13-44	DISO	arterial	23-31	ANATOMY
26821419_en	AFFECTS	pulmonary arterial hypertension	13-44	DISO	pulmonary arterial	13-31	ANATOMY
26821419_en	SUBCLASS_OF	pulmonary arterial hypertension	226-257	DISO	arterial hypertension	236-257	DISO
26821419_en	ALTERNATIVE_NAME	arterial hypertension	236-257	DISO	hypertension	245-257	DISO
26821419_en	AFFECTS	pulmonary arterial hypertension	226-257	DISO	pulmonary arterial	226-244	ANATOMY
26821419_en	AFFECTS	pulmonary arterial hypertension	226-257	DISO	pulmonary	226-235	ANATOMY
26821419_en	AFFECTS	pulmonary arterial hypertension	226-257	DISO	arterial	236-244	ANATOMY
26821419_en	PART_OF	pulmonary arterial	226-244	ANATOMY	pulmonary	226-235	ANATOMY
26821419_en	SUBCLASS_OF	pulmonary arterial	226-244	ANATOMY	arterial	236-244	ANATOMY
26821419_en	SUBCLASS_OF	connective tissue	280-297	ANATOMY	tissue	291-297	ANATOMY
26821419_en	FINDING_OF	Survival rates	933-947	FINDING	Survival	933-941	PHYS
26821419_en	SUBCLASS_OF	Three-year survival rates	1039-1064	FINDING	survival rates	1050-1064	FINDING
26821419_en	FINDING_OF	survival rates	1050-1064	FINDING	survival	1050-1058	PHYS
26821419_en	FINDING_OF	improves survival	1419-1436	FINDING	survival	1428-1436	PHYS
26821419_en	SUBCLASS_OF	right atrial pressure	1261-1282	PHYS	atrial pressure	1267-1282	PHYS
26821419_en	PHYSIOLOGY_OF	vascular resistance	1298-1317	PHYS	vascular	1298-1306	ANATOMY
26821419_en	SUBCLASS_OF	right atrial pressure	1261-1282	PHYS	hemodynamic parameters	1237-1259	PHYS
26821419_en	SUBCLASS_OF	vascular resistance	1298-1317	PHYS	hemodynamic parameters	1237-1259	PHYS
26821419_en	HAS_CAUSE	time to clinical deterioration	1152-1182	FINDING	clinical deterioration	1160-1182	FINDING
26821419_en	HAS_CAUSE	time to clinical deterioration	1152-1182	FINDING	duration of the follow-up	1207-1232	FINDING
26821419_en	HAS_CAUSE	time to clinical deterioration	1152-1182	FINDING	hemodynamic parameters	1237-1259	PHYS
26953424_en	AFFECTS	odontogenic sinusitis	61-82	DISO	odontogenic	61-72	ANATOMY
26953424_en	ALTERNATIVE_NAME	Odontogenic maxillary sinusitis	175-206	DISO	odontogenic sinusitis	61-82	DISO
26953424_en	AFFECTS	Odontogenic maxillary sinusitis	175-206	DISO	Odontogenic	175-186	ANATOMY
26953424_en	SUBCLASS_OF	maxillary sinusitis	187-206	DISO	sinusitis	197-206	DISO
26953424_en	SUBCLASS_OF	Odontogenic maxillary sinusitis	175-206	DISO	sinusitis	197-206	DISO
26953424_en	AFFECTS	Odontogenic maxillary sinusitis	175-206	DISO	maxillofacial area	258-276	ANATOMY
26953424_en	SUBCLASS_OF	odontogenic lesions	394-413	DISO	lesions	406-413	DISO
26953424_en	AFFECTS	odontogenic lesions	394-413	DISO	odontogenic	394-405	ANATOMY
26953424_en	AFFECTS	odontogenic lesions	394-413	DISO	maxillofacial area	258-276	ANATOMY
26953424_en	AFFECTS	odontogenic sinusitis	502-523	DISO	odontogenic	502-513	ANATOMY
26953424_en	SUBCLASS_OF	odontogenic sinusitis	502-523	DISO	sinusitis	514-523	DISO
26953424_en	SUBCLASS_OF	maxillary sinusitis	752-771	DISO	sinusitis	762-771	DISO
26953424_en	AFFECTS	foreign bodies in the maxillary sinuses	1146-1185	DISO	maxillary sinuses	1168-1185	ANATOMY
26953424_en	AFFECTS	odontogenic cysts	1333-1350	DISO	odontogenic	1333-1344	ANATOMY
26953424_en	HAS_CAUSE	mycotic infection	1406-1423	DISO	odontogenic cysts	1333-1350	DISO
26953424_en	SUBCLASS_OF	odontogenic cysts	1333-1350	DISO	cysts	1345-1350	DISO
26953424_en	USED_IN	CT PISASSO TRIO	826-841	DEVICE	X-ray examinations	789-807	LABPROC
26953424_en	AFFECTS	Inflammatory diseases	86-107	DISO	maxillary sinuses	115-132	ANATOMY
26953424_en	AFFECTS	inflammatory processes	232-254	DISO	maxillofacial area	258-276	ANATOMY
26953424_en	USED_IN	Brillians 64	889-901	DEVICE	X-ray examinations	789-807	LABPROC
26953424_en	HAS_CAUSE	chronic inflammatory processes	1795-1825	DISO	sinusitis	1747-1756	DISO
26953424_en	AFFECTS	chronic inflammatory processes	1795-1825	DISO	maxillary sinuses	1833-1850	ANATOMY
26953424_en	SUBCLASS_OF	odontogenic sinusitis	61-82	DISO	sinusitis	73-82	DISO
26953424_en	TO_DETECT_OR_STUDY	radiological	21-33	LABPROC	odontogenic sinusitis	61-82	DISO
26953424_en	TO_DETECT_OR_STUDY	radiological	21-33	LABPROC	odontogenic	61-72	ANATOMY
26953424_en	SUBCLASS_OF	maxillary sinuses	115-132	ANATOMY	sinuses	125-132	ANATOMY
26953424_en	PART_OF	maxillary sinuses	115-132	ANATOMY	maxillary	115-124	ANATOMY
26953424_en	ASSOCIATED_WITH	odontogenic sinusitis	502-523	DISO	clinical and radiological characteristics of odontogenic sinusitis	457-523	FINDING
26953424_en	TO_DETECT_OR_STUDY	radiological	470-482	LABPROC	odontogenic sinusitis	502-523	DISO
26953424_en	TO_DETECT_OR_STUDY	radiological	470-482	LABPROC	odontogenic	502-513	ANATOMY
26953424_en	AFFECTS	maxillary sinusitis	752-771	DISO	maxillary	752-761	ANATOMY
26953424_en	USED_IN	Brillians 6	873-884	DEVICE	MSCT	868-872	LABPROC
26953424_en	USED_IN	Brillians 64	889-901	DEVICE	MSCT	868-872	LABPROC
26953424_en	SUBCLASS_OF	maxillary sinuses	1168-1185	ANATOMY	sinuses	1178-1185	ANATOMY
26953424_en	PART_OF	maxillary sinuses	1168-1185	ANATOMY	maxillary	1168-1177	ANATOMY
26953424_en	SUBCLASS_OF	rubber drains	1253-1266	DEVICE	drains	1260-1266	DEVICE
26953424_en	SUBCLASS_OF	mycotic infection	1406-1423	DISO	infection	1414-1423	DISO
26953424_en	ALTERNATIVE_NAME	mycotic infection	1406-1423	DISO	mycotic	1406-1413	DISO
26953424_en	SUBCLASS_OF	volumetric tomography	1593-1614	LABPROC	tomography	1604-1614	LABPROC
26953424_en	SUBCLASS_OF	dental volumetric tomography	1586-1614	LABPROC	volumetric tomography	1593-1614	LABPROC
26953424_en	SUBCLASS_OF	multislice CT	1618-1631	LABPROC	CT	1629-1631	LABPROC
26953424_en	ORIGINS_FROM	ensure the correct clinical and radiological approaches	1636-1691	FINDING	multislice CT	1618-1631	LABPROC
26953424_en	ORIGINS_FROM	ensure the correct clinical and radiological approaches	1636-1691	FINDING	dental volumetric tomography	1586-1614	LABPROC
26953424_en	HAS_CAUSE	relapses	1782-1790	DISO	sinusitis	1747-1756	DISO
26953424_en	ASSOCIATED_WITH	relapses	1782-1790	DISO	reduce the incidence	1758-1778	FINDING
26953424_en	ASSOCIATED_WITH	chronic inflammatory processes	1795-1825	DISO	reduce the incidence	1758-1778	FINDING
26953424_en	SUBCLASS_OF	maxillary sinuses	1833-1850	ANATOMY	sinuses	1843-1850	ANATOMY
26953424_en	SUBCLASS_OF	chronic inflammatory processes	1795-1825	DISO	nflammatory processes	1804-1825	DISO
26953424_en	PART_OF	maxillary sinuses	1833-1850	ANATOMY	maxillary	1833-1842	ANATOMY
26977723_en	AFFECTS	bullous keratopathy	198-217	DISO	cornea	174-180	ANATOMY
26977723_en	AFFECTS	bullous keratopathy	94-113	DISO	corneal	15-22	ANATOMY
26977723_en	ABBREVIATION	Ocular response analyzer	271-295	DEVICE	ORA	297-300	DEVICE
26977723_en	AFFECTS	bullous keratopathy	363-382	DISO	eyes	352-356	ANATOMY
26977723_en	ABBREVIATION	Corneal hysteresis	752-770	PHYS	CH	772-774	PHYS
26977723_en	PHYSIOLOGY_OF	Corneal hysteresis	752-770	PHYS	Corneal	752-759	ANATOMY
26977723_en	PHYSIOLOGY_OF	corneal resistance factor	780-805	PHYS	corneal	780-787	ANATOMY
26977723_en	ABBREVIATION	corneal resistance factor	780-805	PHYS	CRF	807-810	PHYS
26977723_en	AFFECTS	bullous keratopathy	864-883	DISO	eyes	884-888	ANATOMY
26977723_en	PHYSIOLOGY_OF	Corneal hysteresis	752-770	PHYS	eyes	884-888	ANATOMY
26977723_en	PHYSIOLOGY_OF	corneal resistance factor	780-805	PHYS	eyes	884-888	ANATOMY
26977723_en	AFFECTS	bullous keratopathy	1204-1223	DISO	eyes	1194-1198	ANATOMY
26977723_en	PHYSIOLOGY_OF	corneal-compensated intraocular pressure	1234-1274	PHYS	corneal	1234-1241	ANATOMY
26977723_en	ABBREVIATION	corneal-compensated intraocular pressure	1234-1274	PHYS	IOPcc	1276-1281	PHYS
26977723_en	ABBREVIATION	Goldman-related IOP	1301-1320	PHYS	IOPg	1322-1326	PHYS
26977723_en	SUBCLASS_OF	Goldman-related IOP	1301-1320	PHYS	IOP	1317-1320	PHYS
26977723_en	SUBCLASS_OF	corneal-compensated intraocular pressure	1234-1274	PHYS	intraocular pressure	1254-1274	PHYS
26977723_en	ABBREVIATION	intraocular pressure	1254-1274	PHYS	IOP	1317-1320	PHYS
26977723_en	AFFECTS	Chronic edema	1647-1660	DISO	cornea	1668-1674	ANATOMY
26977723_en	PHYSIOLOGY_OF	CRF	1759-1762	PHYS	eye	1800-1803	ANATOMY
26977723_en	PHYSIOLOGY_OF	CH	1752-1754	PHYS	eye	1800-1803	ANATOMY
26977723_en	PHYSIOLOGY_OF	IOP	1585-1588	PHYS	fellow healthy eyes	1557-1576	ANATOMY
26977723_en	PHYSIOLOGY_OF	CH	1752-1754	PHYS	fellow healthy eye	1832-1850	ANATOMY
26977723_en	PHYSIOLOGY_OF	CRF	1759-1762	PHYS	fellow healthy eye	1832-1850	ANATOMY
26977723_en	AFFECTS	chronically swollen	2067-2086	DISO	cornea	2057-2063	ANATOMY
26977723_en	PHYSIOLOGY_OF	corneal thickness	2105-2122	PHYS	corneal	2105-2112	ANATOMY
26977723_en	PHYSIOLOGY_OF	corneal rigidity	2192-2208	PHYS	corneal	2192-2199	ANATOMY
26977723_en	PHYSIOLOGY_OF	corneal rigidity	2192-2208	PHYS	eyes	2212-2216	ANATOMY
26977723_en	AFFECTS	bullous keratopathy	2222-2241	DISO	eyes	2212-2216	ANATOMY
26977723_en	HAS_CAUSE	bullous keratopathy	2222-2241	DISO	glaucoma	2362-2370	DISO
26977723_en	AFFECTS	glaucoma	2362-2370	DISO	eyes	2212-2216	ANATOMY
26977723_en	PHYSIOLOGY_OF	biomechanical properties	142-166	PHYS	cornea	174-180	ANATOMY
26977723_en	PART_OF	corneal	780-787	ANATOMY	eyes	884-888	ANATOMY
26977723_en	PART_OF	Corneal	752-759	ANATOMY	eyes	884-888	ANATOMY
26977723_en	PART_OF	corneal	1234-1241	ANATOMY	eyes	1194-1198	ANATOMY
26977723_en	SUBCLASS_OF	Chronic edema	1647-1660	DISO	edema	1655-1660	DISO
26977723_en	PHYSIOLOGY_OF	viscoelastic properties	1704-1727	PHYS	cornea	1668-1674	ANATOMY
26977723_en	FINDING_OF	CH and CRF values decrease significantly	1752-1792	FINDING	CRF	1759-1762	PHYS
26977723_en	FINDING_OF	CH and CRF values decrease significantly	1752-1792	FINDING	CH	1752-1754	PHYS
26977723_en	PHYSIOLOGY_OF	biomechanical indices	2142-2163	PHYS	corneal	2105-2112	ANATOMY
26977723_en	FINDING_OF	correlate with its biomechanical indices	2123-2163	FINDING	corneal thickness	2105-2122	PHYS
26977723_en	FINDING_OF	correlate with its biomechanical indices	2123-2163	FINDING	biomechanical indices	2142-2163	PHYS
26977723_en	FINDING_OF	Postoperative reduction in corneal rigidity	2165-2208	FINDING	corneal rigidity	2192-2208	PHYS
26977723_en	PART_OF	corneal	2192-2199	ANATOMY	eyes	2212-2216	ANATOMY
26977723_en	SUBCLASS_OF	bullous keratopathy	198-217	DISO	keratopathy	206-217	DISO
26977723_en	SUBCLASS_OF	bullous keratopathy	94-113	DISO	keratopathy	102-113	DISO
26977723_en	PHYSIOLOGY_OF	biomechanics	23-35	PHYS	corneal	15-22	ANATOMY
26977723_en	ALTERNATIVE_NAME	biomechanics	23-35	PHYS	biomechanical properties	142-166	PHYS
26977723_en	ALTERNATIVE_NAME	corneal	15-22	ANATOMY	cornea	174-180	ANATOMY
26977723_en	SUBCLASS_OF	bullous keratopathy	363-382	DISO	keratopathy	371-382	DISO
26977723_en	SUBCLASS_OF	bullous keratopathy	864-883	DISO	keratopathy	872-883	DISO
26977723_en	ASSOCIATED_WITH	bullous keratopathy	864-883	DISO	significantly decreased in non-operated bullous keratopathy eyes	824-888	FINDING
26977723_en	AFFECTS	significantly decreased in non-operated bullous keratopathy eyes	824-888	FINDING	eyes	884-888	ANATOMY
26977723_en	FINDING_OF	significantly decreased in non-operated bullous keratopathy eyes	824-888	FINDING	Corneal hysteresis	752-770	PHYS
26977723_en	FINDING_OF	significantly decreased in non-operated bullous keratopathy eyes	824-888	FINDING	corneal resistance factor	780-805	PHYS
26977723_en	SUBCLASS_OF	bullous keratopathy	1204-1223	DISO	keratopathy	1212-1223	DISO
26977723_en	FINDING_OF	exceeded the mean Goldman-related IOP	1283-1320	FINDING	corneal-compensated intraocular pressure	1234-1274	PHYS
26977723_en	PHYSIOLOGY_OF	corneal-compensated intraocular pressure	1234-1274	PHYS	eyes	1194-1198	ANATOMY
26977723_en	PHYSIOLOGY_OF	Goldman-related IOP	1301-1320	PHYS	eyes	1194-1198	ANATOMY
26977723_en	FINDING_OF	difference between IOPcc and IOPg	1375-1408	FINDING	IOPg	1404-1408	PHYS
26977723_en	FINDING_OF	difference between IOPcc and IOPg	1375-1408	FINDING	IOPcc	1394-1399	PHYS
26977723_en	SUBCLASS_OF	fellow healthy eyes	1557-1576	ANATOMY	eyes	1572-1576	ANATOMY
26977723_en	PHYSIOLOGY_OF	healthy	1564-1571	PHYS	fellow healthy eyes	1557-1576	ANATOMY
26977723_en	AFFECTS	not statistically different.	1607-1635	FINDING	fellow healthy eyes	1557-1576	ANATOMY
26977723_en	FINDING_OF	not statistically different.	1607-1635	FINDING	IOP	1585-1588	PHYS
26977723_en	HAS_CAUSE	alteration of its viscoelastic properties	1686-1727	FINDING	Chronic edema	1647-1660	DISO
26977723_en	FINDING_OF	alteration of its viscoelastic properties	1686-1727	FINDING	viscoelastic properties	1704-1727	PHYS
26977723_en	PHYSIOLOGY_OF	healthy	1839-1846	PHYS	fellow healthy eye	1832-1850	ANATOMY
26977723_en	AFFECTS	CH and CRF values decrease significantly	1752-1792	FINDING	eye	1800-1803	ANATOMY
26977723_en	SUBCLASS_OF	chronically swollen	2067-2086	DISO	swollen	2079-2086	DISO
26977723_en	SUBCLASS_OF	bullous keratopathy	2222-2241	DISO	keratopathy	2230-2241	DISO
26977723_en	ASSOCIATED_WITH	glaucoma	2362-2370	DISO	delays in diagnosis of concomitant glaucoma	2327-2370	FINDING
26977723_en	HAS_CAUSE	lead to underestimation of the true level of IOP	2263-2311	FINDING	Postoperative reduction in corneal rigidity	2165-2208	FINDING
26977723_en	HAS_CAUSE	delays in diagnosis of concomitant glaucoma	2327-2370	FINDING	Postoperative reduction in corneal rigidity	2165-2208	FINDING
26977764_en	SUBCLASS_OF	bronchial cancer	72-88	DISO	cancer	82-88	DISO
26977764_en	AFFECTS	bronchial cancer	72-88	DISO	bronchial	72-81	ANATOMY
26977764_en	PART_OF	tracheal bifurcation	29-49	ANATOMY	tracheal	29-37	ANATOMY
26977764_en	SUBCLASS_OF	cancer	201-207	DISO	bronchial cancer	191-207	DISO
26977764_en	AFFECTS	bronchial cancer	191-207	DISO	bronchial	191-200	ANATOMY
26977764_en	AFFECTS	bronchial malignant tumors	263-289	DISO	bronchial	263-272	ANATOMY
26977764_en	SUBCLASS_OF	bronchial malignant tumors	263-289	DISO	malignant tumors	273-289	DISO
26977764_en	SUBCLASS_OF	malignant tumors	273-289	DISO	tumors	283-289	DISO
26977764_en	SUBCLASS_OF	Squamous cell carcinoma	406-429	DISO	carcinoma	420-429	DISO
26977764_en	AFFECTS	Squamous cell carcinoma	406-429	DISO	Squamous cell	406-419	ANATOMY
26977764_en	SUBCLASS_OF	dimorphic cancer	447-463	DISO	cancer	457-463	DISO
26977764_en	SUBCLASS_OF	small cell cancer	496-513	DISO	cancer	507-513	DISO
26977764_en	SUBCLASS_OF	adenocystic cancer	476-494	DISO	cancer	488-494	DISO
26977764_en	AFFECTS	renal cancer	529-541	DISO	renal	529-534	ANATOMY
26977764_en	AFFECTS	clear cell renal cancer	518-541	DISO	renal	529-534	ANATOMY
26977764_en	SUBCLASS_OF	clear cell renal cancer	518-541	DISO	cancer	535-541	DISO
26977764_en	PART_OF	bronchopulmonary segment	965-989	ANATOMY	bronchopulmonary	965-981	ANATOMY
26977764_en	SUBCLASS_OF	right upper lobe	993-1009	ANATOMY	upper lobe	999-1009	ANATOMY
26977764_en	PHYSIOLOGY_OF	head adduction	1304-1318	PHYS	head	1304-1308	ANATOMY
26977764_en	SUBCLASS_OF	N0-tumors	1695-1704	DISO	tumors	1698-1704	DISO
26977764_en	PART_OF	bronchopulmonary segment	965-989	ANATOMY	right upper lobe	993-1009	ANATOMY
26977764_en	HAS_CAUSE	reduced broncho-pleural fistula incidence and mortality	1319-1374	FINDING	head adduction	1304-1318	PHYS
26977764_en	SUBCLASS_OF	Squamous cell	406-419	ANATOMY	cell	415-419	ANATOMY
26977764_en	SUBCLASS_OF	small cell	496-506	ANATOMY	cell	502-506	ANATOMY
26977764_en	SUBCLASS_OF	clear cell	518-528	ANATOMY	cell	524-528	ANATOMY
26977764_en	AFFECTS	clear cell renal cancer	518-541	DISO	clear cell	518-528	ANATOMY
26977764_en	AFFECTS	small cell cancer	496-513	DISO	small cell	496-506	ANATOMY
26977764_en	ALTERNATIVE_NAME	Tracheal carina	722-737	ANATOMY	carina	731-737	ANATOMY
26977764_en	SUBCLASS_OF	Tracheal carina	722-737	ANATOMY	Tracheal	722-730	ANATOMY
26977764_en	SUBCLASS_OF	Postoperative complications	1171-1198	DISO	complications	1185-1198	DISO
26977764_en	SUBCLASS_OF	In-hospital mortality	1236-1257	FINDING	mortality	1248-1257	FINDING
26977764_en	HAS_CAUSE	reduced broncho-pleural fistula incidence and mortality	1319-1374	FINDING	mortality	1365-1374	FINDING
26977764_en	PART_OF	broncho	1327-1334	ANATOMY	broncho-pleural	1327-1342	ANATOMY
26977764_en	PART_OF	pleural	1335-1342	ANATOMY	broncho-pleural	1327-1342	ANATOMY
26977764_en	ASSOCIATED_WITH	broncho-pleural fistula	1327-1350	DISO	reduced broncho-pleural fistula incidence and mortality	1319-1374	FINDING
26977764_en	AFFECTS	broncho-pleural fistula	1327-1350	DISO	broncho-pleural	1327-1342	ANATOMY
26977764_en	SUBCLASS_OF	broncho-pleural fistula	1327-1350	DISO	fistula	1343-1350	DISO
26977764_en	SUBCLASS_OF	5-year survival	1478-1493	FINDING	survival	1485-1493	FINDING
26977764_en	SUBCLASS_OF	T3-4N1-2 tumors	1461-1476	DISO	tumors	1470-1476	DISO
26977764_en	SUBCLASS_OF	T3-T4N0 tumors	1406-1420	DISO	tumors	1414-1420	DISO
26977764_en	ASSOCIATED_WITH	T3-T4N0 tumors	1406-1420	DISO	Long-term results in T3-T4N0 tumors were significantly better compared with T3-4N1-2 tumors	1385-1476	FINDING
26977764_en	ASSOCIATED_WITH	T3-4N1-2 tumors	1461-1476	DISO	Long-term results in T3-T4N0 tumors were significantly better compared with T3-4N1-2 tumors	1385-1476	FINDING
26977764_en	ALTERNATIVE_NAME	T3-T4N0 tumors	1406-1420	DISO	T3-T4N0	1406-1413	DISO
26977764_en	ALTERNATIVE_NAME	T3-4N1-2 tumors	1461-1476	DISO	T3-4N1-2	1461-1469	DISO
26977764_en	HAS_CAUSE	5-year survival	1478-1493	FINDING	Long-term results in T3-T4N0 tumors were significantly better compared with T3-4N1-2 tumors	1385-1476	FINDING
26977764_en	ASSOCIATED_WITH	N0-tumors	1695-1704	DISO	satisfactory long-term results	1647-1677	FINDING
26977789_en	AFFECTS	brain gliomas	2205-2218	DISO	brain	2205-2210	ANATOMY
26977789_en	ABBREVIATION	diffusion kurtosis imaging	166-192	LABPROC	DKI	194-197	LABPROC
26977789_en	TO_DETECT_OR_STUDY	diffusion kurtosis imaging	166-192	LABPROC	proliferative activity	226-248	DISO
26977789_en	ABBREVIATION	contralateral normal appearing white matter	360-403	ANATOMY	CNAWM	405-410	ANATOMY
26977789_en	APPLIED_TO	diffusion kurtosis imaging	166-192	LABPROC	contralateral normal appearing white matter	360-403	ANATOMY
26977789_en	AFFECTS	brain glioma	84-96	DISO	brain	84-89	ANATOMY
26977789_en	AFFECTS	brain gliomas	486-499	DISO	brain	486-491	ANATOMY
26977789_en	SUBCLASS_OF	radial diffusivities	679-704	LABPROC	diffusivities	691-704	LABPROC
26977789_en	SUBCLASS_OF	axial diffusivities	663-704	LABPROC	diffusivities	691-704	LABPROC
26977789_en	SUBCLASS_OF	mean diffusivities	652-704	LABPROC	diffusivities	691-704	LABPROC
26977789_en	ABBREVIATION	fractional anisotropies	706-752	LABPROC	FA	718-720	LABPROC
26977789_en	ABBREVIATION	relative anisotropies	726-752	LABPROC	RA	736-738	LABPROC
26977789_en	SUBCLASS_OF	radial kurtosis	805-825	LABPROC	kurtosis	817-825	LABPROC
26977789_en	SUBCLASS_OF	axial kurtosis	789-825	LABPROC	kurtosis	817-825	LABPROC
26977789_en	SUBCLASS_OF	mean kurtosis	778-825	LABPROC	kurtosis	817-825	LABPROC
26977789_en	ABBREVIATION	mean kurtosis	778-825	LABPROC	MK	784-786	LABPROC
26977789_en	ABBREVIATION	axial kurtosis	789-825	LABPROC	AK	796-798	LABPROC
26977789_en	ABBREVIATION	radial kurtosis	805-825	LABPROC	RK	813-815	LABPROC
26977789_en	ABBREVIATION	kurtosis anisotropy	827-846	LABPROC	KA	848-850	LABPROC
26977789_en	HAS_CAUSE	proliferative activity	861-883	DISO	malignant glioma parts	902-924	DISO
26977789_en	SUBCLASS_OF	MK	1317-1319	LABPROC	Kurtosis	1307-1315	LABPROC
26977789_en	SUBCLASS_OF	AK	1321-1323	LABPROC	Kurtosis	1307-1315	LABPROC
26977789_en	SUBCLASS_OF	RK	1329-1331	LABPROC	Kurtosis	1307-1315	LABPROC
26977789_en	SUBCLASS_OF	KA	1349-1351	LABPROC	anisotropy	1337-1347	LABPROC
26977789_en	SUBCLASS_OF	FA	1353-1355	LABPROC	anisotropy	1337-1347	LABPROC
26977789_en	SUBCLASS_OF	RA	1357-1359	LABPROC	anisotropy	1337-1347	LABPROC
26977789_en	SUBCLASS_OF	MD	1396-1398	LABPROC	diffusivity	1383-1394	LABPROC
26977789_en	SUBCLASS_OF	AD	1400-1402	LABPROC	diffusivity	1383-1394	LABPROC
26977789_en	SUBCLASS_OF	RD	1404-1406	LABPROC	diffusivity	1383-1394	LABPROC
26977789_en	APPLIED_TO	RA	1931-1933	LABPROC	CNAWM	1956-1961	ANATOMY
26977789_en	APPLIED_TO	FA	1904-1906	LABPROC	CNAWM	1956-1961	ANATOMY
26977789_en	TO_DETECT_OR_STUDY	RD	1882-1884	LABPROC	CNAWM	1956-1961	ANATOMY
26977789_en	TO_DETECT_OR_STUDY	KA	1859-1861	LABPROC	CNAWM	1956-1961	ANATOMY
26977789_en	TO_DETECT_OR_STUDY	RK	1836-1838	LABPROC	CNAWM	1956-1961	ANATOMY
26977789_en	APPLIED_TO	DKI	2061-2064	LABPROC	contralateral normal appearing white matter	2144-2187	ANATOMY
26977789_en	APPLIED_TO	DKI	1984-1987	LABPROC	CNAWM	1956-1961	ANATOMY
26977789_en	HAS_CAUSE	proliferative activity	58-80	DISO	brain glioma	84-96	DISO
26977789_en	ORIGINS_FROM	strong correlation between the proliferative activity index	1481-1540	FINDING	RK	1554-1556	LABPROC
26977789_en	ORIGINS_FROM	correlation between diffusion kurtosis imaging and the proliferative activity	3-80	FINDING	diffusion kurtosis imaging	23-49	LABPROC
26977789_en	TO_DETECT_OR_STUDY	diffusion parameters	332-352	LABPROC	contralateral normal appearing white matter	360-403	ANATOMY
26977789_en	TO_DETECT_OR_STUDY	glioma proliferative activity index	292-327	LABPROC	contralateral normal appearing white matter	360-403	ANATOMY
26977789_en	PART_OF	contralateral normal appearing white matter	360-403	ANATOMY	brain	84-89	ANATOMY
26977789_en	TO_DETECT_OR_STUDY	kurtosis	993-1001	LABPROC	CNAWM	1016-1021	ANATOMY
26977789_en	TO_DETECT_OR_STUDY	tensor	982-988	LABPROC	CNAWM	1016-1021	ANATOMY
26977789_en	ORIGINS_FROM	values increased	1361-1377	FINDING	anisotropy	1337-1347	LABPROC
26977789_en	ORIGINS_FROM	values increased	1361-1377	FINDING	Kurtosis	1307-1315	LABPROC
26977789_en	ORIGINS_FROM	values decreased	1408-1424	FINDING	diffusivity	1383-1394	LABPROC
26977789_en	TO_DETECT_OR_STUDY	DKI	1984-1987	LABPROC	gliomas	2051-2058	DISO
26977789_en	ASSOCIATED_WITH	proliferative activity	58-80	DISO	correlation between diffusion kurtosis imaging and the proliferative activity	3-80	FINDING
26977789_en	SUBCLASS_OF	contralateral normal appearing white matter	360-403	ANATOMY	normal appearing white matter	374-403	ANATOMY
26977789_en	SUBCLASS_OF	normal appearing white matter	374-403	ANATOMY	white matter	391-403	ANATOMY
26977789_en	HAS_CAUSE	proliferative activity	226-248	DISO	glioma	219-225	DISO
26977789_en	HAS_CAUSE	proliferative activity	299-321	DISO	glioma	292-298	DISO
26977789_en	SUBCLASS_OF	brain glioma	84-96	DISO	glioma	90-96	DISO
26977789_en	SUBCLASS_OF	brain gliomas	486-499	DISO	gliomas	492-499	DISO
26977789_en	SUBCLASS_OF	diffusion kurtosis	23-41	LABPROC	kurtosis	33-41	LABPROC
26977789_en	USED_IN	diffusion kurtosis	23-41	LABPROC	diffusion kurtosis imaging	23-49	LABPROC
26977789_en	SUBCLASS_OF	diffusion kurtosis	166-184	LABPROC	kurtosis	176-184	LABPROC
26977789_en	USED_IN	diffusion kurtosis	166-184	LABPROC	diffusion kurtosis imaging	166-192	LABPROC
26977789_en	ABBREVIATION	mean diffusivities	652-704	LABPROC	MD	658-660	LABPROC
26977789_en	ABBREVIATION	axial diffusivities	663-704	LABPROC	AD	670-672	LABPROC
26977789_en	ABBREVIATION	radial diffusivities	679-704	LABPROC	RD	687-689	LABPROC
26977789_en	SUBCLASS_OF	diffusivities	691-704	LABPROC	diffusion tensor	634-650	LABPROC
26977789_en	SUBCLASS_OF	anisotropies	740-752	LABPROC	diffusion tensor	634-650	LABPROC
26977789_en	SUBCLASS_OF	relative anisotropies	726-752	LABPROC	anisotropies	740-752	LABPROC
26977789_en	SUBCLASS_OF	fractional anisotropies	706-752	LABPROC	anisotropies	740-752	LABPROC
26977789_en	SUBCLASS_OF	diffusion kurtosis	758-776	LABPROC	kurtosis	768-776	LABPROC
26977789_en	SUBCLASS_OF	malignant glioma parts	902-924	DISO	glioma	912-918	DISO
26977789_en	ORIGINS_FROM	correlation between all the absolute and normalized diffusion parameters and the glioma proliferative activity index	1088-1204	FINDING	diffusion parameters	1140-1160	LABPROC
26977789_en	HAS_CAUSE	proliferative activity	1176-1198	DISO	glioma	1169-1175	DISO
26977789_en	ORIGINS_FROM	relationship between the tensor and kurtosis parameters of CNAWM and the glioma proliferative activity index	957-1065	FINDING	tensor	982-988	LABPROC
26977789_en	ORIGINS_FROM	relationship between the tensor and kurtosis parameters of CNAWM and the glioma proliferative activity index	957-1065	FINDING	kurtosis	993-1001	LABPROC
26977789_en	SUBCLASS_OF	FA	1237-1239	LABPROC	diffusion parameters	1140-1160	LABPROC
26977789_en	SUBCLASS_OF	RA	1244-1246	LABPROC	diffusion parameters	1140-1160	LABPROC
26977789_en	HAS_CAUSE	proliferative activity	1439-1461	DISO	glioma	1432-1438	DISO
26977789_en	HAS_CAUSE	proliferative activity	1037-1059	DISO	glioma	1030-1036	DISO
26977789_en	ASSOCIATED_WITH	proliferative activity	1439-1461	DISO	glioma proliferative activity index increased	1432-1477	FINDING
26977789_en	HAS_CAUSE	proliferative activity	1786-1808	DISO	glioma	1779-1785	DISO
26977789_en	ASSOCIATED_WITH	proliferative activity	1786-1808	DISO	statistically significant correlation between the glioma proliferative activity index and diffusion values	1729-1835	FINDING
26977789_en	ORIGINS_FROM	strong correlation between the proliferative activity index	1481-1540	FINDING	MK	1603-1605	LABPROC
26977789_en	ORIGINS_FROM	strong correlation between the proliferative activity index	1481-1540	FINDING	AK	1627-1629	LABPROC
26977789_en	ORIGINS_FROM	strong correlation between the proliferative activity index	1481-1540	FINDING	RK	1652-1654	LABPROC
26977789_en	ORIGINS_FROM	strong correlation between the proliferative activity index	1481-1540	FINDING	RD	1681-1683	LABPROC
26977789_en	ASSOCIATED_WITH	proliferative activity	1512-1534	DISO	strong correlation between the proliferative activity index	1481-1540	FINDING
26977789_en	ORIGINS_FROM	statistically significant correlation between the glioma proliferative activity index and diffusion values	1729-1835	FINDING	RK	1836-1838	LABPROC
26977789_en	ORIGINS_FROM	statistically significant correlation between the glioma proliferative activity index and diffusion values	1729-1835	FINDING	KA	1859-1861	LABPROC
26977789_en	ORIGINS_FROM	statistically significant correlation between the glioma proliferative activity index and diffusion values	1729-1835	FINDING	RD	1882-1884	LABPROC
26977789_en	ORIGINS_FROM	statistically significant correlation between the glioma proliferative activity index and diffusion values	1729-1835	FINDING	FA	1904-1906	LABPROC
26977789_en	ORIGINS_FROM	statistically significant correlation between the glioma proliferative activity index and diffusion values	1729-1835	FINDING	RA	1931-1933	LABPROC
26977789_en	HAS_CAUSE	immunohistochemical changes	2020-2047	FINDING	gliomas	2051-2058	DISO
26977789_en	ORIGINS_FROM	immunohistochemical changes	2020-2047	FINDING	immunohistochemical	2020-2039	LABPROC
26977789_en	TO_DETECT_OR_STUDY	immunohistochemical	2020-2039	LABPROC	gliomas	2051-2058	DISO
26977789_en	SUBCLASS_OF	normal appearing white matter	2158-2187	ANATOMY	white matter	2175-2187	ANATOMY
26977789_en	SUBCLASS_OF	contralateral normal appearing white matter	2144-2187	ANATOMY	normal appearing white matter	2158-2187	ANATOMY
26977789_en	AFFECTS	microstructural changes	2113-2136	FINDING	contralateral normal appearing white matter	2144-2187	ANATOMY
26977789_en	ORIGINS_FROM	microstructural changes	2113-2136	FINDING	DKI	2061-2064	LABPROC
26977789_en	SUBCLASS_OF	brain gliomas	2205-2218	DISO	gliomas	2211-2218	DISO
26977789_en	HAS_CAUSE	microstructural changes	2113-2136	FINDING	brain gliomas	2205-2218	DISO
26977789_en	ORIGINS_FROM	DKI demonstrated a high sensitivity	2061-2096	FINDING	DKI	2061-2064	LABPROC
26977789_en	TO_DETECT_OR_STUDY	glioma proliferative activity index	292-327	LABPROC	glioma	292-298	DISO
26977789_en	TO_DETECT_OR_STUDY	glioma proliferative activity index	292-327	LABPROC	proliferative activity	299-321	DISO
26977789_en	SUBCLASS_OF	kurtosis anisotropy	827-846	LABPROC	anisotropy	836-846	LABPROC
26977908_en	SUBCLASS_OF	middle cerebral artery	232-254	ANATOMY	cerebral artery	239-254	ANATOMY
26977908_en	PART_OF	cerebral artery	239-254	ANATOMY	artery	248-254	ANATOMY
26977908_en	AFFECTS	cerebral infarction	193-212	DISO	middle cerebral artery	232-254	ANATOMY
26977908_en	SUBCLASS_OF	middle cerebral artery	452-474	ANATOMY	cerebral artery	459-474	ANATOMY
26977908_en	SUBCLASS_OF	cerebral artery	459-474	ANATOMY	artery	468-474	ANATOMY
26977908_en	AFFECTS	cerebral infarction	413-432	DISO	middle cerebral artery	452-474	ANATOMY
26977908_en	AFFECTS	chronic brain ischemia	545-567	DISO	brain	553-558	ANATOMY
26977908_en	SUBCLASS_OF	left-hemispheric cerebral infarction	30-66	DISO	infarction	56-66	DISO
26977908_en	AFFECTS	left-hemispheric cerebral infarction	30-66	DISO	left-hemispheric	30-46	ANATOMY
26977908_en	AFFECTS	cerebral infarction	193-212	DISO	cerebral	193-201	ANATOMY
26977908_en	SUBCLASS_OF	cerebral infarction	193-212	DISO	infarction	202-212	DISO
26977908_en	AFFECTS	cerebral infarction	413-432	DISO	cerebral	413-421	ANATOMY
26977908_en	SUBCLASS_OF	cerebral infarction	413-432	DISO	infarction	422-432	DISO
26977908_en	SUBCLASS_OF	chronic brain ischemia	545-567	DISO	brain ischemia	553-567	DISO
26977908_en	SUBCLASS_OF	brain ischemia	553-567	DISO	ischemia	559-567	DISO
26977908_en	HAS_CAUSE	alexithymia	807-818	DISO	cerebral infarction	763-782	DISO
26977908_en	SUBCLASS_OF	cerebral infarction	763-782	DISO	infarction	772-782	DISO
26977908_en	AFFECTS	cerebral infarction	763-782	DISO	cerebral	763-771	ANATOMY
26977908_en	SUBCLASS_OF	cerebral infarction	850-869	DISO	infarction	859-869	DISO
26977908_en	AFFECTS	cerebral infarction	850-869	DISO	cerebral	850-858	ANATOMY
26977908_en	PART_OF	left-hemispheric	30-46	ANATOMY	cerebral	47-55	ANATOMY
26977908_en	PART_OF	cerebral artery	239-254	ANATOMY	cerebral	239-247	ANATOMY
26977908_en	PART_OF	cerebral artery	459-474	ANATOMY	cerebral	459-467	ANATOMY
26977908_en	ASSOCIATED_WITH	alexithymia	660-671	DISO	correlation between the level of alexithymia	627-671	FINDING
26977908_en	HAS_CAUSE	correlation between the level of alexithymia	627-671	FINDING	neurological deficit	692-712	DISO
26977908_en	HAS_CAUSE	correlation between the level of alexithymia	627-671	FINDING	anxiety	735-742	DISO
26977908_en	HAS_CAUSE	correlation between the level of alexithymia	627-671	FINDING	depression	747-757	DISO
26977908_en	HAS_CAUSE	anxiety	735-742	DISO	sex	714-717	PHYS
26977908_en	HAS_CAUSE	complicate the rehabilitation	945-974	FINDING	Alexithymia	821-832	DISO
26977908_en	HAS_CAUSE	affects the adequate self-esteem of physical and mental condition	870-935	FINDING	Alexithymia	821-832	DISO
26977916_en	TREATED_USING	chronic pain syndromes	14-36	DISO	Melatonin	1-10	CHEM
26977916_en	SUBCLASS_OF	Melatonin	39-48	CHEM	neurohormone	52-64	CHEM
26977916_en	ORIGINS_FROM	Melatonin	39-48	CHEM	epiphysis	84-93	ANATOMY
26977916_en	ORIGINS_FROM	Melatonin	39-48	CHEM	extrapineal structures	98-120	ANATOMY
26977916_en	AFFECTS	irritated bowel syndrome	592-616	DISO	bowel	602-607	ANATOMY
26977916_en	AFFECTS	chronic back pain	618-635	DISO	back	626-630	ANATOMY
26977916_en	SUBCLASS_OF	chronic back pain	618-635	DISO	back pain	626-635	DISO
26977916_en	SUBCLASS_OF	rheumatoid arthritis	640-660	DISO	arthritis	651-660	DISO
26977916_en	TREATED_USING	fibromyalgia	568-580	DISO	melatonin	542-551	CHEM
26977916_en	TREATED_USING	headache	582-590	DISO	melatonin	542-551	CHEM
26977916_en	TREATED_USING	irritated bowel syndrome	592-616	DISO	melatonin	542-551	CHEM
26977916_en	TREATED_USING	chronic back pain	618-635	DISO	melatonin	542-551	CHEM
26977916_en	TREATED_USING	rheumatoid arthritis	640-660	DISO	melatonin	542-551	CHEM
26977916_en	HAS_CAUSE	analgesic properties of melatonin	686-719	FINDING	melatonin	710-719	CHEM
26977916_en	TREATED_USING	sleep	776-781	PHYS	melatonin	826-835	CHEM
26977916_en	SUBCLASS_OF	chronic pain syndromes	893-915	DISO	pain syndromes	901-915	DISO
26977916_en	TREATED_USING	chronic pain syndromes	893-915	DISO	melatonin	826-835	CHEM
26977916_en	HAS_CAUSE	analgesic effect of melatonin	963-992	FINDING	melatonin	983-992	CHEM
26977916_en	ASSOCIATED_WITH	reproductive functions	335-357	PHYS	Melatonin	39-48	CHEM
26977916_en	ASSOCIATED_WITH	metabolism and body mass regulation	359-394	PHYS	Melatonin	39-48	CHEM
26977916_en	TREATED_USING	pain syndromes	468-482	DISO	melatonin	455-464	CHEM
26977916_en	HAS_CAUSE	pain syndromes	468-482	DISO	pain	468-472	DISO
26977916_en	ASSOCIATED_WITH	sleep	776-781	PHYS	chronic pain syndromes	893-915	DISO
26977916_en	SUBCLASS_OF	chronic pain syndromes	14-36	DISO	pain syndromes	22-36	DISO
26977916_en	ASSOCIATED_WITH	chronobiotic	154-166	PHYS	Melatonin	39-48	CHEM
26977916_en	ASSOCIATED_WITH	antioxidant	168-179	PHYS	Melatonin	39-48	CHEM
26977916_en	ASSOCIATED_WITH	oncostatic	181-191	PHYS	Melatonin	39-48	CHEM
26977916_en	ASSOCIATED_WITH	immunomodulating	193-209	PHYS	Melatonin	39-48	CHEM
26977916_en	ASSOCIATED_WITH	normothymic	211-222	PHYS	Melatonin	39-48	CHEM
26977916_en	ASSOCIATED_WITH	anxiolytic	227-237	PHYS	Melatonin	39-48	CHEM
26977916_en	HAS_CAUSE	improvement of sleep	761-781	FINDING	melatonin	826-835	CHEM
26977916_en	HAS_CAUSE	normalizing circadian rhythms	839-868	FINDING	melatonin	826-835	CHEM
26977916_en	TREATED_USING	circadian rhythms	851-868	PHYS	melatonin	826-835	CHEM
26977916_en	SUBCLASS_OF	back pain	626-635	DISO	pain	631-635	DISO
26977916_en	HAS_CAUSE	pain syndromes	22-36	DISO	pain	22-26	DISO
26977916_en	PHYSIOLOGY_OF	synthesized	65-76	PHYS	epiphysis	84-93	ANATOMY
26977916_en	PHYSIOLOGY_OF	synthesized	65-76	PHYS	extrapineal structures	98-120	ANATOMY
26977916_en	ASSOCIATED_WITH	synthesized	65-76	PHYS	Melatonin	39-48	CHEM
26977916_en	APPLIED_TO	Melatonin	39-48	CHEM	cardiovascular system	263-284	ANATOMY
26977916_en	APPLIED_TO	Melatonin	39-48	CHEM	gastrointestinal tract	293-315	ANATOMY
26977916_en	ASSOCIATED_WITH	metabolism and body mass regulation	359-394	PHYS	body mass	374-383	PHYS
26977916_en	PHYSIOLOGY_OF	body mass	374-383	PHYS	body	374-378	ANATOMY
26977916_en	ASSOCIATED_WITH	metabolism and body mass regulation	359-394	PHYS	metabolism	359-369	PHYS
26977916_en	HAS_CAUSE	efficacy of melatonin	443-464	FINDING	melatonin	455-464	CHEM
26977916_en	FINDING_OF	improvement of sleep	761-781	FINDING	sleep	776-781	PHYS
26977916_en	FINDING_OF	normalizing circadian rhythms	839-868	FINDING	circadian rhythms	851-868	PHYS
26977916_en	HAS_CAUSE	pain syndromes	901-915	DISO	pain	901-905	DISO
26977916_en	SUBCLASS_OF	melatonin receptors	1010-1029	CHEM	receptors	1020-1029	CHEM
26977916_en	USED_IN	melatonin	1010-1019	CHEM	melatonin receptors	1010-1029	CHEM
26977916_en	USED_IN	neurotransmitter	1042-1058	CHEM	neurotransmitter systems	1042-1066	CHEM
26977916_en	FINDING_OF	activation of own adaptive potential	786-822	FINDING	adaptive potential	804-822	PHYS
26977916_en	HAS_CAUSE	activation of own adaptive potential	786-822	FINDING	melatonin	826-835	CHEM
26977916_en	ASSOCIATED_WITH	adaptive potential	804-822	PHYS	melatonin	826-835	CHEM
26977916_en	ASSOCIATED_WITH	circadian rhythms	851-868	PHYS	chronic pain syndromes	893-915	DISO
26977916_en	SUBCLASS_OF	analgesic effect of melatonin	963-992	FINDING	analgesic effect	963-979	FINDING
26977916_en	SUBCLASS_OF	analgesic properties of melatonin	686-719	FINDING	analgesic properties	686-706	FINDING
26978046_en	ALTERNATIVE_NAME	arterial hypertension	71-92	DISO	hypertension	80-92	DISO
26978046_en	PHYSIOLOGY_OF	Topochemistry	1-14	PHYS	internuclear interneurons	18-43	ANATOMY
26978046_en	ABBREVIATION	internuclear interneurons	118-143	ANATOMY	IN	145-147	ANATOMY
26978046_en	PART_OF	caudal brainstem	237-253	ANATOMY	brainstem	244-253	ANATOMY
26978046_en	PHYSIOLOGY_OF	metabolism	165-175	PHYS	internuclear interneurons	118-143	ANATOMY
26978046_en	ALTERNATIVE_NAME	arterial hypertension	440-461	DISO	hypertension	449-461	DISO
26978046_en	SUBCLASS_OF	NADPH-diaphorase	542-558	CHEM	diaphorase	548-558	CHEM
26978046_en	PART_OF	nucleus of the solitary tract	690-719	ANATOMY	solitary tract	705-719	ANATOMY
26978046_en	PART_OF	lateral reticular nucleus	744-769	ANATOMY	reticular nucleus	752-769	ANATOMY
26978046_en	PART_OF	small cell reticular nuclei	618-645	ANATOMY	IN1	647-650	ANATOMY
26978046_en	PART_OF	giant cell reticular nuclei	608-645	ANATOMY	IN1	647-650	ANATOMY
26978046_en	PART_OF	nucleus of the solitary tract	690-719	ANATOMY	IN2	721-724	ANATOMY
26978046_en	PART_OF	small cell reticular nucleus	653-681	ANATOMY	IN2	721-724	ANATOMY
26978046_en	PART_OF	lateral reticular nucleus	744-769	ANATOMY	IN3	771-774	ANATOMY
26978046_en	ALTERNATIVE_NAME	high blood pressure	973-992	DISO	hypertension	296-308	DISO
26978046_en	ORIGINS_FROM	nNOS-positive	1310-1323	CHEM	nNOS-positive neurons	1310-1331	ANATOMY
26978046_en	SUBCLASS_OF	intranuclear	1646-1658	ANATOMY	interneurons	1632-1644	ANATOMY
26978046_en	SUBCLASS_OF	internuclear	1663-1675	ANATOMY	interneurons	1632-1644	ANATOMY
26978046_en	PHYSIOLOGY_OF	blood pressure	978-992	PHYS	blood	978-983	ANATOMY
26978046_en	PHYSIOLOGY_OF	blood pressure	1750-1764	PHYS	blood	1750-1755	ANATOMY
26978046_en	FINDING_OF	increases in blood pressure	1737-1764	FINDING	blood pressure	1750-1764	PHYS
26978046_en	TO_DETECT_OR_STUDY	Immunohistochemistry	464-484	LABPROC	nNOS	497-501	CHEM
26978046_en	TO_DETECT_OR_STUDY	Immunohistochemistry	464-484	LABPROC	HO-2	503-507	CHEM
26978046_en	TO_DETECT_OR_STUDY	Immunohistochemistry	464-484	LABPROC	CBS	509-512	CHEM
26978046_en	TO_DETECT_OR_STUDY	histochemical	517-530	LABPROC	NADPH-diaphorase	542-558	CHEM
26978046_en	APPLIED_TO	histochemical	517-530	LABPROC	IN	578-580	ANATOMY
26978046_en	APPLIED_TO	Immunohistochemistry	464-484	LABPROC	IN	578-580	ANATOMY
26978046_en	SUBCLASS_OF	blood pressure	1750-1764	PHYS	hemodynamics	1820-1832	PHYS
26978046_en	ASSOCIATED_WITH	metabolism	165-175	PHYS	nitric oxide	179-191	CHEM
26978046_en	ASSOCIATED_WITH	metabolism	165-175	PHYS	hydrogen sulfide	193-209	CHEM
26978046_en	ASSOCIATED_WITH	metabolism	165-175	PHYS	carbon monoxide	214-229	CHEM
26978046_en	PART_OF	internuclear interneurons	18-43	ANATOMY	brain stem	57-67	ANATOMY
26978046_en	PART_OF	IN1	647-650	ANATOMY	IN	578-580	ANATOMY
26978046_en	PART_OF	IN3	771-774	ANATOMY	IN	578-580	ANATOMY
26978046_en	PART_OF	IN2	721-724	ANATOMY	IN	578-580	ANATOMY
26978046_en	TO_DETECT_OR_STUDY	immunohistochemical reaction	906-934	LABPROC	IN	785-787	ANATOMY
26978046_en	SUBCLASS_OF	internuclear interneurons	18-43	ANATOMY	interneurons	31-43	ANATOMY
26978046_en	PART_OF	brain stem	57-67	ANATOMY	brain	57-62	ANATOMY
26978046_en	AFFECTS	arterial hypertension	71-92	DISO	arterial	71-79	ANATOMY
26978046_en	SUBCLASS_OF	internuclear interneurons	118-143	ANATOMY	interneurons	131-143	ANATOMY
26978046_en	SUBCLASS_OF	nitric oxide	179-191	CHEM	oxide	186-191	CHEM
26978046_en	USED_IN	nitric	179-185	CHEM	nitric oxide	179-191	CHEM
26978046_en	SUBCLASS_OF	carbon monoxide	214-229	CHEM	monoxide	221-229	CHEM
26978046_en	USED_IN	carbon	214-220	CHEM	carbon monoxide	214-229	CHEM
26978046_en	SUBCLASS_OF	hydrogen sulfide	193-209	CHEM	sulfide	202-209	CHEM
26978046_en	USED_IN	hydrogen	193-201	CHEM	hydrogen sulfide	193-209	CHEM
26978046_en	ORIGINS_FROM	carbon monoxide	214-229	CHEM	caudal brainstem	237-253	ANATOMY
26978046_en	ORIGINS_FROM	hydrogen sulfide	193-209	CHEM	caudal brainstem	237-253	ANATOMY
26978046_en	ORIGINS_FROM	nitric oxide	179-191	CHEM	caudal brainstem	237-253	ANATOMY
26978046_en	AFFECTS	arterial hypertension	440-461	DISO	arterial	440-448	ANATOMY
26978046_en	SUBCLASS_OF	nucleus of the solitary tract	690-719	ANATOMY	nucleus	690-697	ANATOMY
26978046_en	SUBCLASS_OF	reticular nucleus	664-681	ANATOMY	nucleus	674-681	ANATOMY
26978046_en	SUBCLASS_OF	small cell	653-663	ANATOMY	cell	659-663	ANATOMY
26978046_en	SUBCLASS_OF	reticular nucleus	752-769	ANATOMY	nucleus	762-769	ANATOMY
26978046_en	SUBCLASS_OF	small cell	618-628	ANATOMY	cell	624-628	ANATOMY
26978046_en	SUBCLASS_OF	reticular nuclei	629-645	ANATOMY	nuclei	639-645	ANATOMY
26978046_en	PART_OF	sprouts	835-842	ANATOMY	IN	785-787	ANATOMY
26978046_en	PHYSIOLOGY_OF	size	798-802	PHYS	IN	785-787	ANATOMY
26978046_en	PHYSIOLOGY_OF	shape	804-809	PHYS	IN	785-787	ANATOMY
26978046_en	PHYSIOLOGY_OF	length and structure of sprouts	811-842	PHYS	sprouts	835-842	ANATOMY
26978046_en	AFFECTS	high blood pressure	973-992	DISO	blood	978-983	ANATOMY
26978046_en	PHYSIOLOGY_OF	cell size	1008-1017	PHYS	cell	1008-1012	ANATOMY
26978046_en	SUBCLASS_OF	small MN	1071-1079	ANATOMY	MN	1077-1079	ANATOMY
26978046_en	AFFECTS	intensity of MN response	941-965	FINDING	MN	954-956	ANATOMY
26978046_en	HAS_CAUSE	intensity of MN response	941-965	FINDING	cell size	1008-1017	PHYS
26978046_en	HAS_CAUSE	intensity of MN response	941-965	FINDING	high blood pressure	973-992	DISO
26978046_en	SUBCLASS_OF	major MN	1111-1119	ANATOMY	MN	1117-1119	ANATOMY
26978046_en	USED_IN	nNOS	1310-1314	CHEM	nNOS-positive	1310-1323	CHEM
26978046_en	SUBCLASS_OF	nNOS-positive neurons	1310-1331	ANATOMY	neurons	1324-1331	ANATOMY
26978046_en	PHYSIOLOGY_OF	quantitative indicators	1270-1293	PHYS	nNOS-positive neurons	1310-1331	ANATOMY
26978046_en	FINDING_OF	significant reduction in the proportion of these cells, concentration and reaction rate	1143-1230	FINDING	concentration	1199-1212	PHYS
26978046_en	FINDING_OF	significant reduction in the proportion of these cells, concentration and reaction rate	1143-1230	FINDING	reaction rate	1217-1230	PHYS
26978046_en	AFFECTS	significant reduction in the proportion of these cells, concentration and reaction rate	1143-1230	FINDING	major MN	1111-1119	ANATOMY
26978046_en	PHYSIOLOGY_OF	concentration	1199-1212	PHYS	major MN	1111-1119	ANATOMY
26978046_en	PHYSIOLOGY_OF	reaction rate	1217-1230	PHYS	major MN	1111-1119	ANATOMY
26978046_en	FINDING_OF	More significant changes in quantitative indicators	1242-1293	FINDING	quantitative indicators	1270-1293	PHYS
26978046_en	AFFECTS	More significant changes in quantitative indicators	1242-1293	FINDING	nNOS-positive neurons	1310-1331	ANATOMY
26978046_en	FINDING_OF	reduction in the quantitative indicators	1337-1377	FINDING	quantitative indicators	1354-1377	PHYS
26978046_en	PHYSIOLOGY_OF	localization of cells	1393-1414	PHYS	cells	1409-1414	ANATOMY
26978046_en	PHYSIOLOGY_OF	quantitative indicators	1354-1377	PHYS	cells	1409-1414	ANATOMY
26978046_en	HAS_CAUSE	reduction in the quantitative indicators	1337-1377	FINDING	localization of cells	1393-1414	PHYS
26978046_en	AFFECTS	reduction in the quantitative indicators	1337-1377	FINDING	cells	1409-1414	ANATOMY
26978046_en	ASSOCIATED_WITH	hemodynamic control	1579-1598	PHYS	hemodynamic	1579-1590	PHYS
26978046_en	AFFECTS	changes are more pronounced	1455-1482	FINDING	IN1	1419-1422	ANATOMY
26978046_en	SUBCLASS_OF	arge IN	1446-1453	ANATOMY	IN	1451-1453	ANATOMY
26978046_en	PHYSIOLOGY_OF	hemodynamic control	1579-1598	PHYS	intranuclear	1646-1658	ANATOMY
26978046_en	PHYSIOLOGY_OF	hemodynamic control	1579-1598	PHYS	internuclear	1663-1675	ANATOMY
26978046_en	SUBCLASS_OF	large IN	1710-1718	ANATOMY	IN	1716-1718	ANATOMY
26978046_en	PHYSIOLOGY_OF	responsive	1723-1733	PHYS	large IN	1710-1718	ANATOMY
26978046_en	ALTERNATIVE_NAME	hemodynamic control	1579-1598	PHYS	regulation of hemodynamics	1806-1832	PHYS
26978046_en	ASSOCIATED_WITH	regulation of hemodynamics	1806-1832	PHYS	hemodynamics	1820-1832	PHYS
26978046_en	SUBCLASS_OF	Small IN	1834-1842	ANATOMY	IN	1840-1842	ANATOMY
26978046_en	AFFECTS	stable, obviously, integrating function	1898-1937	FINDING	Small IN	1834-1842	ANATOMY
26978046_en	HAS_CAUSE	responsive	1723-1733	PHYS	increases in blood pressure	1737-1764	FINDING
26978046_en	PHYSIOLOGY_OF	regulation of hemodynamics	1806-1832	PHYS	large IN	1710-1718	ANATOMY
26978046_en	AFFECTS	intensity of immunohistochemical reaction	893-934	FINDING	IN	785-787	ANATOMY
26978172_en	SUBCLASS_OF	type 2 diabetes	71-86	DISO	diabetes	78-86	DISO
26978172_en	SUBCLASS_OF	diabetes mellitus	273-290	DISO	diabetes	273-281	DISO
26978172_en	ABBREVIATION	T2DM	292-296	DISO	type 2 diabetes mellitus	266-290	DISO
26978172_en	ABBREVIATION	interleukin	644-655	CHEM	IL	657-659	CHEM
26978172_en	SUBCLASS_OF	interleukin (IL)-6	644-662	CHEM	interleukin	644-655	CHEM
26978172_en	SUBCLASS_OF	IL-10	667-672	CHEM	interleukin	644-655	CHEM
26978172_en	HAS_CAUSE	lower adiponectin concentrations	742-774	DISO	T2DM	807-811	DISO
26978172_en	HAS_CAUSE	hyperresistinemia	719-736	DISO	T2DM	807-811	DISO
26978172_en	HAS_CAUSE	Hyperleptinemia	702-717	DISO	T2DM	807-811	DISO
26978172_en	ABBREVIATION	insulin resistance	969-987	DISO	IR	989-991	DISO
26978172_en	HAS_CAUSE	compensatory hyperinsulinemia	1008-1037	DISO	insulin resistance	969-987	DISO
26978172_en	HAS_CAUSE	hyperleptinemia	1756-1771	DISO	T2DM	1689-1693	DISO
26978172_en	HAS_CAUSE	hyperresistinemia	1773-1790	DISO	T2DM	1689-1693	DISO
26978172_en	HAS_CAUSE	decreasing adiponectin values	1808-1837	FINDING	T2DM	1689-1693	DISO
26978172_en	HAS_CAUSE	compensatory hyperinsulinemia	1546-1575	DISO	IR	1528-1530	DISO
26978172_en	HAS_CAUSE	IR	1528-1530	DISO	T2DM	1462-1466	DISO
26978172_en	HAS_CAUSE	IR	1528-1530	DISO	asthma	1503-1509	DISO
26978172_en	HAS_CAUSE	Hyperleptinemia	702-717	DISO	subclinical inflammation	935-959	DISO
26978172_en	HAS_CAUSE	hyperresistinemia	719-736	DISO	subclinical inflammation	935-959	DISO
26978172_en	HAS_CAUSE	lower adiponectin concentrations	742-774	DISO	subclinical inflammation	935-959	DISO
26978172_en	HAS_CAUSE	increases in the levels of total cholesterol (C), triglycerides, low-density lipoprotein C, and atherogenic index	1126-1239	FINDING	atherogenic dyslipidemia	1089-1113	DISO
26978172_en	HAS_CAUSE	decrease in those of high-density lipoprotein C	1249-1296	FINDING	atherogenic dyslipidemia	1089-1113	DISO
26978172_en	FINDING_OF	positive correlation of the level of resistin with insulin	1354-1412	FINDING	level of resistin	1382-1399	PHYS
26978172_en	HAS_CAUSE	hyperleptinemia	1756-1771	DISO	asthma	1730-1736	DISO
26978172_en	HAS_CAUSE	hyperresistinemia	1773-1790	DISO	asthma	1730-1736	DISO
26978172_en	ASSOCIATED_WITH	hormonal and metabolic parameters	23-56	PHYS	hormonal	23-31	CHEM
26978172_en	ASSOCIATED_WITH	metabolic	36-45	PHYS	hormonal and metabolic parameters	23-56	PHYS
26978172_en	ASSOCIATED_WITH	hormonal and metabolic parameters	215-248	PHYS	hormonal	215-223	CHEM
26978172_en	ASSOCIATED_WITH	metabolic	228-237	PHYS	hormonal and metabolic parameters	215-248	PHYS
26978172_en	ASSOCIATED_WITH	metabolic parameters	587-607	PHYS	metabolic	587-596	PHYS
26978172_en	ASSOCIATED_WITH	levels	673-679	PHYS	IL-10	667-672	CHEM
26978172_en	ASSOCIATED_WITH	levels	673-679	PHYS	interleukin (IL)-6	644-662	CHEM
26978172_en	ASSOCIATED_WITH	levels	673-679	PHYS	adiponectin	631-642	CHEM
26978172_en	ASSOCIATED_WITH	levels	673-679	PHYS	resistin	621-629	CHEM
26978172_en	ASSOCIATED_WITH	levels	673-679	PHYS	leptin	613-619	CHEM
26978172_en	ASSOCIATED_WITH	metabolic parameters	587-607	PHYS	lipid	581-586	CHEM
26978172_en	ASSOCIATED_WITH	metabolic parameters	587-607	PHYS	carbohydrate	564-576	CHEM
26978172_en	SUBCLASS_OF	subclinical inflammation	935-959	DISO	inflammation	947-959	DISO
26978172_en	HAS_CAUSE	insulin resistance	969-987	DISO	insulin	969-976	CHEM
26978172_en	SUBCLASS_OF	compensatory hyperinsulinemia	1008-1037	DISO	hyperinsulinemia	1021-1037	DISO
26978172_en	ASSOCIATED_WITH	levels of total cholesterol	1143-1170	PHYS	total cholesterol	1153-1170	CHEM
26978172_en	SUBCLASS_OF	levels of total cholesterol	1143-1170	PHYS	levels	1143-1149	PHYS
26978172_en	ASSOCIATED_WITH	levels	1143-1149	PHYS	triglycerides	1176-1189	CHEM
26978172_en	ASSOCIATED_WITH	levels	1143-1149	PHYS	low-density lipoprotein C	1191-1216	CHEM
26978172_en	ABBREVIATION	cholesterol	1159-1170	CHEM	C	1172-1173	CHEM
26978172_en	SUBCLASS_OF	total cholesterol	1153-1170	CHEM	cholesterol	1159-1170	CHEM
26978172_en	SUBCLASS_OF	low-density lipoprotein	1191-1214	CHEM	lipoprotein	1203-1214	CHEM
26978172_en	SUBCLASS_OF	low-density lipoprotein C	1191-1216	CHEM	C	1215-1216	CHEM
26978172_en	USED_IN	low-density lipoprotein C	1191-1216	CHEM	low-density lipoprotein	1191-1214	CHEM
26978172_en	SUBCLASS_OF	atherogenic dyslipidemia	1089-1113	DISO	dyslipidemia	1101-1113	DISO
26978172_en	SUBCLASS_OF	high-density lipoprotein C	1270-1296	CHEM	C	1295-1296	CHEM
26978172_en	SUBCLASS_OF	high-density lipoprotein	1270-1294	CHEM	lipoprotein	1283-1294	CHEM
26978172_en	HAS_CAUSE	decrease in those of high-density lipoprotein C	1249-1296	FINDING	high-density lipoprotein C	1270-1296	CHEM
26978172_en	USED_IN	high-density lipoprotein C	1270-1296	CHEM	high-density lipoprotein	1270-1294	CHEM
26978172_en	ASSOCIATED_WITH	level of resistin	1382-1399	PHYS	resistin	1391-1399	CHEM
26978172_en	HAS_CAUSE	positive correlation of the level of resistin with insulin	1354-1412	FINDING	insulin	1405-1412	CHEM
26978172_en	HAS_CAUSE	positive correlation of the level of resistin with insulin	1354-1412	FINDING	resistin	1391-1399	CHEM
26978172_en	SUBCLASS_OF	compensatory hyperinsulinemia	1546-1575	DISO	hyperinsulinemia	1559-1575	DISO
26978172_en	HAS_CAUSE	Hyperresistinemia	1577-1594	DISO	IR	1630-1632	DISO
26978172_en	FINDING_OF	decreasing adiponectin values	1808-1837	FINDING	adiponectin values	1819-1837	PHYS
26978172_en	HAS_CAUSE	decreasing adiponectin values	1808-1837	FINDING	adiponectin	1819-1830	CHEM
26978172_en	ASSOCIATED_WITH	adiponectin values	1819-1837	PHYS	adiponectin	1819-1830	CHEM
26978172_en	SUBCLASS_OF	subclinical inflammation	1857-1881	DISO	inflammation	1869-1881	DISO
26978172_en	HAS_CAUSE	subclinical inflammation	1857-1881	DISO	T2DM	1689-1693	DISO
26978176_en	AFFECTS	podocyte injury	34-49	DISO	podocyte	34-42	ANATOMY
26978176_en	HAS_CAUSE	podocyte injury	34-49	DISO	diabetes mellitus	67-84	DISO
26978176_en	SUBCLASS_OF	diabetes	67-75	DISO	diabetes mellitus	67-84	DISO
26978176_en	AFFECTS	podocyte injury	141-156	DISO	podocyte	141-149	ANATOMY
26978176_en	ABBREVIATION	DN	230-232	DISO	diabetic nephropathy	208-228	DISO
26978176_en	HAS_CAUSE	podocyte injury	141-156	DISO	diabetic nephropathy	208-228	DISO
26978176_en	SUBCLASS_OF	diabetes mellitus	294-311	DISO	diabetes	294-302	DISO
26978176_en	ABBREVIATION	diabetes mellitus	294-311	DISO	DM	313-315	DISO
26978176_en	HAS_CAUSE	albuminuria	341-352	DISO	diabetic nephropathy	208-228	DISO
26978176_en	HAS_CAUSE	proteinuria	353-364	DISO	diabetic nephropathy	208-228	DISO
26978176_en	ALTERNATIVE_NAME	diabetic	399-407	DISO	diabetes	294-302	DISO
26978176_en	ABBREVIATION	normal albuminuria	582-600	PHYS	NAU	602-605	PHYS
26978176_en	SUBCLASS_OF	normal albuminuria	582-600	PHYS	albuminuria	589-600	PHYS
26978176_en	ABBREVIATION	microalbuminuria	639-655	DISO	MAU	657-660	DISO
26978176_en	ABBREVIATION	proteinuria	697-708	DISO	PU	710-712	DISO
26978176_en	ABBREVIATION	Nephrinuria	898-909	DISO	NU	911-913	DISO
26978176_en	HAS_CAUSE	Nephrinuria	898-909	DISO	NAU	968-971	PHYS
26978176_en	HAS_CAUSE	Nephrinuria	898-909	DISO	MAU	973-976	DISO
26978176_en	HAS_CAUSE	Nephrinuria	898-909	DISO	PU	982-984	DISO
26978176_en	ABBREVIATION	Podocinuria	1000-1011	DISO	PDU	1013-1016	DISO
26978176_en	HAS_CAUSE	Podocinuria	1000-1011	DISO	NAU	1061-1064	PHYS
26978176_en	HAS_CAUSE	Podocinuria	1000-1011	DISO	MAU	1066-1069	DISO
26978176_en	HAS_CAUSE	Podocinuria	1000-1011	DISO	PU	1075-1077	DISO
26978176_en	HAS_CAUSE	NU	1093-1095	DISO	DN	1099-1101	DISO
26978176_en	HAS_CAUSE	PU	1107-1109	DISO	DN	1099-1101	DISO
26978176_en	HAS_CAUSE	NAU	1156-1159	PHYS	DM	1148-1150	DISO
26978176_en	HAS_CAUSE	PU	1182-1184	DISO	DM	1273-1275	DISO
26978176_en	HAS_CAUSE	MAU	1173-1176	DISO	DM	1273-1275	DISO
26978176_en	HAS_CAUSE	NAU	1168-1171	PHYS	DM	1273-1275	DISO
26978176_en	HAS_CAUSE	albuminuria	1420-1431	DISO	DM	1393-1395	DISO
26978176_en	AFFECTS	DM	1950-1952	DISO	glomerular apparatus	1926-1946	ANATOMY
26978176_en	AFFECTS	DN	1897-1899	DISO	glomerular apparatus	1926-1946	ANATOMY
26978176_en	HAS_CAUSE	DN	1897-1899	DISO	DM	1950-1952	DISO
26978176_en	ASSOCIATED_WITH	urinary excretion	108-125	PHYS	diabetic nephropathy	208-228	DISO
26978176_en	TO_DETECT_OR_STUDY	urinary concentration in one urinary portion	516-560	LABPROC	normal albuminuria	582-600	PHYS
26978176_en	TO_DETECT_OR_STUDY	urinary concentration in one urinary portion	516-560	LABPROC	microalbuminuria	639-655	DISO
26978176_en	TO_DETECT_OR_STUDY	urinary concentration in one urinary portion	516-560	LABPROC	proteinuria	697-708	DISO
26978176_en	TO_DETECT_OR_STUDY	enzyme immunoassay	870-888	LABPROC	nephrin	831-838	CHEM
26978176_en	TO_DETECT_OR_STUDY	enzyme immunoassay	870-888	LABPROC	podocin	843-850	CHEM
26978176_en	ASSOCIATED_WITH	podocin excretion	1196-1213	PHYS	PU	1182-1184	DISO
26978176_en	ASSOCIATED_WITH	podocin excretion	1196-1213	PHYS	MAU	1173-1176	DISO
26978176_en	ASSOCIATED_WITH	podocin excretion	1196-1213	PHYS	NAU	1168-1171	PHYS
26978176_en	HAS_CAUSE	NU	1447-1449	DISO	DM	1393-1395	DISO
26978176_en	HAS_CAUSE	PDU	1454-1457	DISO	DM	1393-1395	DISO
26978176_en	HAS_CAUSE	PDU	1454-1457	DISO	creatinine levels	1487-1504	PHYS
26978176_en	HAS_CAUSE	NU	1447-1449	DISO	creatinine levels	1487-1504	PHYS
26978176_en	HAS_CAUSE	albuminuria	1420-1431	DISO	creatinine levels	1487-1504	PHYS
26978176_en	ORIGINS_FROM	creatinine	1487-1497	CHEM	serum	1481-1486	ANATOMY
26978176_en	ASSOCIATED_WITH	NU	1311-1313	DISO	direct correlation of NU with albuminuria	1289-1330	FINDING
26978176_en	ASSOCIATED_WITH	albuminuria	1319-1330	DISO	direct correlation of NU with albuminuria	1289-1330	FINDING
26978176_en	FINDING_OF	direct significant correlation of systolic blood pressure	1682-1739	FINDING	systolic blood pressure	1716-1739	PHYS
26978176_en	ASSOCIATED_WITH	NU	1745-1747	DISO	direct significant correlation of systolic blood pressure	1682-1739	FINDING
26978176_en	HAS_CAUSE	albuminuria	341-352	DISO	diabetes mellitus	294-311	DISO
26978176_en	HAS_CAUSE	proteinuria	353-364	DISO	diabetes mellitus	294-311	DISO
26978176_en	SUBCLASS_OF	type 1 DM	426-435	DISO	DM	433-435	DISO
26978176_en	SUBCLASS_OF	type 2 DM	448-457	DISO	DM	455-457	DISO
26978176_en	ASSOCIATED_WITH	albuminuria	589-600	PHYS	microalbuminuria	639-655	DISO
26978176_en	PHYSIOLOGY_OF	urinary levels of the podocyte structural proteins	780-830	PHYS	podocyte	802-810	ANATOMY
26978176_en	ASSOCIATED_WITH	NU	1093-1095	DISO	significantly higher	1114-1134	FINDING
26978176_en	HAS_CAUSE	significantly higher	1114-1134	FINDING	PU	1107-1109	DISO
26978176_en	HAS_CAUSE	significantly higher	1114-1134	FINDING	DN	1099-1101	DISO
26978176_en	FINDING_OF	equally higher and did not differ between the types of DM	1218-1275	FINDING	podocin excretion	1196-1213	PHYS
26978176_en	FINDING_OF	correlated directly	1458-1477	FINDING	creatinine levels	1487-1504	PHYS
26978176_en	FINDING_OF	correlated inversely	1458-1518	FINDING	glomerular filtration rate	1524-1550	PHYS
26978176_en	ASSOCIATED_WITH	NU	1552-1554	DISO	directly correlated with glycated hemoglobin levels	1555-1606	FINDING
26978176_en	FINDING_OF	directly correlated with glycated hemoglobin levels	1555-1606	FINDING	glycated hemoglobin levels	1580-1606	PHYS
26978176_en	HAS_CAUSE	direct significant correlation of systolic blood pressure	1682-1739	FINDING	type 2 DM	1772-1781	DISO
26978176_en	HAS_CAUSE	directly correlated with glycated hemoglobin levels	1555-1606	FINDING	types 2 DM	1628-1644	DISO
26978176_en	HAS_CAUSE	directly correlated with glycated hemoglobin levels	1555-1606	FINDING	types 1 DM	1628-1644	DISO
26978176_en	PHYSIOLOGY_OF	Urinary excretion	1-18	PHYS	Urinary	1-8	ANATOMY
26978176_en	SUBCLASS_OF	Urinary excretion	1-18	PHYS	excretion	9-18	PHYS
26978176_en	HAS_CAUSE	markers for podocyte injury	22-49	PHYS	podocyte injury	34-49	DISO
26978176_en	ASSOCIATED_WITH	Urinary excretion	1-18	PHYS	markers for podocyte injury	22-49	PHYS
26978176_en	SUBCLASS_OF	urinary excretion	108-125	PHYS	excretion	116-125	PHYS
26978176_en	PHYSIOLOGY_OF	urinary excretion	108-125	PHYS	urinary	108-115	ANATOMY
26978176_en	ASSOCIATED_WITH	urinary excretion	108-125	PHYS	markers for podocyte injury	129-156	PHYS
26978176_en	HAS_CAUSE	markers for podocyte injury	129-156	PHYS	podocyte injury	141-156	DISO
26978176_en	SUBCLASS_OF	diabetic nephropathy	208-228	DISO	nephropathy	217-228	DISO
26978176_en	HAS_CAUSE	diabetic nephropathy	208-228	DISO	diabetic	208-216	DISO
26978176_en	ALTERNATIVE_NAME	diabetes	67-75	DISO	diabetic	208-216	DISO
26978176_en	PHYSIOLOGY_OF	urinary concentration	516-537	PHYS	urinary	516-523	ANATOMY
26978176_en	TO_DETECT_OR_STUDY	urinary concentration in one urinary portion	516-560	LABPROC	urinary concentration	516-537	PHYS
26978176_en	TO_DETECT_OR_STUDY	urinary concentration in one urinary portion	516-560	LABPROC	urinary	545-552	ANATOMY
26978176_en	PHYSIOLOGY_OF	urinary levels of the podocyte structural proteins	780-830	PHYS	urinary	780-787	ANATOMY
26978176_en	SUBCLASS_OF	nephrin	831-838	CHEM	podocyte structural proteins	802-830	CHEM
26978176_en	SUBCLASS_OF	podocin	843-850	CHEM	podocyte structural proteins	802-830	CHEM
26978176_en	ORIGINS_FROM	podocyte structural proteins	802-830	CHEM	podocyte	802-810	ANATOMY
26978176_en	ASSOCIATED_WITH	urinary levels of the podocyte structural proteins	780-830	PHYS	podocyte structural proteins	802-830	CHEM
26978176_en	SUBCLASS_OF	podocyte structural proteins	802-830	CHEM	structural proteins	811-830	CHEM
26978176_en	SUBCLASS_OF	structural proteins	811-830	CHEM	proteins	822-830	CHEM
26978176_en	TO_DETECT_OR_STUDY	enzyme immunoassay	870-888	LABPROC	urinary levels of the podocyte structural proteins	780-830	PHYS
26978176_en	APPLIED_TO	enzyme immunoassay	870-888	LABPROC	urinary	780-787	ANATOMY
26978176_en	TO_DETECT_OR_STUDY	enzyme immunoassay	870-888	LABPROC	podocyte	802-810	ANATOMY
26978176_en	USED_IN	enzyme	870-876	CHEM	enzyme immunoassay	870-888	LABPROC
26978176_en	SUBCLASS_OF	podocin excretion	1196-1213	PHYS	excretion	1204-1213	PHYS
26978176_en	ASSOCIATED_WITH	podocin excretion	1196-1213	PHYS	podocin	1196-1203	CHEM
26978176_en	ASSOCIATED_WITH	DM	1273-1275	DISO	equally higher and did not differ between the types of DM	1218-1275	FINDING
26978176_en	PHYSIOLOGY_OF	glomerular filtration	1524-1545	PHYS	glomerular	1524-1534	ANATOMY
26978176_en	ASSOCIATED_WITH	glomerular filtration rate	1524-1550	PHYS	glomerular filtration	1524-1545	PHYS
26978176_en	ASSOCIATED_WITH	NU	1447-1449	DISO	correlated directly	1458-1477	FINDING
26978176_en	ASSOCIATED_WITH	PDU	1454-1457	DISO	correlated directly	1458-1477	FINDING
26978176_en	ASSOCIATED_WITH	NU	1447-1449	DISO	correlated inversely	1458-1518	FINDING
26978176_en	ASSOCIATED_WITH	PDU	1454-1457	DISO	correlated inversely	1458-1518	FINDING
26978176_en	PHYSIOLOGY_OF	creatinine levels	1487-1504	PHYS	serum	1481-1486	ANATOMY
26978176_en	ASSOCIATED_WITH	glycated hemoglobin levels	1580-1606	PHYS	hemoglobin	1589-1599	CHEM
26978176_en	ASSOCIATED_WITH	glycated	1580-1588	PHYS	hemoglobin	1589-1599	CHEM
26978176_en	SUBCLASS_OF	systolic blood pressure	1716-1739	PHYS	blood pressure	1725-1739	PHYS
26978176_en	PHYSIOLOGY_OF	systolic blood pressure	1716-1739	PHYS	blood	1725-1730	ANATOMY
26978176_en	PHYSIOLOGY_OF	urinary nephrin and podocin levels	1811-1845	PHYS	urinary	1811-1818	ANATOMY
26978176_en	ORIGINS_FROM	nephrin	1819-1826	CHEM	urinary	1811-1818	ANATOMY
26978176_en	ORIGINS_FROM	podocin	1831-1838	CHEM	urinary	1811-1818	ANATOMY
26978176_en	ASSOCIATED_WITH	urinary nephrin and podocin levels	1811-1845	PHYS	nephrin	1819-1826	CHEM
26978176_en	ASSOCIATED_WITH	urinary nephrin and podocin levels	1811-1845	PHYS	podocin	1831-1838	CHEM
26978176_en	SUBCLASS_OF	type 2 DM	1772-1781	DISO	DM	1779-1781	DISO
26978176_en	FINDING_OF	may be used for the early preclinical diagnosis of DN	1846-1899	FINDING	urinary nephrin and podocin levels	1811-1845	PHYS
26978176_en	ASSOCIATED_WITH	DN	1897-1899	DISO	may be used for the early preclinical diagnosis of DN	1846-1899	FINDING
26978232_en	AFFECTS	inflammatory bowel disease	115-141	DISO	bowel	128-133	ANATOMY
26978232_en	ABBREVIATION	inflammatory bowel disease	115-141	DISO	IBD	143-146	DISO
26978232_en	ABBREVIATION	Crohn's disease	258-273	DISO	CD	275-277	DISO
26978232_en	SUBCLASS_OF	Crohn's disease	258-273	DISO	inflammatory bowel disease	115-141	DISO
26978232_en	ABBREVIATION	IBD unclassified	313-329	DISO	IBDU	331-335	DISO
26978232_en	SUBCLASS_OF	indeterminate colitis of IBD unclassified	288-329	DISO	IBD unclassified	313-329	DISO
26978232_en	ABBREVIATION	somatostatin receptor type 2	456-484	CHEM	SSTR-2	486-492	CHEM
26978232_en	ALTERNATIVE_NAME	SSTR2	523-528	CHEM	SSTR-2	486-492	CHEM
26978232_en	ORIGINS_FROM	somatostatin receptor	45-66	CHEM	ileal mucosa	85-97	ANATOMY
26978232_en	APPLIED_TO	biopsy	176-182	LABPROC	Ileal	170-175	ANATOMY
26978232_en	APPLIED_TO	SSTR2	1327-1332	CHEM	cytoplasmic	1375-1386	ANATOMY
26978232_en	ALTERNATIVE_NAME	SSTR-2	1121-1127	CHEM	SSTR2	1327-1332	CHEM
26978232_en	USED_IN	anti-somatostatin receptor type 2	451-484	CHEM	Immunohistochemical examination	399-430	LABPROC
26978232_en	PHYSIOLOGY_OF	somatostatin receptor expression	45-77	PHYS	ileal mucosa	85-97	ANATOMY
26978232_en	HAS_CAUSE	somatostatin receptor expression	45-77	PHYS	inflammatory bowel disease	115-141	DISO
26978232_en	PART_OF	Ileal biopsy specimens	170-192	ANATOMY	Ileal	170-175	ANATOMY
26978232_en	PART_OF	ileal mucosa	364-376	ANATOMY	ileal	364-369	ANATOMY
26978232_en	PHYSIOLOGY_OF	membranous expression	744-765	PHYS	cells	733-738	ANATOMY
26978232_en	PHYSIOLOGY_OF	receptor expression	616-635	PHYS	cytoplasmic	669-680	ANATOMY
26978232_en	ORIGINS_FROM	SSTR-2	1121-1127	CHEM	cells	1139-1144	ANATOMY
26978232_en	ASSOCIATED_WITH	Crohn's disease	1192-1207	DISO	number of SSTR-2-expressing cells was significantly smaller	1111-1170	FINDING
26978232_en	FINDING_OF	number of SSTR-2-expressing cells was significantly smaller	1111-1170	FINDING	SSTR-2-expressing	1121-1138	PHYS
26978232_en	PHYSIOLOGY_OF	SSTR-2-expressing	1121-1138	PHYS	cells	1139-1144	ANATOMY
26978232_en	HAS_CAUSE	SSTR-2-expressing	1121-1138	PHYS	Crohn's disease	1192-1207	DISO
26978232_en	HAS_CAUSE	SSTR-2-expressing	1121-1138	PHYS	indeterminate (unclassified) colitis	1271-1307	DISO
26978232_en	PART_OF	membranous	744-754	ANATOMY	cells	733-738	ANATOMY
26978232_en	SUBCLASS_OF	neuroendocrine	1474-1488	ANATOMY	cells	1428-1433	ANATOMY
26978232_en	PHYSIOLOGY_OF	cytoplasmic expression	1501-1523	PHYS	intraepithelial T lymphocytes	1529-1558	ANATOMY
26978232_en	PHYSIOLOGY_OF	membranous-cytoplasmic expression	1575-1608	PHYS	neuroendocrine	1619-1633	ANATOMY
26978232_en	PHYSIOLOGY_OF	membranous-cytoplasmic expression	1575-1608	PHYS	epithelial	1638-1648	ANATOMY
26978232_en	SUBCLASS_OF	somatostatin receptor	45-66	CHEM	receptor	58-66	CHEM
26978232_en	ASSOCIATED_WITH	somatostatin receptor expression	45-77	PHYS	somatostatin receptor	45-66	CHEM
26978232_en	SUBCLASS_OF	inflammatory bowel disease	115-141	DISO	inflammatory	115-127	DISO
26978232_en	SUBCLASS_OF	ileal mucosa	85-97	ANATOMY	mucosa	91-97	ANATOMY
26978232_en	PART_OF	ileal mucosa	85-97	ANATOMY	ileal	85-90	ANATOMY
26978232_en	SUBCLASS_OF	ileal mucosa	364-376	ANATOMY	mucosa	370-376	ANATOMY
26978232_en	APPLIED_TO	biopsy	176-182	LABPROC	Ileal biopsy specimens	170-192	ANATOMY
26978232_en	SUBCLASS_OF	Ileal biopsy specimens	170-192	ANATOMY	biopsy specimens	176-192	ANATOMY
26978232_en	SUBCLASS_OF	indeterminate colitis	288-309	DISO	colitis	302-309	DISO
26978232_en	SUBCLASS_OF	IBD unclassified	313-329	DISO	IBD	313-316	DISO
26978232_en	TO_DETECT_OR_STUDY	SSTR2-positively stained cells were counted	523-566	LABPROC	cells	548-553	ANATOMY
26978232_en	APPLIED_TO	SSTR2-positively stained cells were counted	523-566	LABPROC	epitheliocytes	575-589	ANATOMY
26978232_en	SUBCLASS_OF	epitheliocytes	575-589	ANATOMY	cells	548-553	ANATOMY
26978232_en	SUBCLASS_OF	anti-somatostatin receptor type 2	451-484	CHEM	antibodies	494-504	CHEM
26978232_en	SUBCLASS_OF	somatostatin receptor type 2	456-484	CHEM	somatostatin receptor	456-477	CHEM
26978232_en	SUBCLASS_OF	somatostatin receptor	456-477	CHEM	receptor	469-477	CHEM
26978232_en	ASSOCIATED_WITH	receptor expression	616-635	PHYS	receptor	616-624	CHEM
26978232_en	PHYSIOLOGY_OF	receptor expression	616-635	PHYS	membranous	657-667	ANATOMY
26978232_en	ORIGINS_FROM	receptor	616-624	CHEM	membranous	657-667	ANATOMY
26978232_en	ORIGINS_FROM	receptor	616-624	CHEM	cytoplasmic	669-680	ANATOMY
26978232_en	PHYSIOLOGY_OF	cytoplasmic expression	1001-1023	PHYS	cytoplasmic	1001-1012	ANATOMY
26978232_en	SUBCLASS_OF	SSTR-2-expressing	1121-1138	PHYS	expressing	1128-1138	PHYS
26978232_en	SUBCLASS_OF	SSTR-2	1121-1127	CHEM	SSTR	1121-1125	CHEM
26978232_en	ASSOCIATED_WITH	SSTR-2-expressing	1121-1138	PHYS	SSTR-2	1121-1127	CHEM
26978232_en	SUBCLASS_OF	indeterminate (unclassified) colitis	1271-1307	DISO	colitis	1300-1307	DISO
26978232_en	ASSOCIATED_WITH	SSTR2 staining types	1327-1347	PHYS	SSTR2	1327-1332	CHEM
26978232_en	PHYSIOLOGY_OF	SSTR2 staining types	1327-1347	PHYS	membranous	1363-1373	ANATOMY
26978232_en	PHYSIOLOGY_OF	SSTR2 staining types	1327-1347	PHYS	cytoplasmic	1375-1386	ANATOMY
26978232_en	PHYSIOLOGY_OF	membranous staining	1439-1458	PHYS	membranous	1439-1449	ANATOMY
26978232_en	PHYSIOLOGY_OF	membranous staining	1439-1458	PHYS	cells	1428-1433	ANATOMY
26978232_en	SUBCLASS_OF	cytoplasmic expression	1501-1523	PHYS	expression	1513-1523	PHYS
26978232_en	PHYSIOLOGY_OF	cytoplasmic expression	1501-1523	PHYS	cytoplasmic	1501-1512	ANATOMY
26978232_en	SUBCLASS_OF	T lymphocytes	1545-1558	ANATOMY	lymphocytes	1547-1558	ANATOMY
26978232_en	SUBCLASS_OF	intraepithelial T lymphocytes	1529-1558	ANATOMY	T lymphocytes	1545-1558	ANATOMY
26978232_en	PART_OF	intraepithelial T lymphocytes	1529-1558	ANATOMY	intraepithelial	1529-1544	ANATOMY
26978232_en	SUBCLASS_OF	intraepithelial T lymphocytes	1529-1558	ANATOMY	cells	1428-1433	ANATOMY
26978232_en	SUBCLASS_OF	membranous-cytoplasmic expression	1575-1608	PHYS	expression	1598-1608	PHYS
26978232_en	PHYSIOLOGY_OF	membranous-cytoplasmic expression	1575-1608	PHYS	membranous	1575-1585	ANATOMY
26978232_en	PHYSIOLOGY_OF	membranous-cytoplasmic expression	1575-1608	PHYS	cytoplasmic	1586-1597	ANATOMY
26978232_en	SUBCLASS_OF	neuroendocrine	1619-1633	ANATOMY	cells	1428-1433	ANATOMY
26978232_en	SUBCLASS_OF	epithelial	1638-1648	ANATOMY	cells	1428-1433	ANATOMY
26978232_en	SUBCLASS_OF	SSTR-2	486-492	CHEM	SSTR	486-490	CHEM
26978233_en	AFFECTS	colorectal liver metastases	79-106	DISO	colorectal	79-89	ANATOMY
26978233_en	AFFECTS	colorectal liver metastases	79-106	DISO	liver	90-95	ANATOMY
26978233_en	SUBCLASS_OF	colorectal adenocarcinoma	226-251	DISO	adenocarcinoma	237-251	DISO
26978233_en	AFFECTS	colorectal adenocarcinoma	226-251	DISO	colorectal	226-236	ANATOMY
26978233_en	AFFECTS	colorectal adenocarcinoma metastases to the liver	226-275	DISO	liver	270-275	ANATOMY
26978233_en	AFFECTS	colorectal adenocarcinoma metastases to the liver	226-275	DISO	colorectal	226-236	ANATOMY
26978233_en	ALTERNATIVE_NAME	colorectal adenocarcinoma metastases to the liver	226-275	DISO	colorectal liver metastases	79-106	DISO
26978233_en	AFFECTS	colorectal carcinoma	452-472	DISO	colorectal	452-462	ANATOMY
26978233_en	SUBCLASS_OF	colorectal carcinoma	452-472	DISO	carcinoma	463-472	DISO
26978233_en	AFFECTS	colorectal carcinoma metastases to the liver	452-496	DISO	liver	491-496	ANATOMY
26978233_en	AFFECTS	colorectal carcinoma metastases to the liver	452-496	DISO	colorectal	452-462	ANATOMY
26978233_en	ALTERNATIVE_NAME	effector caspases -7	156-182	CHEM	caspase-7	1227-1236	CHEM
26978233_en	SUBCLASS_OF	colorectal adenocarcinoma	1391-1416	DISO	adenocarcinoma	1402-1416	DISO
26978233_en	AFFECTS	colorectal adenocarcinoma	1391-1416	DISO	colorectal	1391-1401	ANATOMY
26978233_en	AFFECTS	colorectal adenocarcinoma metastases to the liver	1391-1440	DISO	liver	1435-1440	ANATOMY
26978233_en	AFFECTS	colorectal adenocarcinoma metastases to the liver	1391-1440	DISO	colorectal	1391-1401	ANATOMY
26978233_en	SUBCLASS_OF	effector caspases-3	156-175	CHEM	effector caspases	156-173	CHEM
26978233_en	SUBCLASS_OF	survivin	214-222	CHEM	antiapoptotic protein	192-213	CHEM
26978233_en	SUBCLASS_OF	survivin	1696-1704	CHEM	antiapoptotic protein	1674-1695	CHEM
26978233_en	HAS_CAUSE	activated apoptosis	1450-1469	FINDING	bevacizumab	1333-1344	CHEM
26978233_en	HAS_CAUSE	expression	44-54	PHYS	colorectal liver metastases	79-106	DISO
26978233_en	HAS_CAUSE	expression	129-139	PHYS	colorectal adenocarcinoma metastases to the liver	226-275	DISO
26978233_en	TO_DETECT_OR_STUDY	immunohistologically examined	502-531	LABPROC	colorectal carcinoma metastases to the liver	452-496	DISO
26978233_en	ALTERNATIVE_NAME	p53 protein	143-154	CHEM	p53	143-146	CHEM
26978233_en	ALTERNATIVE_NAME	effector caspases-3	156-175	CHEM	Caspase 3	804-813	CHEM
26978233_en	FINDING_OF	no statistically significant differences	1254-1294	FINDING	expression	1213-1223	PHYS
26978233_en	TREATED_USING	colorectal adenocarcinoma metastases to the liver	1391-1440	DISO	bevacizumab	1333-1344	CHEM
26978233_en	HAS_CAUSE	activated apoptosis	1450-1469	FINDING	enhancing the expression of effector caspase 3	1489-1535	FINDING
26978233_en	HAS_CAUSE	activated apoptosis	1617-1636	FINDING	decreasing the expression of the antiapoptotic protein survivi	1641-1703	FINDING
26978233_en	ASSOCIATED_WITH	Expression	790-800	PHYS	Caspase 3	804-813	CHEM
26978233_en	ASSOCIATED_WITH	Expression	790-800	PHYS	survivin	833-841	CHEM
26978233_en	FINDING_OF	significantly more frequently detected	847-885	FINDING	Expression	790-800	PHYS
26978233_en	ASSOCIATED_WITH	survivin expression	1160-1179	PHYS	survivin	1160-1168	CHEM
26978233_en	ASSOCIATED_WITH	expression	1213-1223	PHYS	p53	1241-1244	CHEM
26978233_en	ASSOCIATED_WITH	expression	1213-1223	PHYS	caspase-7	1227-1236	CHEM
26978233_en	ASSOCIATED_WITH	expression	1503-1513	PHYS	effector caspase 3	1517-1535	CHEM
26978233_en	SUBCLASS_OF	effector caspase 3	1517-1535	CHEM	effector caspase	1517-1533	CHEM
26978233_en	SUBCLASS_OF	effector caspase	1517-1533	CHEM	caspase	1526-1533	CHEM
26978233_en	ASSOCIATED_WITH	expression	1656-1666	PHYS	antiapoptotic protein	1674-1695	CHEM
26978233_en	SUBCLASS_OF	antiapoptotic protein	1674-1695	CHEM	protein	1688-1695	CHEM
26978233_en	SUBCLASS_OF	colorectal liver metastases	79-106	DISO	liver metastases	90-106	DISO
26978233_en	SUBCLASS_OF	liver metastases	90-106	DISO	metastases	96-106	DISO
26978233_en	HAS_CAUSE	apoptosis markers	58-75	PHYS	apoptosis	58-67	PHYS
26978233_en	ASSOCIATED_WITH	expression	44-54	PHYS	apoptosis markers	58-75	PHYS
26978233_en	HAS_CAUSE	apoptosis markers	58-75	PHYS	colorectal liver metastases	79-106	DISO
26978233_en	SUBCLASS_OF	p53 protein	143-154	CHEM	protein	147-154	CHEM
26978233_en	ASSOCIATED_WITH	expression	129-139	PHYS	p53 protein	143-154	CHEM
26978233_en	SUBCLASS_OF	antiapoptotic protein	192-213	CHEM	protein	206-213	CHEM
26978233_en	ASSOCIATED_WITH	expression	129-139	PHYS	effector caspases-3	156-175	CHEM
26978233_en	SUBCLASS_OF	effector caspases	156-173	CHEM	caspases	165-173	CHEM
26978233_en	SUBCLASS_OF	effector caspases -7	156-182	CHEM	effector caspases	156-173	CHEM
26978233_en	ASSOCIATED_WITH	expression	129-139	PHYS	effector caspases -7	156-182	CHEM
26978233_en	ASSOCIATED_WITH	expression	129-139	PHYS	survivin	214-222	CHEM
26978233_en	ASSOCIATED_WITH	expression	129-139	PHYS	colorectal adenocarcinoma metastases to the liver	226-275	DISO
26978233_en	SUBCLASS_OF	colorectal adenocarcinoma metastases to the liver	226-275	DISO	metastases	252-262	DISO
26978233_en	SUBCLASS_OF	colorectal carcinoma metastases to the liver	452-496	DISO	metastases	473-483	DISO
26978233_en	TO_DETECT_OR_STUDY	immunohistologically examined	502-531	LABPROC	Intraoperative samples	406-428	ANATOMY
26978233_en	FINDING_OF	no survivin expression	1157-1179	FINDING	survivin expression	1160-1179	PHYS
26978233_en	SUBCLASS_OF	colorectal adenocarcinoma metastases to the liver	1391-1440	DISO	metastases	1417-1427	DISO
26978233_en	SUBCLASS_OF	tumor cells	1473-1484	ANATOMY	cells	1479-1484	ANATOMY
26978233_en	PHYSIOLOGY_OF	apoptosis	1460-1469	PHYS	tumor cells	1473-1484	ANATOMY
26978233_en	FINDING_OF	activated apoptosis	1450-1469	FINDING	apoptosis	1460-1469	PHYS
26978233_en	AFFECTS	activated apoptosis	1450-1469	FINDING	tumor cells	1473-1484	ANATOMY
26978233_en	HAS_CAUSE	enhancing the expression of effector caspase 3	1489-1535	FINDING	effector caspase 3	1517-1535	CHEM
26978233_en	FINDING_OF	activated apoptosis	1617-1636	FINDING	apoptosis	1627-1636	PHYS
26978233_en	FINDING_OF	decreasing the expression of the antiapoptotic protein survivi	1641-1703	FINDING	expression	1656-1666	PHYS
26978233_en	HAS_CAUSE	decreasing the expression of the antiapoptotic protein survivi	1641-1703	FINDING	survivin	1696-1704	CHEM
26978233_en	SUBCLASS_OF	Caspase 3	804-813	CHEM	Caspase	804-811	CHEM
26978233_en	SUBCLASS_OF	caspase-7	1227-1236	CHEM	caspase	1227-1234	CHEM
26978418_en	SUBCLASS_OF	knee osteoarthritis	41-60	DISO	osteoarthritis	46-60	DISO
26978418_en	AFFECTS	knee osteoarthritis	41-60	DISO	knee	41-45	ANATOMY
26978418_en	ABBREVIATION	methylsulfonylmethane	322-343	CHEM	MSM	345-348	CHEM
26978418_en	SUBCLASS_OF	knee osteoarthritis	443-462	DISO	osteoarthritis	448-462	DISO
26978418_en	AFFECTS	knee osteoarthritis	443-462	DISO	knee	443-447	ANATOMY
26978418_en	ABBREVIATION	osteoarthritis	448-462	DISO	OA	464-466	DISO
26978418_en	AFFECTS	knee OA	556-563	DISO	knee	556-560	ANATOMY
26978418_en	HAS_CAUSE	positive effect occurred more rapidl	1987-2023	FINDING	ARTRA MSM	2032-2041	CHEM
26978418_en	HAS_CAUSE	improvement in Get-Up and Go test results	2376-2417	FINDING	ARTRA MSM	2326-2335	CHEM
26978418_en	HAS_CAUSE	prompter pain relief	2589-2609	FINDING	ARTRA MSM	2533-2542	CHEM
26978418_en	HAS_CAUSE	prompter pain relief	2589-2609	FINDING	ARTRA	2619-2624	CHEM
26978418_en	TREATED_USING	OA	2693-2695	DISO	ARTRA MSM	2643-2652	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM FORTE	8-23	CHEM	ARTRA MSM	8-17	CHEM
26978418_en	ALTERNATIVE_NAME	ARTRA MSM FORTE	236-251	CHEM	ARTRA MSM	236-245	CHEM
26978418_en	SUBCLASS_OF	knee OA	556-563	DISO	OA	561-563	DISO
26978418_en	USED_IN	chondroitin sulfate	260-279	CHEM	ARTRA MSM FORTE	236-251	CHEM
26978418_en	USED_IN	glucosamine hydrochloride	288-313	CHEM	ARTRA MSM FORTE	236-251	CHEM
26978418_en	USED_IN	methylsulfonylmethane	322-343	CHEM	ARTRA MSM FORTE	236-251	CHEM
26978418_en	USED_IN	sodium hyaluronate	361-379	CHEM	ARTRA MSM FORTE	236-251	CHEM
26978418_en	USED_IN	hyaluronic acid	409-424	CHEM	ARTRA MSM FORTE	236-251	CHEM
26978418_en	TREATED_USING	knee osteoarthritis	41-60	DISO	ARTRA MSM FORTE	8-23	CHEM
26978418_en	HAS_CAUSE	clinical efficacy and safety of the combined medication	180-235	FINDING	ARTRA MSM FORTE	236-251	CHEM
26978418_en	TREATED_USING	knee osteoarthritis	443-462	DISO	ARTRA MSM FORTE	236-251	CHEM
26978418_en	SUBCLASS_OF	significant improvement	2127-2150	FINDING	positive results	2097-2113	FINDING
26978418_en	SUBCLASS_OF	glucosamine hydrochloride	288-313	CHEM	hydrochloride	300-313	CHEM
26978418_en	USED_IN	MSM	14-17	CHEM	ARTRA MSM	8-17	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	8-17	CHEM	ARTRA	8-13	CHEM
26978418_en	HAS_CAUSE	efficacy and tolerability of the drug	122-159	FINDING	ARTRA MSM FORTE	8-23	CHEM
26978418_en	USED_IN	MSM	242-245	CHEM	ARTRA MSM	236-245	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	236-245	CHEM	ARTRA	236-241	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM FORTE	236-251	CHEM	ARTRA MSM	236-245	CHEM
26978418_en	SUBCLASS_OF	chondroitin sulfate	260-279	CHEM	sulfate	272-279	CHEM
26978418_en	USED_IN	chondroitin	260-271	CHEM	chondroitin sulfate	260-279	CHEM
26978418_en	USED_IN	glucosamine	288-299	CHEM	glucosamine hydrochloride	288-313	CHEM
26978418_en	SUBCLASS_OF	sodium hyaluronate	361-379	CHEM	hyaluronate	368-379	CHEM
26978418_en	USED_IN	sodium	361-367	CHEM	sodium hyaluronate	361-379	CHEM
26978418_en	SUBCLASS_OF	hyaluronic acid	409-424	CHEM	acid	420-424	CHEM
26978418_en	HAS_CAUSE	pain syndrome	577-590	DISO	knee OA	556-563	DISO
26978418_en	HAS_CAUSE	pain syndrome	577-590	DISO	pain	577-581	DISO
26978418_en	ASSOCIATED_WITH	pain	592-596	DISO	pain intensity scores	592-613	FINDING
26978418_en	USED_IN	MSM	991-994	CHEM	ARTRA MSM	985-994	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	985-994	CHEM	ARTRA	985-990	CHEM
26978418_en	ASSOCIATED_WITH	pain	1301-1305	DISO	significant decrease in pain	1277-1305	FINDING
26978418_en	HAS_CAUSE	Reduced pain intensity	1329-1351	FINDING	pain intensity	1337-1351	FINDING
26978418_en	ASSOCIATED_WITH	pain	1337-1341	DISO	pain intensity	1337-1351	FINDING
26978418_en	ASSOCIATED_WITH	pain	1337-1341	DISO	Reduced pain intensity	1329-1351	FINDING
26978418_en	ALTERNATIVE_NAME	significant decrease in pain	1277-1305	FINDING	Reduced pain intensity	1329-1351	FINDING
26978418_en	ASSOCIATED_WITH	stiffness	1473-1482	DISO	diminished stiffness	1462-1482	FINDING
26978418_en	FINDING_OF	alleviated joint function	1519-1544	FINDING	joint function	1530-1544	PHYS
26978418_en	AFFECTS	alleviated joint function	1519-1544	FINDING	joint	1530-1535	ANATOMY
26978418_en	PHYSIOLOGY_OF	joint function	1530-1544	PHYS	joint	1530-1535	ANATOMY
26978418_en	USED_IN	MSM	1760-1763	CHEM	ARTRA MSM	1754-1763	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	1754-1763	CHEM	ARTRA	1754-1759	CHEM
26978418_en	USED_IN	MSM	1843-1846	CHEM	ARTRA MSM	1837-1846	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	1837-1846	CHEM	ARTRA	1837-1842	CHEM
26978418_en	USED_IN	MSM	2038-2041	CHEM	ARTRA MSM	2032-2041	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	2032-2041	CHEM	ARTRA	2032-2037	CHEM
26978418_en	HAS_CAUSE	effect ARTRA MSM occurred more rapidly	1830-1868	FINDING	ARTRA MSM	1837-1846	CHEM
26978418_en	SUBCLASS_OF	positive effect occurred more rapidl	1987-2023	FINDING	evaluations of the efficiency of treatment	1918-1960	FINDING
26978418_en	HAS_CAUSE	no adverse reactions	2263-2283	FINDING	ARTRA MSM	2326-2335	CHEM
26978418_en	HAS_CAUSE	no adverse reactions	2263-2283	FINDING	ARTRA	2619-2624	CHEM
26978418_en	USED_IN	MSM	2539-2542	CHEM	ARTRA MSM	2533-2542	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	2533-2542	CHEM	ARTRA	2533-2538	CHEM
26978418_en	USED_IN	MSM	2649-2652	CHEM	ARTRA MSM	2643-2652	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	2643-2652	CHEM	ARTRA	2643-2648	CHEM
26978418_en	ASSOCIATED_WITH	OA	2693-2695	DISO	may be recommended for the treatment of OA	2653-2695	FINDING
26978418_en	HAS_CAUSE	may be recommended for the treatment of OA	2653-2695	FINDING	ARTRA MSM	2643-2652	CHEM
26978418_en	ASSOCIATED_WITH	pain	2598-2602	DISO	prompter pain relief	2589-2609	FINDING
26978418_en	HAS_CAUSE	evaluations of the efficiency of treatment	2444-2486	FINDING	ARTRA MSM	2326-2335	CHEM
26978418_en	USED_IN	MSM	2332-2335	CHEM	ARTRA MSM	2326-2335	CHEM
26978418_en	SUBCLASS_OF	ARTRA MSM	2326-2335	CHEM	ARTRA	2326-2331	CHEM
26978418_en	HAS_CAUSE	well tolerated	2237-2251	FINDING	ARTRA MSM	2326-2335	CHEM
26978418_en	HAS_CAUSE	well tolerated	2237-2251	FINDING	ARTRA	2619-2624	CHEM
26978418_en	SUBCLASS_OF	significant decrease in pain	1277-1305	FINDING	decrease in pain	1289-1305	FINDING
26978418_en	HAS_CAUSE	rapider in its effect	2339-2360	FINDING	ARTRA MSM	2326-2335	CHEM
26978491_en	SUBCLASS_OF	chronic kidney disease	47-69	DISO	kidney disease	55-69	DISO
26978491_en	ABBREVIATION	cognitive impairment	128-148	DISO	CI	150-152	DISO
26978491_en	PART_OF	vascular	194-202	ANATOMY	vascular-wall	194-207	ANATOMY
26978491_en	SUBCLASS_OF	chronic kidney disease	236-258	DISO	kidney disease	244-258	DISO
26978491_en	ABBREVIATION	chronic kidney disease	236-258	DISO	CKD	260-263	DISO
26978491_en	PHYSIOLOGY_OF	frontal lobe functions	595-617	PHYS	frontal lobe	595-607	ANATOMY
26978491_en	TO_DETECT_OR_STUDY	24h arterial blood pressure monitoring	679-717	LABPROC	arterial blood pressure	683-706	PHYS
26978491_en	PHYSIOLOGY_OF	arterial blood pressure	683-706	PHYS	arterial	683-691	ANATOMY
26978491_en	PHYSIOLOGY_OF	blood pressure	692-706	PHYS	blood	692-697	ANATOMY
26978491_en	PHYSIOLOGY_OF	thickness of carotid intima-media	738-771	PHYS	carotid	751-758	ANATOMY
26978491_en	SUBCLASS_OF	brain MRI	825-834	LABPROC	MRI	831-834	LABPROC
26978491_en	TO_DETECT_OR_STUDY	brain MRI	825-834	LABPROC	brain	825-830	ANATOMY
26978491_en	HAS_CAUSE	CI	1113-1115	DISO	CKD	1080-1083	DISO
26978491_en	AFFECTS	focal lesions	1171-1184	DISO	white matter	1192-1204	ANATOMY
26978491_en	PART_OF	white matter	1192-1204	ANATOMY	brain	1325-1330	ANATOMY
26978491_en	AFFECTS	lateral ventricular dilatation	1249-1279	DISO	lateral ventricular	1249-1268	ANATOMY
26978491_en	PART_OF	brain hemispheres	1325-1342	ANATOMY	brain	1325-1330	ANATOMY
26978491_en	PART_OF	sulci of brain hemispheres	1316-1342	ANATOMY	brain hemispheres	1325-1342	ANATOMY
26978491_en	AFFECTS	dilatation in the sulci of brain hemispheres	1298-1342	DISO	sulci of brain hemispheres	1316-1342	ANATOMY
26978491_en	AFFECTS	left ventricular myocardial hypertrophy	1450-1489	DISO	left ventricular	1450-1466	ANATOMY
26978491_en	PHYSIOLOGY_OF	arterial rigidity	1631-1648	PHYS	arterial	1631-1639	ANATOMY
26978491_en	TO_DETECT_OR_STUDY	MRI	1154-1157	LABPROC	focal lesions	1171-1184	DISO
26978491_en	TO_DETECT_OR_STUDY	MRI	1154-1157	LABPROC	leukoaraiosis	1225-1238	DISO
26978491_en	TO_DETECT_OR_STUDY	MRI	1154-1157	LABPROC	lateral ventricular dilatation	1249-1279	DISO
26978491_en	TO_DETECT_OR_STUDY	MRI	1154-1157	LABPROC	dilatation in the sulci of brain hemispheres	1298-1342	DISO
26978491_en	AFFECTS	atherosclerotic lesions	1565-1588	DISO	common carotid arteries	1592-1615	ANATOMY
26978491_en	AFFECTS	dysfunction of frontal lobes	1734-1762	DISO	frontal lobes	1749-1762	ANATOMY
26978491_en	HAS_CAUSE	CI	867-869	DISO	CKD, stages I-II	919-935	DISO
26978491_en	SUBCLASS_OF	chronic kidney disease (CKD), stages I-IV	236-277	DISO	chronic kidney disease	236-258	DISO
26978491_en	HAS_CAUSE	chronic kidney disease (CKD), stages I-IV	236-277	DISO	vascular-wall remodeling	194-218	DISO
26978491_en	SUBCLASS_OF	CKD, stages I-II	356-372	DISO	CKD	356-359	DISO
26978491_en	SUBCLASS_OF	CKD, stage III	382-396	DISO	CKD	382-385	DISO
26978491_en	SUBCLASS_OF	CKD, stage IV	410-423	DISO	CKD	410-413	DISO
26978491_en	SUBCLASS_OF	CKD, stages I-II	919-935	DISO	CKD	919-922	DISO
26978491_en	SUBCLASS_OF	CKD, stage IV	952-965	DISO	CKD	952-955	DISO
26978491_en	SUBCLASS_OF	CKD, stages III-IV	1014-1032	DISO	CKD	1014-1017	DISO
26978491_en	SUBCLASS_OF	CKD stages I-II	1014-1068	DISO	CKD	1014-1017	DISO
26978491_en	SUBCLASS_OF	CKD, stages III-IV	1822-1840	DISO	CKD	1822-1825	DISO
26978491_en	SUBCLASS_OF	CKD, stages III-IV	1842-1860	DISO	CKD	1842-1845	DISO
26978491_en	AFFECTS	chronic kidney disease	47-69	DISO	kidney	55-61	ANATOMY
26978491_en	SUBCLASS_OF	predialysis stages of chronic kidney disease	25-69	DISO	chronic kidney disease	47-69	DISO
26978491_en	HAS_CAUSE	Cognitive impairment	1-21	DISO	predialysis stages of chronic kidney disease	25-69	DISO
26978491_en	AFFECTS	chronic kidney disease (CKD), stages I-IV	236-277	DISO	kidney	244-250	ANATOMY
26978491_en	HAS_CAUSE	cognitive impairment	128-148	DISO	chronic kidney disease (CKD), stages I-IV	236-277	DISO
26978491_en	HAS_CAUSE	CI	867-869	DISO	CKD, stage IV	952-965	DISO
26978491_en	HAS_CAUSE	CI	983-985	DISO	CKD, stages III-IV	1014-1032	DISO
26978491_en	HAS_CAUSE	CI	983-985	DISO	CKD stages I-II	1014-1068	DISO
26978491_en	HAS_CAUSE	severity of CI was higher	971-996	FINDING	CKD, stages III-IV	1014-1032	DISO
26978491_en	HAS_CAUSE	severity of CI was higher	971-996	FINDING	CKD stages I-II	1014-1068	DISO
26978491_en	HAS_CAUSE	higher the severity of CI	1702-1727	FINDING	increased the CKD severity	1670-1696	FINDING
26978491_en	HAS_CAUSE	development of CI	1787-1804	FINDING	dysfunction of frontal lobes	1734-1762	DISO
26978491_en	HAS_CAUSE	CKD, stages III-IV	1822-1840	DISO	CI	1802-1804	DISO
26978491_en	HAS_CAUSE	CI	1893-1895	DISO	CKD, stages III-IV	1842-1860	DISO
26978491_en	SUBCLASS_OF	predialysis stages	1909-1927	DISO	CKD, stages III-IV	1842-1860	DISO
26978491_en	AFFECTS	vascular-wall remodeling	194-218	DISO	vascular-wall	194-207	ANATOMY
26978491_en	ASSOCIATED_WITH	CI	477-479	DISO	Frequency, severity and character of CI	440-479	FINDING
26978491_en	SUBCLASS_OF	delayed memory	579-593	PHYS	memory	587-593	PHYS
26978491_en	SUBCLASS_OF	short-term memory	564-593	PHYS	memory	587-593	PHYS
26978491_en	ASSOCIATED_WITH	CI	983-985	DISO	severity of CI was higher	971-996	FINDING
26978491_en	SUBCLASS_OF	male sex	1391-1399	PHYS	sex	1396-1399	PHYS
26978491_en	ASSOCIATED_WITH	CI	1529-1531	DISO	frequency and severity of CI	1503-1531	FINDING
26978491_en	ALTERNATIVE_NAME	atherosclerotic lesions	1565-1588	DISO	atherosclerotic	1565-1580	DISO
26978491_en	SUBCLASS_OF	atherosclerotic lesions	1565-1588	DISO	lesions	1581-1588	DISO
26978491_en	SUBCLASS_OF	common carotid arteries	1592-1615	ANATOMY	carotid arteries	1599-1615	ANATOMY
26978491_en	FINDING_OF	pulse-wave velocity	781-800	FINDING	pulse-wave	781-791	PHYS
26978491_en	ALTERNATIVE_NAME	sulci of brain hemispheres	1316-1342	ANATOMY	sulci	1316-1321	ANATOMY
26978491_en	SUBCLASS_OF	abdominal obesity	1431-1448	DISO	obesity	1441-1448	DISO
26978491_en	AFFECTS	abdominal obesity	1431-1448	DISO	abdominal	1431-1440	ANATOMY
26978491_en	SUBCLASS_OF	left ventricular	1450-1466	ANATOMY	ventricular	1455-1466	ANATOMY
26978491_en	ASSOCIATED_WITH	male sex	1391-1399	PHYS	CI	1384-1386	DISO
26978491_en	HAS_CAUSE	hyperhomocysteinemia	1401-1421	DISO	CI	1384-1386	DISO
26978491_en	HAS_CAUSE	anemia	1423-1429	DISO	CI	1384-1386	DISO
26978491_en	HAS_CAUSE	abdominal obesity	1431-1448	DISO	CI	1384-1386	DISO
26978491_en	HAS_CAUSE	left ventricular myocardial hypertrophy	1450-1489	DISO	CI	1384-1386	DISO
26978491_en	ASSOCIATED_WITH	age	1494-1497	PHYS	CI	1384-1386	DISO
26978491_en	ASSOCIATED_WITH	atherosclerotic lesions	1565-1588	DISO	frequency and severity of CI	1503-1531	FINDING
26978491_en	SUBCLASS_OF	carotid arteries	1599-1615	ANATOMY	arteries	1607-1615	ANATOMY
26978491_en	FINDING_OF	frequency and severity of CI	1503-1531	FINDING	arterial rigidity	1631-1648	PHYS
26978491_en	ASSOCIATED_WITH	CKD	1684-1687	DISO	increased the CKD severity	1670-1696	FINDING
26978491_en	ASSOCIATED_WITH	CI	1725-1727	DISO	higher the severity of CI	1702-1727	FINDING
26978491_en	SUBCLASS_OF	dysfunction of frontal lobes	1734-1762	DISO	dysfunction	1734-1745	DISO
26978491_en	ASSOCIATED_WITH	CI	1893-1895	DISO	independent predictor of CI	1868-1895	FINDING
26978491_en	HAS_CAUSE	independent predictor of CI	1868-1895	FINDING	CKD, stages III-IV	1842-1860	DISO
26978491_en	SUBCLASS_OF	frontal lobe	595-607	ANATOMY	lobe	603-607	ANATOMY
26978491_en	ASSOCIATED_WITH	CI	1113-1115	DISO	predicted the development of CI	1084-1115	FINDING
26978491_en	ASSOCIATED_WITH	CKD	1080-1083	DISO	predicted the development of CI	1084-1115	FINDING
26978491_en	ASSOCIATED_WITH	cognitive impairment	128-148	DISO	development and progression of cognitive impairment	97-148	FINDING
26978491_en	ASSOCIATED_WITH	cognitive impairment	128-148	DISO	risk factors	159-171	FINDING
26978498_en	SUBCLASS_OF	chronic brain ischemia	96-118	DISO	brain ischemia	104-118	DISO
26978498_en	AFFECTS	chronic brain ischemia	96-118	DISO	brain	104-109	ANATOMY
26978498_en	ALTERNATIVE_NAME	agomelatine	174-185	CHEM	valdoxan	187-195	CHEM
26978498_en	AFFECTS	chronic brain ischemia	253-275	DISO	brain	261-266	ANATOMY
26978498_en	SUBCLASS_OF	chronic brain ischemia	253-275	DISO	brain ischemia	261-275	DISO
26978498_en	ABBREVIATION	chronic brain ischemia	253-275	DISO	CBI	277-280	DISO
26978498_en	TREATED_USING	depression	81-91	DISO	agomelatine	35-46	CHEM
26978498_en	ALTERNATIVE_NAME	Agomelatine	1121-1132	CHEM	valdoxan	1134-1142	CHEM
26978498_en	TREATED_USING	sleep	1258-1263	PHYS	Agomelatine	1237-1248	CHEM
26978498_en	HAS_CAUSE	anxiety symptoms	1307-1323	DISO	anxiety	1307-1314	DISO
26978498_en	HAS_CAUSE	reduced anxiety symptoms	1299-1323	FINDING	Agomelatine	1237-1248	CHEM
26978498_en	HAS_CAUSE	improved sleep	1249-1263	FINDING	Agomelatine	1237-1248	CHEM
26978498_en	TREATED_USING	anxiety symptoms	1307-1323	DISO	Agomelatine	1237-1248	CHEM
26978498_en	TREATED_USING	depressive symptoms	1344-1363	DISO	Agomelatine	1237-1248	CHEM
26978498_en	HAS_CAUSE	improvement of cognitive functions	1387-1421	FINDING	Agomelatine	1237-1248	CHEM
26978498_en	HAS_CAUSE	No side-effects	1441-1456	FINDING	Agomelatine	1237-1248	CHEM
26978498_en	ALTERNATIVE_NAME	improvement of cognitive functions	1387-1421	FINDING	positive effect on cognitive functions	1688-1726	FINDING
26978498_en	ABBREVIATION	chronic brain ischemia	1593-1615	DISO	CBI	1794-1797	DISO
26978498_en	TREATED_USING	anxiety	1653-1660	DISO	agomelatine	1752-1763	CHEM
26978498_en	TREATED_USING	depression	1662-1672	DISO	agomelatine	1752-1763	CHEM
26978498_en	TREATED_USING	insomnia	1674-1682	DISO	agomelatine	1752-1763	CHEM
26978498_en	HAS_CAUSE	high antidepressive activity	1496-1524	FINDING	agomelatine	1752-1763	CHEM
26978498_en	HAS_CAUSE	positive effect on cognitive functions	1688-1726	FINDING	agomelatine	1752-1763	CHEM
26978498_en	SUBCLASS_OF	CBI stage I	414-426	DISO	CBI	414-417	DISO
26978498_en	SUBCLASS_OF	CBI stage II	448-461	DISO	CBI	448-451	DISO
26978498_en	AFFECTS	chronic brain ischemia	1593-1615	DISO	brain	1601-1606	ANATOMY
26978498_en	SUBCLASS_OF	chronic brain ischemia	1593-1615	DISO	brain ischemia	1601-1615	DISO
26978498_en	TREATED_USING	mild depressive states	213-235	DISO	agomelatine	174-185	CHEM
26978498_en	HAS_CAUSE	efficacy and tolerability of agomelatine	145-185	FINDING	agomelatine	174-185	CHEM
26978498_en	SUBCLASS_OF	mild depressive states	213-235	DISO	depressive states	218-235	DISO
26978498_en	ALTERNATIVE_NAME	depressive states	218-235	DISO	depressive	218-228	DISO
26978498_en	SUBCLASS_OF	brain ischemia	261-275	DISO	ischemia	267-275	DISO
26978498_en	SUBCLASS_OF	brain ischemia	104-118	DISO	ischemia	110-118	DISO
26978498_en	SUBCLASS_OF	depressive episode of mild severity	489-524	DISO	depressive episode	489-507	DISO
26978498_en	HAS_CAUSE	depressive episode	489-507	DISO	depressive	489-499	DISO
26978498_en	SUBCLASS_OF	night sleep	740-751	PHYS	sleep	746-751	PHYS
26978498_en	ASSOCIATED_WITH	anxiety symptoms	1307-1323	DISO	reduced anxiety symptoms	1299-1323	FINDING
26978498_en	FINDING_OF	improved sleep	1249-1263	FINDING	sleep	1258-1263	PHYS
26978498_en	HAS_CAUSE	depressive symptoms	1344-1363	DISO	depressive	1344-1354	DISO
26978498_en	SUBCLASS_OF	high antidepressive activity	1496-1524	FINDING	antidepressive activity	1501-1524	FINDING
26978498_en	SUBCLASS_OF	mild depressive states	1553-1575	DISO	depressive states	1558-1575	DISO
26978498_en	SUBCLASS_OF	brain ischemia	1601-1615	DISO	ischemia	1607-1615	DISO
26978498_en	HAS_CAUSE	balanced spectrum of effects on anxiety, depression, insomnia	1621-1682	FINDING	agomelatine	1752-1763	CHEM
26978498_en	ASSOCIATED_WITH	anxiety	1653-1660	DISO	balanced spectrum of effects on anxiety, depression, insomnia	1621-1682	FINDING
26978498_en	ASSOCIATED_WITH	depression	1662-1672	DISO	balanced spectrum of effects on anxiety, depression, insomnia	1621-1682	FINDING
26978498_en	ASSOCIATED_WITH	insomnia	1674-1682	DISO	balanced spectrum of effects on anxiety, depression, insomnia	1621-1682	FINDING
26978498_en	HAS_CAUSE	recommend agomelatine in treatment of patients	1742-1788	FINDING	agomelatine	1752-1763	CHEM
26978498_en	ASSOCIATED_WITH	CBI	1794-1797	DISO	recommend agomelatine in treatment of patients	1742-1788	FINDING
26978499_en	AFFECTS	brain ischemia	55-69	DISO	brain	55-60	ANATOMY
26978499_en	AFFECTS	brain ischemia	230-244	DISO	brain	230-235	ANATOMY
26978499_en	AFFECTS	brain ischemia	350-364	DISO	brain	350-355	ANATOMY
26978499_en	TO_DETECT_OR_STUDY	Neurophysiological examination	740-770	LABPROC	autonomic changes	647-664	PHYS
26978499_en	TO_DETECT_OR_STUDY	Neurophysiological examination	740-770	LABPROC	Neurological status	626-645	PHYS
26978499_en	AFFECTS	vascular disorders	1127-1145	DISO	vascular	1127-1135	ANATOMY
26978499_en	AFFECTS	brain ischemia	1345-1359	DISO	brain	1345-1350	ANATOMY
26978499_en	HAS_CAUSE	positive dynamics of the decrease of psychoautonomic symptoms	892-953	FINDING	teraligen	471-480	CHEM
26978499_en	HAS_CAUSE	Good tolerability	1056-1073	FINDING	teraligen	471-480	CHEM
26978499_en	HAS_CAUSE	no side-effects	1078-1093	FINDING	teraligen	471-480	CHEM
26978499_en	USED_IN	EEG	772-775	LABPROC	Neurophysiological examination	740-770	LABPROC
26978499_en	TREATED_USING	psychoautonomic syndrome	92-116	DISO	teraligen	28-37	CHEM
26978499_en	TREATED_USING	psychoautonomic syndrome	193-217	DISO	teraligen	166-175	CHEM
26978499_en	TREATED_USING	brain ischemia	230-244	DISO	teraligen	166-175	CHEM
26978499_en	SUBCLASS_OF	brain ischemia, stages I and II	55-86	DISO	brain ischemia	55-69	DISO
26978499_en	SUBCLASS_OF	brain ischemia	55-69	DISO	ischemia	61-69	DISO
26978499_en	TREATED_USING	brain ischemia, stages I and II	55-86	DISO	teraligen	28-37	CHEM
26978499_en	HAS_CAUSE	efficacy and safety of teraligen	5-37	FINDING	teraligen	28-37	CHEM
26978499_en	HAS_CAUSE	efficacy and safety of teraligen	143-175	FINDING	teraligen	166-175	CHEM
26978499_en	SUBCLASS_OF	brain ischemia	230-244	DISO	ischemia	236-244	DISO
26978499_en	SUBCLASS_OF	brain ischemia	350-364	DISO	ischemia	356-364	DISO
26978499_en	SUBCLASS_OF	brain ischemia, stages I and II	350-381	DISO	brain ischemia	350-364	DISO
26978499_en	SUBCLASS_OF	P300 event-related potential	780-808	LABPROC	event-related potential	785-808	LABPROC
26978499_en	ASSOCIATED_WITH	cephalgic syndrome	955-973	DISO	positive dynamics of the decrease of psychoautonomic symptoms	892-953	FINDING
26978499_en	FINDING_OF	sleep normalization	975-994	FINDING	sleep	975-980	PHYS
26978499_en	SUBCLASS_OF	decrease of psychoautonomic symptoms, cephalgic syndrome	917-973	FINDING	positive dynamics of the decrease of psychoautonomic symptoms	892-953	FINDING
26978499_en	SUBCLASS_OF	sleep normalization	975-994	FINDING	positive dynamics of the decrease of psychoautonomic symptoms	892-953	FINDING
26978499_en	SUBCLASS_OF	improvement of cognitive function	1010-1043	FINDING	positive dynamics of the decrease of psychoautonomic symptoms	892-953	FINDING
26978499_en	ASSOCIATED_WITH	psychoautonomic symptoms	929-953	DISO	decrease of psychoautonomic symptoms, cephalgic syndrome	917-973	FINDING
26978499_en	ASSOCIATED_WITH	cephalgic syndrome	955-973	DISO	decrease of psychoautonomic symptoms, cephalgic syndrome	917-973	FINDING
26978499_en	SUBCLASS_OF	vascular disorders	1127-1145	DISO	disorders	1136-1145	DISO
26978499_en	SUBCLASS_OF	brain ischemia, stages I and II	1345-1376	DISO	brain ischemia	1345-1359	DISO
26978499_en	SUBCLASS_OF	brain ischemia	1345-1359	DISO	ischemia	1351-1359	DISO
26978499_en	ASSOCIATED_WITH	psychoautonomic syndrome	1295-1319	DISO	recommended for treatment of psychoautonomic syndrome	1266-1319	FINDING
26978499_en	ORIGINS_FROM	positive dynamics of the decrease of psychoautonomic symptoms	892-953	FINDING	neurophysiological examinations	1216-1247	LABPROC
26978499_en	ORIGINS_FROM	improvement of cognitive function	1010-1043	FINDING	neurophysiological examinations	1216-1247	LABPROC
26978504_en	AFFECTS	low-back pain	86-99	DISO	low-back	86-94	ANATOMY
26978504_en	AFFECTS	low-back pain	259-272	DISO	low-back	259-267	ANATOMY
26978504_en	SUBCLASS_OF	spinal osteochondrosis	396-418	DISO	osteochondrosis	403-418	DISO
26978504_en	AFFECTS	spinal osteochondrosis	396-418	DISO	spinal	396-402	ANATOMY
26978504_en	HAS_CAUSE	root syndrome	424-437	DISO	spinal osteochondrosis	396-418	DISO
26978504_en	AFFECTS	radiculopathia	442-456	DISO	lumbar/sacral spine	464-483	ANATOMY
26978504_en	SUBCLASS_OF	pain syndrome	489-502	DISO	pain	489-493	DISO
26978504_en	HAS_CAUSE	pain syndrome	489-502	DISO	radiculopathia	442-456	DISO
26978504_en	ALTERNATIVE_NAME	reduction of pain syndrome	1328-1354	FINDING	pain reduction	1515-1529	FINDING
26978504_en	HAS_CAUSE	high clinical efficacy of electrode pharmaphoresis	1185-1235	FINDING	mydocalm-richter	1254-1270	CHEM
26978504_en	HAS_CAUSE	radiculopathia	442-456	DISO	spinal osteochondrosis	396-418	DISO
26978504_en	HAS_CAUSE	clinical efficacy and tolerability of electrode pharmaphoresis	124-186	FINDING	xefocam	206-213	CHEM
26978504_en	HAS_CAUSE	clinical efficacy and tolerability of electrode pharmaphoresis	124-186	FINDING	mydocalm-richter	218-234	CHEM
26978504_en	HAS_CAUSE	increased significantly	1599-1622	FINDING	pain reduction	1515-1529	FINDING
26978504_en	SUBCLASS_OF	low-back pain	86-99	DISO	pain	95-99	DISO
26978504_en	PART_OF	low-back	86-94	ANATOMY	back	90-94	ANATOMY
26978504_en	SUBCLASS_OF	low-back pain	259-272	DISO	pain	268-272	DISO
26978504_en	SUBCLASS_OF	low-back	259-267	ANATOMY	back	263-267	ANATOMY
26978504_en	AFFECTS	root syndrome	424-437	DISO	root	424-428	ANATOMY
26978504_en	SUBCLASS_OF	lumbar/sacral spine	464-483	ANATOMY	spine	478-483	ANATOMY
26978504_en	PART_OF	lumbar	464-470	ANATOMY	lumbar/sacral spine	464-483	ANATOMY
26978504_en	PART_OF	sacral	471-477	ANATOMY	lumbar/sacral spine	464-483	ANATOMY
26978504_en	AFFECTS	pain syndrome	489-502	DISO	lumbar/sacral spine	464-483	ANATOMY
26978504_en	HAS_CAUSE	pain syndrome	582-595	DISO	pain	582-586	DISO
26978504_en	ASSOCIATED_WITH	pain syndrome	582-595	DISO	Treatment efficacy	531-549	FINDING
26978504_en	ASSOCIATED_WITH	Quality-of-life	707-722	PHYS	life	718-722	PHYS
26978504_en	SUBCLASS_OF	solution for injections	1006-1029	CHEM	solution	1006-1014	CHEM
26978504_en	SUBCLASS_OF	solution for injections	1078-1101	CHEM	solution	1078-1086	CHEM
26978504_en	PART_OF	lumbar/sacral spine	1137-1156	ANATOMY	spine	1151-1156	ANATOMY
26978504_en	PART_OF	lumbar	1137-1143	ANATOMY	lumbar/sacral spine	1137-1156	ANATOMY
26978504_en	PART_OF	sacral	1144-1150	ANATOMY	lumbar/sacral spine	1137-1156	ANATOMY
26978504_en	ORIGINS_FROM	mydocalm-richter	1060-1076	CHEM	lumbar/sacral spine	1137-1156	ANATOMY
26978504_en	APPLIED_TO	xefocam	997-1004	CHEM	lumbar/sacral spine	1137-1156	ANATOMY
26978504_en	SUBCLASS_OF	mydocalm-richter	1254-1270	CHEM	mydocalm	1254-1262	CHEM
26978504_en	SUBCLASS_OF	mydocalm-richter	1060-1076	CHEM	mydocalm	1060-1068	CHEM
26978504_en	HAS_CAUSE	high clinical efficacy of electrode pharmaphoresis	1185-1235	FINDING	xefocam	1242-1249	CHEM
26978504_en	HAS_CAUSE	pain syndrome	1341-1354	DISO	pain	1341-1345	DISO
26978504_en	ASSOCIATED_WITH	pain syndrome	1341-1354	DISO	reduction of pain syndrome	1328-1354	FINDING
26978504_en	ASSOCIATED_WITH	Pain	1372-1376	DISO	reduced to mild grade	1390-1411	FINDING
26978504_en	HAS_CAUSE	quality of self-service	1556-1579	FINDING	increased significantly	1599-1622	FINDING
26978504_en	HAS_CAUSE	increased significantly	1599-1622	FINDING	quality of self-service	1556-1579	FINDING
26978504_en	ASSOCIATED_WITH	pain	1515-1519	DISO	pain reduction	1515-1529	FINDING
26978504_en	SUBCLASS_OF	high clinical efficacy of electrode pharmaphoresis	1185-1235	FINDING	clinical efficacy of electrode pharmaphoresis	1190-1235	FINDING
26978639_en	SUBCLASS_OF	chronic cerebral ischemia	93-118	DISO	cerebral ischemia	101-118	DISO
26978639_en	AFFECTS	chronic cerebral ischemia	93-118	DISO	cerebral	101-109	ANATOMY
26978639_en	SUBCLASS_OF	chronic cerebral ischemia	285-310	DISO	cerebral ischemia	293-310	DISO
26978639_en	AFFECTS	chronic cerebral ischemia	285-310	DISO	cerebral	293-301	ANATOMY
26978639_en	ABBREVIATION	chronic cerebral ischemia	285-310	DISO	CCI	312-315	DISO
26978639_en	ABBREVIATION	post-infarct cardiosclerosis	655-683	DISO	PICS	685-689	DISO
26978639_en	HAS_CAUSE	infarct	660-667	DISO	post-infarct cardiosclerosis	655-683	DISO
26978639_en	ABBREVIATION	peptic ulcer disease	771-791	DISO	PUD	793-796	DISO
26978639_en	ORIGINS_FROM	cholesterol	175-186	CHEM	plasma	168-174	ANATOMY
26978639_en	ORIGINS_FROM	triglyceride	191-203	CHEM	plasma	168-174	ANATOMY
26978639_en	ORIGINS_FROM	cholesterol	947-958	CHEM	Plasma	940-946	ANATOMY
26978639_en	ORIGINS_FROM	triglyceride	963-975	CHEM	Plasma	940-946	ANATOMY
26978639_en	ORIGINS_FROM	cholesterol	1252-1263	CHEM	plasma	1245-1251	ANATOMY
26978639_en	ORIGINS_FROM	triglyceride	1268-1280	CHEM	plasma	1245-1251	ANATOMY
26978639_en	HAS_CAUSE	cognitive impairment	1319-1339	DISO	plasma cholesterol and triglyceride levels	1245-1287	PHYS
26978639_en	PHYSIOLOGY_OF	cholesterol and triglyceride levels	947-982	PHYS	Plasma	940-946	ANATOMY
26978639_en	FINDING_OF	correlations between plasma cholesterol and triglyceride levels	147-210	FINDING	plasma cholesterol and triglyceride levels	168-210	PHYS
26978639_en	HAS_CAUSE	higher level of neurotization	1110-1139	FINDING	psychosomatic illnesses	1177-1200	DISO
26978639_en	HAS_CAUSE	Cognitive impairment	1085-1105	DISO	psychosomatic illnesses	1177-1200	DISO
26978639_en	SUBCLASS_OF	cerebral ischemia	101-118	DISO	ischemia	110-118	DISO
26978639_en	ASSOCIATED_WITH	lipid profile	5-18	PHYS	lipid	5-10	CHEM
26978639_en	PHYSIOLOGY_OF	plasma cholesterol and triglyceride levels	168-210	PHYS	plasma	168-174	ANATOMY
26978639_en	ASSOCIATED_WITH	plasma cholesterol and triglyceride levels	168-210	PHYS	triglyceride	191-203	CHEM
26978639_en	ASSOCIATED_WITH	plasma cholesterol and triglyceride levels	168-210	PHYS	cholesterol	175-186	CHEM
26978639_en	HAS_CAUSE	correlations between plasma cholesterol and triglyceride levels	147-210	FINDING	cholesterol	175-186	CHEM
26978639_en	HAS_CAUSE	correlations between plasma cholesterol and triglyceride levels	147-210	FINDING	triglyceride	191-203	CHEM
26978639_en	SUBCLASS_OF	cerebral ischemia	293-310	DISO	ischemia	302-310	DISO
26978639_en	TO_DETECT_OR_STUDY	cholesterol and triglyceride tests	478-512	LABPROC	triglyceride	494-506	CHEM
26978639_en	TO_DETECT_OR_STUDY	cholesterol and triglyceride tests	478-512	LABPROC	cholesterol	478-489	CHEM
26978639_en	ASSOCIATED_WITH	Cholesterol levels	607-625	PHYS	Cholesterol	607-618	CHEM
26978639_en	HAS_CAUSE	Cholesterol levels were higher	607-637	FINDING	Cholesterol	607-618	CHEM
26978639_en	SUBCLASS_OF	post-infarct cardiosclerosis	655-683	DISO	cardiosclerosis	668-683	DISO
26978639_en	ASSOCIATED_WITH	Triglyceride levels	800-819	PHYS	Triglyceride	800-812	CHEM
26978639_en	FINDING_OF	Triglyceride levels were high	800-829	FINDING	Triglyceride levels	800-819	PHYS
26978639_en	HAS_CAUSE	Triglyceride levels were high	800-829	FINDING	Triglyceride	800-812	CHEM
26978639_en	FINDING_OF	Cholesterol levels were higher	607-637	FINDING	Cholesterol levels	607-625	PHYS
26978639_en	ASSOCIATED_WITH	cholesterol and triglyceride levels	947-982	PHYS	triglyceride	963-975	CHEM
26978639_en	ASSOCIATED_WITH	cholesterol and triglyceride levels	947-982	PHYS	cholesterol	947-958	CHEM
26978639_en	ASSOCIATED_WITH	neurotization	1126-1139	DISO	higher level of neurotization	1110-1139	FINDING
26978639_en	ASSOCIATED_WITH	plasma cholesterol and triglyceride levels	1245-1287	PHYS	cholesterol	1252-1263	CHEM
26978639_en	ASSOCIATED_WITH	plasma cholesterol and triglyceride levels	1245-1287	PHYS	triglyceride	1268-1280	CHEM
26978639_en	PHYSIOLOGY_OF	plasma cholesterol and triglyceride levels	1245-1287	PHYS	plasma	1245-1251	ANATOMY
26978639_en	ASSOCIATED_WITH	post-infarct cardiosclerosis	655-683	DISO	Cholesterol levels were higher	607-637	FINDING
26978639_en	FINDING_OF	not differ from those of patients with peptic ulcer disease	732-791	FINDING	Cholesterol levels	607-625	PHYS
26978639_en	SUBCLASS_OF	peptic ulcer disease	771-791	DISO	ulcer disease	778-791	DISO
26978639_en	FINDING_OF	higher levels in the patients with PICS	865-904	FINDING	Triglyceride levels	800-819	PHYS
26978639_en	ASSOCIATED_WITH	PICS	900-904	DISO	higher levels in the patients with PICS	865-904	FINDING
26978639_en	FINDING_OF	not correlated with assessments of cognitive functions	988-1042	FINDING	cholesterol and triglyceride levels	947-982	PHYS
26978639_en	ASSOCIATED_WITH	cognitive impairment	1319-1339	DISO	prognostic factor for cognitive impairment	1297-1339	FINDING
27022660_en	ALTERNATIVE_NAME	granulomatosis with polyangiitis	33-65	DISO	Wegener's granulomatosis	67-91	DISO
27022660_en	ABBREVIATION	Granulomatosis with polyangiitis	96-128	DISO	GPA	130-133	DISO
27022660_en	ALTERNATIVE_NAME	Granulomatosis with polyangiitis	96-128	DISO	Wegener's granulomatosis	162-186	DISO
27022660_en	SUBCLASS_OF	small and medium-sized vessels	232-262	ANATOMY	vessels	255-262	ANATOMY
27022660_en	AFFECTS	necrotizing vasculitis	206-228	DISO	small and medium-sized vessels	232-262	ANATOMY
27022660_en	SUBCLASS_OF	Granulomatosis with polyangiitis	96-128	DISO	necrotizing vasculitis	206-228	DISO
27022660_en	HAS_CAUSE	granulomatous inflammation	315-341	DISO	Granulomatosis with polyangiitis	96-128	DISO
27022660_en	AFFECTS	GPA	371-374	DISO	organ of vision	382-397	ANATOMY
27022660_en	AFFECTS	inflammation	567-579	DISO	ocular superficial structures	587-616	ANATOMY
27022660_en	AFFECTS	inflammation	567-579	DISO	orbital	646-653	ANATOMY
27022660_en	AFFECTS	inflammation	567-579	DISO	ocular	658-664	ANATOMY
27022660_en	AFFECTS	GPA	733-736	DISO	organ of vision	767-782	ANATOMY
27022660_en	PART_OF	fibrous tunic	1024-1037	ANATOMY	eyeball:	1045-1053	ANATOMY
27022660_en	AFFECTS	lesions	955-962	DISO	conjunctiva	1008-1019	ANATOMY
27022660_en	AFFECTS	lesions	955-962	DISO	fibrous tunic	1024-1037	ANATOMY
27022660_en	AFFECTS	lesions	955-962	DISO	retina	1070-1076	ANATOMY
27022660_en	SUBCLASS_OF	optic nerve	1094-1105	ANATOMY	nerve	1100-1105	ANATOMY
27022660_en	AFFECTS	lesions	955-962	DISO	optic nerve	1094-1105	ANATOMY
27022660_en	HAS_CAUSE	inflammatory infiltration	1203-1228	DISO	dacryoadenitis	1176-1190	DISO
27022660_en	AFFECTS	inflammatory infiltration	1203-1228	DISO	surrounding tissues	1236-1255	ANATOMY
27022660_en	AFFECTS	inflammatory infiltration	1203-1228	DISO	oculomotor muscles	1267-1285	ANATOMY
27022660_en	SUBCLASS_OF	necrotizing scleritis	1481-1502	DISO	scleritis	1493-1502	DISO
27022660_en	AFFECTS	stromal keratitis	1529-1546	DISO	stromal	1529-1536	ANATOMY
27022660_en	AFFECTS	compression of the orbit	1688-1712	DISO	orbit	1707-1712	ANATOMY
27022660_en	HAS_CAUSE	reduce quality of life	427-449	FINDING	GPA	371-374	DISO
27022660_en	HAS_CAUSE	fatal outcome	507-520	FINDING	GPA	371-374	DISO
27022660_en	HAS_CAUSE	inflammation	567-579	DISO	GPA	371-374	DISO
27022660_en	HAS_CAUSE	complete blindness	687-705	DISO	GPA	371-374	DISO
27022660_en	HAS_CAUSE	blindness bilateral	696-726	DISO	GPA	371-374	DISO
27022660_en	HAS_CAUSE	dacryoadenitis	1176-1190	DISO	Orbital affection	1107-1124	DISO
27022660_en	HAS_CAUSE	inflammatory infiltration	1203-1228	DISO	Orbital affection	1107-1124	DISO
27022660_en	HAS_CAUSE	destruction of orbital bony walls	1291-1324	DISO	Orbital affection	1107-1124	DISO
27022660_en	HAS_CAUSE	conjunctivitis	1338-1352	DISO	Orbital affection	1107-1124	DISO
27022660_en	HAS_CAUSE	episcleritis	1357-1369	DISO	Orbital affection	1107-1124	DISO
27022660_en	PART_OF	fibrous tunic	1413-1426	ANATOMY	eyeball	1434-1441	ANATOMY
27022660_en	AFFECTS	Affection of the fibrous tunic	1396-1426	DISO	fibrous tunic	1413-1426	ANATOMY
27022660_en	AFFECTS	Affection of the fibrous tunic	1396-1426	DISO	eyeball	1434-1441	ANATOMY
27022660_en	HAS_CAUSE	peripheral ulcerative keratitis	1504-1546	DISO	Affection of the fibrous tunic	1396-1426	DISO
27022660_en	HAS_CAUSE	stromal keratitis	1529-1546	DISO	Affection of the fibrous tunic	1396-1426	DISO
27022660_en	HAS_CAUSE	compression of the orbit	1688-1712	DISO	inflamed	1716-1724	DISO
27022660_en	AFFECTS	compression of the orbit	1688-1712	DISO	optic nerve	1640-1651	ANATOMY
27022660_en	ASSOCIATED_WITH	quality of life	434-449	PHYS	life	445-449	PHYS
27022660_en	FINDING_OF	reduce quality of life	427-449	FINDING	quality of life	434-449	PHYS
27022660_en	SUBCLASS_OF	granulomatous inflammation	315-341	DISO	inflammation	329-341	DISO
27022660_en	SUBCLASS_OF	Wegener's granulomatosis	162-186	DISO	granulomatosis	172-186	DISO
27022660_en	SUBCLASS_OF	necrotizing vasculitis	206-228	DISO	vasculitis	218-228	DISO
27022660_en	FINDING_OF	fatal outcome	507-520	FINDING	fatal	507-512	PHYS
27022660_en	HAS_CAUSE	inflammatory infiltration	1203-1228	DISO	inflammatory	1203-1215	DISO
27022660_en	ALTERNATIVE_NAME	inflammatory	1203-1215	DISO	inflamed	1716-1724	DISO
27022660_en	ALTERNATIVE_NAME	inflammation	567-579	DISO	inflammatory	1203-1215	DISO
27022660_en	SUBCLASS_OF	granulomatosis with polyangiitis	33-65	DISO	granulomatosis	33-47	DISO
27022660_en	SUBCLASS_OF	granulomatosis with polyangiitis	33-65	DISO	polyangiitis	53-65	DISO
27022660_en	SUBCLASS_OF	Wegener's granulomatosis	67-91	DISO	granulomatosis	77-91	DISO
27022660_en	SUBCLASS_OF	Granulomatosis with polyangiitis	96-128	DISO	Granulomatosis	96-110	DISO
27022660_en	SUBCLASS_OF	Granulomatosis with polyangiitis	96-128	DISO	polyangiitis	116-128	DISO
27022660_en	PART_OF	ocular superficial structures	587-616	ANATOMY	ocular	587-593	ANATOMY
27022660_en	PART_OF	orbital	646-653	ANATOMY	ocular	658-664	ANATOMY
27022660_en	ALTERNATIVE_NAME	organ of vision	382-397	ANATOMY	ocular	587-593	ANATOMY
27022660_en	SUBCLASS_OF	complete blindness	687-705	DISO	blindness	696-705	DISO
27022660_en	SUBCLASS_OF	blindness bilateral	696-726	DISO	blindness	696-705	DISO
27022660_en	PHYSIOLOGY_OF	vision	776-782	PHYS	organ of vision	767-782	ANATOMY
27022660_en	AFFECTS	lesions of the orbit and appendages	955-990	DISO	orbit	970-975	ANATOMY
27022660_en	AFFECTS	lesions of the orbit and appendages	955-990	DISO	appendages	980-990	ANATOMY
27022660_en	SUBCLASS_OF	lesions of the orbit and appendages	955-990	DISO	lesions	955-962	DISO
27022660_en	AFFECTS	Orbital affection	1107-1124	DISO	Orbital	1107-1114	ANATOMY
27022660_en	HAS_CAUSE	granulomas	1164-1174	DISO	Orbital affection	1107-1124	DISO
27022660_en	SUBCLASS_OF	surrounding tissues	1236-1255	ANATOMY	tissues	1248-1255	ANATOMY
27022660_en	SUBCLASS_OF	oculomotor muscles	1267-1285	ANATOMY	muscles	1278-1285	ANATOMY
27022660_en	PHYSIOLOGY_OF	oculomotor	1267-1277	PHYS	oculomotor muscles	1267-1285	ANATOMY
27022660_en	PART_OF	orbital bony walls	1306-1324	ANATOMY	orbital	1306-1313	ANATOMY
27022660_en	AFFECTS	destruction of orbital bony walls	1291-1324	DISO	orbital bony walls	1306-1324	ANATOMY
27022660_en	SUBCLASS_OF	orbital bony walls	1306-1324	ANATOMY	bony walls	1314-1324	ANATOMY
27022660_en	SUBCLASS_OF	fibrous tunic	1413-1426	ANATOMY	tunic	1421-1426	ANATOMY
27022660_en	SUBCLASS_OF	necrotizing scleritis	1481-1502	DISO	necrotizing	1481-1492	DISO
27022660_en	HAS_CAUSE	necrotizing scleritis	1481-1502	DISO	Affection of the fibrous tunic	1396-1426	DISO
27022660_en	SUBCLASS_OF	stromal keratitis	1529-1546	DISO	keratitis	1537-1546	DISO
27022660_en	SUBCLASS_OF	peripheral ulcerative keratitis	1504-1546	DISO	keratitis	1537-1546	DISO
27022660_en	SUBCLASS_OF	optic nerve	1640-1651	ANATOMY	nerve	1646-1651	ANATOMY
27022660_en	AFFECTS	inflamed	1716-1724	DISO	tissue	1725-1731	ANATOMY
27022660_en	PART_OF	tissue	1725-1731	ANATOMY	orbit	1707-1712	ANATOMY
27022660_en	ASSOCIATED_WITH	complications	485-498	DISO	lead to the severest complications	464-498	FINDING
27022660_en	HAS_CAUSE	lead to the severest complications	464-498	FINDING	GPA	371-374	DISO
27022660_en	HAS_CAUSE	complications	485-498	DISO	GPA	371-374	DISO
27022660_en	PART_OF	oculomotor muscles	1267-1285	ANATOMY	surrounding tissues	1236-1255	ANATOMY
27029445_en	AFFECTS	lesions of carotid arteries	332-359	DISO	carotid arteries	343-359	ANATOMY
27029445_en	PART_OF	carotid arteries	343-359	ANATOMY	carotid	343-350	ANATOMY
27029445_en	SUBCLASS_OF	one-photon emission computed tomography	621-660	LABPROC	computed tomography	641-660	LABPROC
27029445_en	TO_DETECT_OR_STUDY	one-photon emission computed tomography	621-660	LABPROC	cerebral perfusion	586-604	PHYS
27029445_en	SUBCLASS_OF	ischemic strokes	878-894	DISO	strokes	887-894	DISO
27029445_en	SUBCLASS_OF	asymptotic post-surgery ischemic strokes	854-894	DISO	ischemic strokes	878-894	DISO
27029445_en	SUBCLASS_OF	post-surgery ischemic strokes	865-894	DISO	ischemic strokes	878-894	DISO
27029445_en	PART_OF	brain areas	908-919	ANATOMY	brain	908-913	ANATOMY
27029445_en	AFFECTS	asymptotic post-surgery ischemic strokes	854-894	DISO	brain areas	908-919	ANATOMY
27029445_en	PART_OF	carotid artery	1023-1037	ANATOMY	carotid	1023-1030	ANATOMY
27029445_en	AFFECTS	carotid artery stenosis	1023-1046	DISO	carotid artery	1023-1037	ANATOMY
27029445_en	SUBCLASS_OF	carotid artery stenosis	1023-1046	DISO	stenosis	1038-1046	DISO
27029445_en	HAS_CAUSE	efficacy of pharmacological preconditioning	101-144	FINDING	actovegin	150-159	CHEM
27029445_en	ASSOCIATED_WITH	hemodynamically	285-300	PHYS	lesions of carotid arteries	332-359	DISO
27029445_en	SUBCLASS_OF	computed tomography	641-660	LABPROC	tomography	650-660	LABPROC
27029445_en	SUBCLASS_OF	cerebral perfusion	586-604	PHYS	perfusion	595-604	PHYS
27029445_en	PHYSIOLOGY_OF	cerebral perfusion	586-604	PHYS	cerebral	586-594	ANATOMY
27029445_en	AFFECTS	increased the cerebral perfusion	572-604	FINDING	cerebral	586-594	ANATOMY
27029445_en	FINDING_OF	increased the cerebral perfusion	572-604	FINDING	cerebral perfusion	586-604	PHYS
27029445_en	HAS_CAUSE	increased the cerebral perfusion	572-604	FINDING	actovegin	562-571	CHEM
27029445_en	TO_DETECT_OR_STUDY	one-photon emission computed tomography	621-660	LABPROC	increased the cerebral perfusion	572-604	FINDING
27029445_en	HAS_CAUSE	improved significantly results of the surgery	666-711	FINDING	actovegin	562-571	CHEM
27029445_en	FINDING_OF	significant changes in patient's state	724-762	FINDING	patient's state	747-762	PHYS
27029445_en	HAS_CAUSE	ischemic strokes	878-894	DISO	ischemic	878-886	DISO
27029445_en	ASSOCIATED_WITH	asymptotic post-surgery ischemic strokes	854-894	DISO	improvement was correlated with the less number of asymptotic post-surgery ischemic strokes	803-894	FINDING
27029445_en	HAS_CAUSE	positive role of pharmacological preconditioning	934-982	FINDING	actovegin	988-997	CHEM
27029445_en	SUBCLASS_OF	carotid artery	1023-1037	ANATOMY	artery	1031-1037	ANATOMY
27030096_en	TO_DETECT_OR_STUDY	chemical toxicological analysis	5-36	LABPROC	sertindole	40-50	CHEM
27030096_en	TO_DETECT_OR_STUDY	TLC	1162-1165	LABPROC	sertindole	1129-1139	CHEM
27030096_en	TO_DETECT_OR_STUDY	UV spectrophotometry	1167-1187	LABPROC	sertindole	1129-1139	CHEM
27030096_en	TO_DETECT_OR_STUDY	HPLC	1193-1197	LABPROC	sertindole	1129-1139	CHEM
27030096_en	ORIGINS_FROM	sertindole	1232-1242	CHEM	internal organs	1268-1283	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	1232-1242	CHEM	blood plasma	1285-1297	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	1232-1242	CHEM	urine	1303-1308	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	931-941	CHEM	kidneys	958-965	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	931-941	CHEM	brain	967-972	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	931-941	CHEM	heart	974-979	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	931-941	CHEM	contents gastric	1004-988	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	931-941	CHEM	intestinal contents	993-1012	ANATOMY
27030096_en	TO_DETECT_OR_STUDY	TLC-screening	1419-1432	LABPROC	sertindole	1359-1369	CHEM
27030096_en	TREATED_USING	schizophrenic	135-148	DISO	Sertindole	54-64	CHEM
27030096_en	HAS_CAUSE	intoxication	176-188	DISO	Sertindole	54-64	CHEM
27030096_en	USED_IN	isolation from biological objects	524-557	LABPROC	sertindole extraction from solutions	447-483	LABPROC
27030096_en	USED_IN	detection	559-568	LABPROC	sertindole extraction from solutions	447-483	LABPROC
27030096_en	USED_IN	quantitative determination in the extracts	574-616	LABPROC	sertindole extraction from solutions	447-483	LABPROC
27030096_en	USED_IN	organic solvent	790-805	CHEM	isolation of sertindole from solutions	697-735	LABPROC
27030096_en	USED_IN	electrolyte	814-825	CHEM	isolation of sertindole from solutions	697-735	LABPROC
27030096_en	USED_IN	UV spectrophotometry	896-916	LABPROC	measurements of pH, time and frequency of extraction	827-879	LABPROC
27030096_en	USED_IN	measurements of pH, time and frequency of extraction	827-879	LABPROC	isolation of sertindole from solutions	697-735	LABPROC
27030096_en	APPLIED_TO	Isolation of sertindole	918-941	LABPROC	liver	951-956	ANATOMY
27030096_en	APPLIED_TO	Isolation of sertindole	918-941	LABPROC	kidneys	958-965	ANATOMY
27030096_en	APPLIED_TO	Isolation of sertindole	918-941	LABPROC	brain	967-972	ANATOMY
27030096_en	APPLIED_TO	Isolation of sertindole	918-941	LABPROC	heart	974-979	ANATOMY
27030096_en	APPLIED_TO	Isolation of sertindole	918-941	LABPROC	contents gastric	1004-988	ANATOMY
27030096_en	APPLIED_TO	Isolation of sertindole	918-941	LABPROC	intestinal contents	993-1012	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	931-941	CHEM	liver	951-956	ANATOMY
27030096_en	USED_IN	HPLC techniques	1490-1505	LABPROC	determination of sertindole in the extracts	1533-1576	LABPROC
27030096_en	USED_IN	TLC	1458-1461	LABPROC	determination of sertindole in the extracts	1533-1576	LABPROC
27030096_en	USED_IN	UV spectrophotometric	1463-1484	LABPROC	determination of sertindole in the extracts	1533-1576	LABPROC
27030096_en	ORIGINS_FROM	sertindole	1629-1639	CHEM	liver	1660-1665	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	1629-1639	CHEM	brain	1670-1675	ANATOMY
27030096_en	HAS_CAUSE	acute poisoning	1698-1713	INJURY_POISONING	sertindole	1629-1639	CHEM
27030096_en	ORIGINS_FROM	sertindole	1834-1844	CHEM	intestines	1745-1755	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	1834-1844	CHEM	stomach	1732-1739	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	1834-1844	CHEM	kidneys	1723-1730	ANATOMY
27030096_en	ORIGINS_FROM	sertindole	1872-1882	CHEM	blood plasma	1927-1939	ANATOMY
27030096_en	APPLIED_TO	sertindole extraction	1872-1893	LABPROC	blood plasma	1927-1939	ANATOMY
27030096_en	SUBCLASS_OF	Sertindole	54-64	CHEM	neuroleptic	85-96	CHEM
27030096_en	TO_DETECT_OR_STUDY	sertindole extraction from solutions	447-483	LABPROC	sertindole	447-457	CHEM
27030096_en	USED_IN	sertindole	447-457	CHEM	solutions	474-483	CHEM
27030096_en	ALTERNATIVE_NAME	isolation from the biological materials	278-317	LABPROC	isolation from biological objects	524-557	LABPROC
27030096_en	TO_DETECT_OR_STUDY	quantitative determination in the extracts	574-616	LABPROC	extracts	608-616	CHEM
27030096_en	TO_DETECT_OR_STUDY	detection of intoxication with this medication	163-209	LABPROC	intoxication	176-188	DISO
27030096_en	TO_DETECT_OR_STUDY	detection of intoxication with this medication	163-209	LABPROC	Sertindole	54-64	CHEM
27030096_en	ALTERNATIVE_NAME	detection of intoxication with this medication	163-209	LABPROC	detection	559-568	LABPROC
27030096_en	TO_DETECT_OR_STUDY	isolation of sertindole from solutions	697-735	LABPROC	sertindole	710-720	CHEM
27030096_en	TO_DETECT_OR_STUDY	sertindole extraction from solutions	447-483	LABPROC	solutions	474-483	CHEM
27030096_en	TO_DETECT_OR_STUDY	isolation of sertindole from solutions	697-735	LABPROC	solutions	726-735	CHEM
27030096_en	USED_IN	sertindole	710-720	CHEM	solutions	726-735	CHEM
27030096_en	TO_DETECT_OR_STUDY	isolation from the biological materials	278-317	LABPROC	biological materials	297-317	ANATOMY
27030096_en	SUBCLASS_OF	organic solvent	790-805	CHEM	solvent	798-805	CHEM
27030096_en	TO_DETECT_OR_STUDY	measurements of pH, time and frequency of extraction	827-879	LABPROC	pH	843-845	PHYS
27030096_en	TO_DETECT_OR_STUDY	measurements of pH, time and frequency of extraction	827-879	LABPROC	time and frequency of extraction	847-879	FINDING
27030096_en	USED_IN	sertindole	1129-1139	CHEM	extracts	1147-1155	CHEM
27030096_en	TO_DETECT_OR_STUDY	detection of sertindole in the extracts	1116-1155	LABPROC	sertindole	1129-1139	CHEM
27030096_en	TO_DETECT_OR_STUDY	detection of sertindole in the extracts	1116-1155	LABPROC	extracts	1147-1155	CHEM
27030096_en	USED_IN	TLC	1162-1165	LABPROC	detection of sertindole in the extracts	1116-1155	LABPROC
27030096_en	USED_IN	UV spectrophotometry	1167-1187	LABPROC	detection of sertindole in the extracts	1116-1155	LABPROC
27030096_en	USED_IN	HPLC	1193-1197	LABPROC	detection of sertindole in the extracts	1116-1155	LABPROC
27030096_en	TO_DETECT_OR_STUDY	TLC	1162-1165	LABPROC	extracts	1147-1155	CHEM
27030096_en	TO_DETECT_OR_STUDY	UV spectrophotometry	1167-1187	LABPROC	extracts	1147-1155	CHEM
27030096_en	TO_DETECT_OR_STUDY	HPLC	1193-1197	LABPROC	extracts	1147-1155	CHEM
27030096_en	USED_IN	sertindole	1232-1242	CHEM	extracts	1250-1258	CHEM
27030096_en	SUBCLASS_OF	internal organs	1268-1283	ANATOMY	organs	1277-1283	ANATOMY
27030096_en	ALTERNATIVE_NAME	blood plasma	1285-1297	ANATOMY	plasma	1291-1297	ANATOMY
27030096_en	PART_OF	blood plasma	1285-1297	ANATOMY	blood	1285-1290	ANATOMY
27030096_en	TO_DETECT_OR_STUDY	HPLC	1326-1330	LABPROC	urine	1303-1308	ANATOMY
27030096_en	TO_DETECT_OR_STUDY	HPLC	1326-1330	LABPROC	blood plasma	1285-1297	ANATOMY
27030096_en	TO_DETECT_OR_STUDY	HPLC	1326-1330	LABPROC	internal organs	1268-1283	ANATOMY
27030096_en	TO_DETECT_OR_STUDY	HPLC	1326-1330	LABPROC	sertindole	1232-1242	CHEM
27030096_en	TO_DETECT_OR_STUDY	HPLC	1326-1330	LABPROC	extracts	1250-1258	CHEM
27030096_en	ALTERNATIVE_NAME	TLC	1162-1165	LABPROC	TLC-screening	1419-1432	LABPROC
27030096_en	TO_DETECT_OR_STUDY	TLC-screening	1419-1432	LABPROC	extracts	1390-1398	CHEM
27030096_en	USED_IN	TLC-screening	1419-1432	LABPROC	sertindole liberation from the extracts	1359-1398	LABPROC
27030096_en	TO_DETECT_OR_STUDY	sertindole liberation from the extracts	1359-1398	LABPROC	sertindole	1359-1369	CHEM
27030096_en	TO_DETECT_OR_STUDY	sertindole liberation from the extracts	1359-1398	LABPROC	extracts	1390-1398	CHEM
27030096_en	ALTERNATIVE_NAME	HPLC	1326-1330	LABPROC	HPLC techniques	1490-1505	LABPROC
27030096_en	TO_DETECT_OR_STUDY	determination of sertindole in the extracts	1533-1576	LABPROC	sertindole	1550-1560	CHEM
27030096_en	TO_DETECT_OR_STUDY	determination of sertindole in the extracts	1533-1576	LABPROC	extracts	1568-1576	CHEM
27030096_en	TO_DETECT_OR_STUDY	TLC	1458-1461	LABPROC	sertindole	1550-1560	CHEM
27030096_en	TO_DETECT_OR_STUDY	TLC	1458-1461	LABPROC	extracts	1568-1576	CHEM
27030096_en	TO_DETECT_OR_STUDY	UV spectrophotometric	1463-1484	LABPROC	sertindole	1550-1560	CHEM
27030096_en	TO_DETECT_OR_STUDY	UV spectrophotometric	1463-1484	LABPROC	extracts	1568-1576	CHEM
27030096_en	TO_DETECT_OR_STUDY	HPLC techniques	1490-1505	LABPROC	sertindole	1550-1560	CHEM
27030096_en	TO_DETECT_OR_STUDY	HPLC techniques	1490-1505	LABPROC	extracts	1568-1576	CHEM
27030096_en	SUBCLASS_OF	acute poisoning	1698-1713	INJURY_POISONING	poisoning	1704-1713	INJURY_POISONING
27030096_en	AFFECTS	maximum amounts of sertindole	1610-1639	FINDING	liver	1660-1665	ANATOMY
27030096_en	AFFECTS	maximum amounts of sertindole	1610-1639	FINDING	brain	1670-1675	ANATOMY
27030096_en	AFFECTS	accumulated in smaller quantities	1760-1793	FINDING	kidneys	1723-1730	ANATOMY
27030096_en	AFFECTS	accumulated in smaller quantities	1760-1793	FINDING	stomach	1732-1739	ANATOMY
27030096_en	AFFECTS	accumulated in smaller quantities	1760-1793	FINDING	intestines	1745-1755	ANATOMY
27030096_en	HAS_CAUSE	accumulated in smaller quantities	1760-1793	FINDING	sertindole	1834-1844	CHEM
27030096_en	HAS_CAUSE	did not contain sertindole	1818-1844	FINDING	sertindole	1834-1844	CHEM
27030096_en	AFFECTS	did not contain sertindole	1818-1844	FINDING	heart	1812-1817	ANATOMY
27030096_en	ALTERNATIVE_NAME	blood plasma	1927-1939	ANATOMY	plasma	1933-1939	ANATOMY
27030096_en	PART_OF	blood plasma	1927-1939	ANATOMY	blood	1927-1932	ANATOMY
27030096_en	TO_DETECT_OR_STUDY	sertindole extraction	1872-1893	LABPROC	sertindole	1872-1882	CHEM
27030096_en	ORIGINS_FROM	Maximum efficiency of the sertindole extraction	1846-1893	FINDING	sertindole extraction	1872-1893	LABPROC
27030096_en	AFFECTS	Maximum efficiency of the sertindole extraction	1846-1893	FINDING	blood plasma	1927-1939	ANATOMY
27030096_en	SUBCLASS_OF	UV spectrophotometry	896-916	LABPROC	spectrophotometry	899-916	LABPROC
27030096_en	SUBCLASS_OF	UV spectrophotometric	1463-1484	LABPROC	spectrophotometric	1466-1484	LABPROC
27030332_en	ABBREVIATION	protease inhibitors	199-218	CHEM	PIs	220-223	CHEM
27030332_en	ABBREVIATION	chronic hepatitis C	225-244	DISO	CHC	246-249	DISO
27030332_en	USED_IN	boceprevir	736-746	CHEM	PIs	731-734	CHEM
27030332_en	USED_IN	telaprevir	754-764	CHEM	PIs	731-734	CHEM
27030332_en	USED_IN	simeprevir	776-786	CHEM	PIs	731-734	CHEM
27030332_en	SUBCLASS_OF	chronic hepatitis C	88-107	DISO	hepatitis C	96-107	DISO
27030332_en	TREATED_USING	chronic hepatitis C	88-107	DISO	protease inhibitors	15-34	CHEM
27030332_en	HAS_CAUSE	reducing drug susceptibility	1034-1062	FINDING	mutations	988-997	PHYS
27030332_en	SUBCLASS_OF	protease inhibitors	15-34	CHEM	inhibitors	24-34	CHEM
27030332_en	SUBCLASS_OF	hepatitis C	96-107	DISO	hepatitis	96-105	DISO
27030332_en	HAS_CAUSE	Resistance to protease inhibitors	1-34	FINDING	protease inhibitors	15-34	CHEM
27030332_en	SUBCLASS_OF	protease inhibitors	199-218	CHEM	inhibitors	208-218	CHEM
27030332_en	SUBCLASS_OF	chronic hepatitis C	225-244	DISO	hepatitis C	233-244	DISO
27030332_en	SUBCLASS_OF	hepatitis C	233-244	DISO	hepatitis	233-242	DISO
27030332_en	SUBCLASS_OF	hepatitis C virus (HCV) infection	428-461	DISO	infection	452-461	DISO
27030332_en	SUBCLASS_OF	hepatitis C virus (HCV) infection	428-461	DISO	hepatitis C	428-439	DISO
27030332_en	SUBCLASS_OF	hepatitis C	428-439	DISO	hepatitis	428-437	DISO
27030332_en	SUBCLASS_OF	liver cirrhosis	523-538	DISO	cirrhosis	529-538	DISO
27030332_en	AFFECTS	liver cirrhosis	523-538	DISO	liver	523-528	ANATOMY
27030332_en	TREATED_USING	liver cirrhosis	523-538	DISO	peginterferon	578-591	CHEM
27030332_en	TREATED_USING	liver cirrhosis	523-538	DISO	ribavirin	612-621	CHEM
27030332_en	HAS_CAUSE	ineffectively treated	551-572	FINDING	peginterferon	578-591	CHEM
27030332_en	HAS_CAUSE	ineffectively treated	551-572	FINDING	ribavirin	612-621	CHEM
27030332_en	ASSOCIATED_WITH	liver cirrhosis	523-538	DISO	ineffectively treated	551-572	FINDING
27030332_en	HAS_CAUSE	insulin resistance	663-681	DISO	insulin	663-670	CHEM
27030332_en	HAS_CAUSE	failed to achieve a sustained virologic response	810-858	FINDING	sustained virologic response	830-858	FINDING
27030332_en	SUBCLASS_OF	interferon-α	1135-1147	CHEM	interferon	1135-1145	CHEM
